Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016417	p-amylp	U/l (u/l)	34913	87179	0.00%
3016417	p-amylp	— (—)	12094	21378	100.00%	Distribution not available
3016417	p-amylp	U/l_______ (u/l)	2148	4025	0.00%
3016417	s-amylp	U/l (u/l)	248	275	0.00%
3016417	pa-amyl	U/l (u/l)	85	181	0.00%
3016417	s-amylp	— (—)	61	66	100.00%	Distribution not available
3016417	-amylp	U/l (u/l)	50	79	0.00%	Distribution not available
3016417	-amylp	— (—)	13	14	100.00%	Distribution not available
3016417	pa-amyl	— (—)	9	13	100.00%	Distribution not available
3016417	p-amylp	U/L (u/l)	9	15	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Bleeding

6618

28206

1.74

323.31

3.5

2.4

50.40

48.98

u/l

0.06

5685

23809

Noninfective enteritis and colitis

3977

21290

2.02

321.45

3.4

2.5

61.69

45.40

u/l

0.35

3477

18065

Aplastic and other anaemias

3918

19065

2.04

320.45

3.6

2.5

39.30

49.35

u/l

1.13

3364

16037

Malignant neoplasm of pancreas, including Hilmo

978

2740

4.43

318.24

7.4

2.2

96.35

39.11

u/l

0.97

857

2272

Complications of medical and surgical care

6002

32474

1.77

318.01

3.3

2.5

71.69

44.32

u/l

1.10

5114

27532

Viral hepatitis, IBD co-morbidity

707

1558

5.74

315.54

3.3

2.4

30.91

44.51

u/l

2.77

621

1366

Hypertensive diseases (excluding secondary)

4032

12209

2.05

315.27

3.7

2.2

50.20

40.73

u/l

0.37

3438

10448

1443

5112

3.28

315.04

3.6

2.3

33.46

47.84

u/l

0.86

1238

4315

Inflammatory bowel disease treatment related agents

8949

32234

1.61

314.61

3.0

2.5

47.54

45.90

u/l

0.10

7756

27227

Alcohol use disorder, ICD-based

3487

18051

2.10

313.95

3.6

2.6

42.14

51.29

u/l

0.80

2948

15427

Other and unspecified anaemias

3647

17940

2.08

313.40

3.4

2.4

37.24

50.00

u/l

1.71

3130

15091

Other anaemias

3670

18063

2.07

311.89

3.4

2.4

37.21

49.90

u/l

1.71

3147

15189

Psychiatric diseases

7350

22730

1.70

310.80

2.8

2.4

44.12

53.25

u/l

0.54

6215

19381

Recurrent or chronic depression

3192

10812

2.20

310.13

2.9

2.5

37.22

42.90

u/l

1.28

2700

9319

Asthma

6072

17560

1.89

307.65

2.7

2.4

34.12

53.61

u/l

2.76

5128

14949

Hypertension, essential

5932

19449

1.83

307.65

3.3

2.4

46.78

49.33

u/l

0.10

5037

16654

Human immunodeficiency virus [HIV] disease, including avohilmo

510

602

25.48

307.65

2.6

3.1

27.74

119.79

u/l

0.63

504

524

Renal failure

4362

17958

2.28

307.65

4.3

2.5

56.39

49.01

u/l

0.27

3831

15133

Any mental disorder

8658

25773

1.77

307.65

2.9

2.4

41.82

51.91

u/l

0.75

7323

21942

Unspecified privation

1291

4125

3.90

307.65

3.3

2.6

63.11

49.87

u/l

0.19

1119

3491

Other anxiety disorders

4552

17502

2.44

307.65

3.1

2.5

43.41

42.97

u/l

0.01

3897

14979

All anxiety disorders

5780

22312

2.19

307.65

3.0

2.5

42.54

42.78

u/l

0.01

4931

19042

Mood [affective] disorders

8948

32272

1.90

307.65

3.0

2.5

40.98

50.23

u/l

0.76

7545

27511

Acute renal failure

2153

8991

2.74

307.65

4.1

2.4

67.82

46.29

u/l

0.45

1875

7581

Transplanted organ and tissue status

1363

3687

4.96

307.65

7.3

2.5

50.82

52.54

u/l

0.04

1246

3141

Diarrhoea and gastroenteritis of presumed infectious origin

6603

29983

2.13

307.65

3.5

2.4

42.54

47.13

u/l

0.41

5689

25382

Codes for special purposes

4661

24892

2.01

307.65

3.4

2.5

36.60

46.60

u/l

1.83

3944

21138

Asthma, unspecified (mode), excluding more controls

4367

15661

2.15

307.65

2.8

2.4

36.00

52.75

u/l

1.79

3659

13331

Provisional assignment of new diseases of uncertain etiology

4660

24871

2.01

307.65

3.4

2.5

36.61

46.61

u/l

1.83

3943

21120

Bacterial infection, other or unspecified, including avohilmo

6205

21336

2.69

307.65

3.8

2.3

50.85

42.93

u/l

0.42

5320

18003

Anaemias

2275

3513

4.76

307.65

4.2

1.8

42.05

42.78

u/l

0.06

1995

3022

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

9372

31419

2.06

307.65

3.1

2.4

41.07

50.89

u/l

1.20

8006

26634

Condition for Implicit Sepsis (Organ dysfunction codes)

7223

28048

1.91

307.65

3.3

2.4

47.88

46.57

u/l

0.06

6174

23760

Bacterial Sepsis

4487

17031

2.41

307.65

3.6

2.4

49.72

44.86

u/l

0.18

3833

14369

Diverticular disease of intestine

6632

18666

2.43

307.65

2.8

2.4

44.71

56.28

u/l

0.72

5661

15702

Use of hypnotics and sedatives

8432

30302

1.67

307.65

2.9

2.5

39.06

51.16

u/l

1.85

7180

25779

Certain infectious and parasitic diseases

8078

21097

2.04

307.65

3.0

2.2

45.01

48.62

u/l

0.19

6921

17789

Cholecystectomy

7451

27569

2.58

307.65

3.6

2.3

59.01

45.84

u/l

0.56

6509

23168

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

7676

28759

1.92

307.65

3.2

2.4

42.60

46.53

u/l

0.23

6563

24382

Other disorders of urethra and urinary system

5696

22187

1.90

307.65

2.9

2.4

35.07

47.18

u/l

2.03

4775

18779

Exposure to unspecified factor

9357

34262

2.00

307.65

2.9

2.5

39.01

50.21

u/l

1.77

7993

29069

Substance abuse

4979

24682

2.02

307.65

3.5

2.5

54.14

46.36

u/l

0.30

4214

21121

Low back pain

6407

25465

1.80

307.65

2.9

2.5

43.94

46.02

u/l

0.12

5430

21744

Complications of procedures, not elsewhere classified

6767

32217

1.80

307.65

3.3

2.4

77.13

43.30

u/l

1.66

5754

27344

Pain in limb

7534

25188

2.05

307.65

3.0

2.5

42.06

43.26

u/l

0.10

6398

21452

Septicaemia

3741

16312

2.29

307.65

4.1

2.3

75.93

44.11

u/l

0.79

3228

13766

Malaise and fatigue

5408

17101

2.79

307.65

3.4

2.2

38.30

54.53

u/l

1.28

4621

14357

Metabolic disorders

8298

26458

2.02

307.65

3.2

2.4

37.59

49.15

u/l

1.75

7062

22501

All kidney diseases

9190

31317

2.13

307.65

3.4

2.3

49.96

46.86

u/l

0.17

7950

26428

Codeine or tramadol medication

9317

30319

1.76

307.65

2.9

2.5

43.73

49.89

u/l

0.43

7842

25852

Malignant neoplasm, including Hilmo

6852

23209

1.82

307.65

3.0

2.4

39.33

43.13

u/l

0.70

5938

19570

Colorectal adenocarcinoma

2072

7162

3.34

307.65

2.4

2.3

36.44

49.44

u/l

0.99

1846

5991

Colorectal cancer

2467

8515

3.23

307.65

2.5

2.3

35.74

47.15

u/l

1.05

2217

7127

Other medical care

4190

17984

2.13

307.65

3.5

2.3

41.86

47.05

u/l

0.48

3626

15178

Explicit Sepsis

3888

17366

2.23

307.65

4.0

2.4

74.33

44.37

u/l

0.76

3351

14660

Pure hypercholesterolaemia

6498

21826

2.04

307.65

2.8

2.5

38.46

51.66

u/l

1.60

5486

18526

All pneumoniae

8678

32520

1.84

307.65

3.1

2.4

49.33

47.62

u/l

0.07

7384

27630

Malignant neoplasm of digestive organs, including Hilmo

4933

12731

3.34

307.65

3.9

2.4

61.80

46.28

u/l

0.48

4386

10647

Explicit Sepsis, including avohilmo

4004

17708

2.24

307.65

4.0

2.4

73.25

44.18

u/l

0.76

3443

14948

First line medication for Crohn's disease

9266

28656

1.84

307.65

3.4

2.3

37.23

46.65

u/l

2.10

8045

24164

Persons encountering health services for specific procedures, not carried out

1528

3142

7.12

307.65

4.5

2.3

90.37

55.39

u/l

0.33

1341

2668

Pain in joint

4797

12194

2.62

307.65

2.7

2.2

40.37

48.52

u/l

0.47

4049

10243

Implicit viral Sepsis, including avohilmo

2881

12764

2.52

307.65

3.7

2.3

53.44

43.07

u/l

0.27

2477

10777

Any event in cancer register

7045

24979

1.74

307.65

3.0

2.4

38.82

43.30

u/l

0.96

6100

21069

Artificial opening status

942

1994

7.36

307.65

3.4

2.4

30.23

63.29

u/l

0.75

894

1665

Depression or dysthymia

5238

15344

1.98

307.65

2.9

2.5

44.47

55.77

u/l

0.46

4400

13184

Complications of surgical and medical care, not elsewhere classified

8328

33250

1.77

307.65

3.2

2.4

70.18

43.16

u/l

1.59

7077

28236

Gastrointestinal diseases

4848

8320

3.17

307.65

2.9

1.5

49.46

31.61

u/l

1.15

4169

6877

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3784

19312

2.11

307.65

3.6

2.6

54.61

48.11

u/l

0.19

3192

16539

Examination and observation for other reasons

6920

14464

3.07

307.65

3.3

2.3

52.47

49.02

u/l

0.11

5890

12363

Other bacterial diseases, including avohilmo

9337

29922

2.10

307.65

3.6

2.3

52.17

46.89

u/l

0.22

7973

25408

Other soft tissue disorders, not elsewhere classified

8140

25699

1.92

307.65

3.0

2.5

54.04

44.24

u/l

0.42

6911

21903

Pain (limb, back, neck, head abdominally)

5882

12515

2.53

307.65

2.9

2.1

43.90

48.43

u/l

0.17

5009

10489

Primary Sclerosing Cholangitis, IBD and UDCA required

512

613

18.34

307.65

8.5

1.9

39.72

29.98

u/l

5.87

494

514

Intestinal stricture

3215

13210

2.80

307.65

3.8

2.4

38.83

50.75

u/l

1.04

2844

11140

Persons encountering health services in other circumstances, wide

9879

28221

1.92

307.65

3.1

2.4

37.28

52.24

u/l

2.51

8466

23877

Persons encountering health services for other counselling and medical advice, not elsewhere classified

10252

28093

2.09

307.65

3.1

2.4

40.15

52.21

u/l

1.37

8803

23772

Pneumonias (Asthma/COPD co-morbidities)

8627

32474

1.85

307.65

3.1

2.4

49.50

47.61

u/l

0.07

7336

27582

Mood disorders

8959

32293

1.89

307.65

3.0

2.5

40.96

50.22

u/l

0.76

7553

27525

Constipation

7772

29238

1.93

307.65

3.0

2.5

33.62

52.56

u/l

4.22

6618

24745

Renal tubulo-interstitial diseases

8034

30474

2.09

307.65

3.6

2.4

52.36

47.35

u/l

0.26

6931

25715

Special screening examination for infectious and parasitic diseases

2485

7038

2.86

307.65

2.5

2.3

34.91

45.54

u/l

1.57

2166

6060

Mood disorders, excluding more controls

8264

25414

2.05

307.65

3.0

2.4

41.38

51.83

u/l

0.76

6966

21657

Other or unspecified ileus, impaction or obstruction

1971

6488

3.57

307.65

4.0

2.3

38.54

61.31

u/l

1.02

1749

5435

Pain in throat and chest

7928

22789

2.23

307.65

3.0

2.5

34.41

55.70

u/l

3.44

6816

19399

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2672

4399

3.27

307.65

2.7

1.8

54.77

71.91

u/l

0.28

2285

3633

Headache

5612

22377

2.08

307.65

3.0

2.2

43.52

51.79

u/l

0.42

4802

18895

Asthma (mode)

5899

17674

1.85

307.65

2.7

2.4

33.95

53.64

u/l

2.84

4967

15052

Intestinal infectious diseases, including avohilmo, including avohilmo

10520

30855

2.04

307.65

3.1

2.4

45.04

49.74

u/l

0.32

8980

26153

Symptoms and signs involving the circulatory and respiratory systems

7827

23264

1.77

307.65

2.9

2.4

34.54

55.59

u/l

3.51

6687

19790

Other bacterial diseases

8943

29291

2.20

307.65

3.6

2.3

54.37

47.01

u/l

0.32

7663

24810

ILD medications

9154

30210

1.72

307.65

3.3

2.3

38.82

46.28

u/l

1.37

7924

25511

Other diseases of intestines

9763

26480

2.22

307.65

3.0

2.4

37.01

51.56

u/l

2.30

8456

22364

Chronic pancreatitis

1604

4146

5.04

307.65

8.4

1.9

177.08

32.28

u/l

1.87

1378

3526

Solid cancers

6513

22271

1.82

307.65

3.0

2.4

38.42

43.30

u/l

0.97

5649

18789

Influenza and pneumonia

8937

32172

1.82

307.65

3.1

2.4

44.95

47.99

u/l

0.14

7614

27323

Caries of dentine

2155

8321

2.82

307.65

4.7

2.4

60.40

51.82

u/l

0.14

1882

7144

Implicit bacterial Sepsis, including avohilmo

4384

16543

2.45

307.65

3.7

2.4

48.78

45.00

u/l

0.13

3752

13970

Chronic gastritis

2526

10790

2.65

307.65

3.2

2.3

33.54

48.42

u/l

1.45

2139

9076

Other diseases of biliary tract

1193

2923

5.44

307.65

8.9

1.8

88.85

33.71

u/l

1.22

1094

2423

Symptoms and signs involving cognition, perception, emotional state and behaviour

7786

32234

1.70

307.65

2.8

2.5

36.60

50.08

u/l

2.49

6559

27451

Pain, not elsewhere classified

2718

11078

2.75

307.65

3.6

2.2

48.93

52.91

u/l

0.11

2348

9327

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8636

32333

1.93

307.65

3.3

2.4

43.28

49.21

u/l

0.52

7416

27399

Dental caries

2525

9282

2.91

307.65

4.6

2.4

56.89

53.83

u/l

0.05

2200

7964

Ascites

879

2086

5.36

307.65

4.2

1.9

38.14

43.25

u/l

0.61

790

1719

GI-bleeding

2856

13546

2.33

307.65

3.8

2.4

46.72

48.95

u/l

0.10

2511

11421

Malignant neoplasm, wide definition

6868

23231

1.82

307.65

3.0

2.4

39.38

43.11

u/l

0.68

5951

19587

Implicit Sepsis, including avohilmo

7247

27700

2.01

307.65

3.3

2.4

46.89

46.72

u/l

0.01

6189

23468

Nausea and vomiting

2867

8346

3.89

307.65

4.1

1.9

54.33

40.16

u/l

0.49

2521

6832

Abdominal and pelvic pain

10045

18286

3.06

307.65

3.2

2.0

53.17

46.86

u/l

0.27

8720

15125

Pneumonia, organism unspecified

7761

30499

1.86

307.65

3.2

2.4

51.41

48.46

u/l

0.10

6582

25926

ILD medications: prednisolone, methylprednisolone, prednisone

8970

29801

1.77

307.65

3.3

2.3

43.21

46.51

u/l

0.28

7746

25161

Bacterial infection, other or unspecified

5753

19905

2.77

307.65

3.9

2.3

52.08

43.22

u/l

0.44

4943

16785

L04AD Calcineurin inhibitors

1419

4136

4.48

307.65

7.1

2.5

40.60

50.30

u/l

0.39

1308

3522

Diseases of oesophagus, stomach and duodenum

9658

30138

2.04

307.65

3.3

2.4

44.70

48.95

u/l

0.28

8287

25564

Oxycodone

3726

13134

2.71

307.65

4.0

2.1

53.00

53.31

u/l

0.01

3209

11123

Cystitis

6794

23284

1.84

307.65

2.8

2.4

44.81

47.99

u/l

0.11

5774

19733

Asthma, excluding more controls

5846

16437

1.94

307.65

2.7

2.4

33.94

54.62

u/l

2.75

4937

14014

Anxiety disorders, excluding more controls

7295

23976

2.10

307.65

3.0

2.4

41.33

52.60

u/l

0.74

6190

20428

Infections, IBD-co-morbidities

1560

3551

3.51

307.65

4.3

2.4

37.95

44.84

u/l

0.86

1346

3086

Selective serotonin reuptake inhibitors

7729

24572

1.72

307.65

2.7

2.5

46.79

51.73

u/l

0.24

6513

21007

Malignant neoplasm

6647

22721

1.82

307.65

3.0

2.4

38.99

43.19

u/l

0.79

5768

19154

Diaphragmatic hernia

3338

15575

2.40

307.65

3.0

2.4

59.48

44.71

u/l

0.60

2853

13107

Diseases of the digestive system

3937

20548

2.07

307.65

3.9

2.4

44.97

46.23

u/l

0.08

3411

17322

ILD medications: immunosuppressive drugs

5248

27406

1.85

307.65

3.9

2.4

41.60

47.14

u/l

0.66

4626

23176

Intestinal infectious diseases

8515

34677

1.96

307.65

3.4

2.4

41.34

49.59

u/l

0.97

7327

29359

Implicit Sepsis

6887

25916

2.13

307.65

3.4

2.3

47.61

47.06

u/l

0.02

5886

21912

Other diseases of the digestive system

2893

13596

2.36

307.65

3.8

2.4

46.66

48.88

u/l

0.10

2546

11449

Other diseases of urinary system

7679

26413

1.72

307.65

2.8

2.5

44.71

50.02

u/l

0.22

6492

22447

Malignant neoplasm of rectum, including Hilmo

1449

4038

4.52

307.65

2.2

2.3

32.87

51.18

u/l

0.87

1304

3368

Other septicaemia, including avohilmo

3414

15180

2.32

307.65

4.2

2.3

79.45

42.08

u/l

0.88

2960

12825

7659

24639

1.94

307.65

3.1

2.4

45.36

50.94

u/l

0.23

6505

20925

Other diseases of pancreas

1037

2800

4.80

307.65

7.3

1.8

328.11

32.43

u/l

1.92

928

2341

Abnormalities of breathing

6912

23210

1.79

307.65

2.9

2.4

34.54

55.65

u/l

3.49

5895

19743

Cholelithiasis

8518

24634

2.63

307.65

3.5

1.9

51.48

33.86

u/l

1.11

7424

20589

Cholangitis (primary sclerosing, PSC)

928

1984

6.56

307.65

8.7

1.8

43.34

32.43

u/l

2.69

877

1658

Acute tubulo-interstitial nephritis

5246

24493

1.94

307.65

3.3

2.3

45.81

47.59

u/l

0.08

4453

20611

Parasetamol

5545

15543

1.90

307.65

2.9

2.3

49.06

43.49

u/l

0.25

4710

13346

General symptoms and signs

9202

23947

2.06

307.65

3.2

2.2

35.45

51.66

u/l

2.64

7929

20234

All chronic kidney diseases

4673

19128

2.11

307.65

4.1

2.4

44.74

45.83

u/l

0.07

4118

16040

Acute pancreatitis

2385

6900

4.27

307.65

6.8

1.9

187.57

33.45

u/l

4.97

2175

5816

Malignant neoplasm of digestive organs

4404

11927

3.31

307.65

3.9

2.3

48.54

46.42

u/l

0.09

3937

9980

Other functional intestinal disorders

3950

16851

2.32

307.65

3.3

2.3

38.61

54.42

u/l

1.07

3400

14129

Tramadol

8353

19539

2.88

307.65

3.6

2.2

46.92

48.53

u/l

0.05

7141

16639

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

8418

32616

1.83

307.65

3.1

2.5

49.99

47.56

u/l

0.09

7151

27716

Fever of other and unknown origin

5269

20523

2.44

307.65

3.9

2.2

51.04

52.78

u/l

0.06

4606

17283

Depression medications

2156

3841

3.04

307.65

2.8

1.8

59.77

50.09

u/l

0.16

1819

3315

5155

23286

2.15

307.65

3.7

2.5

76.04

41.27

u/l

1.34

4402

19882

Codeine

7803

21277

2.12

307.65

2.9

2.1

42.34

49.45

u/l

0.45

6574

18120

Malignant neoplasm of rectum

1191

3258

4.64

307.65

2.1

2.2

32.19

39.95

u/l

2.62

1086

2706

Certain infectious and parasitic diseases, including avohilmo

5553

13836

2.14

307.65

2.8

2.1

45.29

49.85

u/l

0.17

4703

11698

Malignant neoplasm

6656

22740

1.82

307.65

3.0

2.4

38.99

43.18

u/l

0.79

5776

19172

Colorectal cancer, including Hilmo

2768

9342

3.21

307.65

2.5

2.3

35.93

46.59

u/l

1.09

2472

7814

Nephropathy related operations

1516

4651

4.18

307.65

6.9

2.5

47.22

49.77

u/l

0.08

1387

3972

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2346

10018

2.54

307.65

3.1

2.4

35.82

42.15

u/l

1.04

1993

8589

Neurotic, stress-related and somatoform disorders

7810

29968

1.92

307.65

3.0

2.5

40.77

49.78

u/l

0.64

6643

25509

Opioids

8652

21565

2.23

307.65

3.2

2.1

41.78

49.22

u/l

0.54

7371

18366

Cholelithiasis, broad definition with cholecystitis

8919

25008

2.65

307.65

3.5

1.9

50.90

33.82

u/l

1.13

7766

20904

Benzodiazepine use

8417

34302

1.75

307.65

2.9

2.5

38.61

50.49

u/l

2.06

7070

29239

Human immunodeficiency virus [HIV] disease resulting in other conditions

503

537

36.69

307.65

2.6

3.2

27.83

130.20

u/l

0.62

497

470

Dialysis, with operation codes

1594

4707

4.35

307.65

6.5

2.5

48.08

39.12

u/l

0.89

1448

4016

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

504

541

36.18

307.65

2.6

3.2

27.80

129.56

u/l

0.62

498

473

Implicit bacterial Sepsis

3981

15338

2.48

307.65

3.7

2.4

50.38

45.27

u/l

0.16

3410

12958

Other septicaemia

3316

14860

2.31

307.65

4.2

2.3

80.79

42.16

u/l

0.89

2880

12550

Diseases of liver

3686

15125

2.81

307.65

4.0

2.5

73.74

45.68

u/l

0.55

3228

12814

Paralytic ileus and intestinal obstruction

2775

9485

3.41

307.65

3.8

2.3

37.32

57.61

u/l

1.45

2441

7954

Substance abuse, excluding more controls

4979

19655

2.31

307.65

3.5

2.5

54.14

49.87

u/l

0.14

4214

16804

Human immunodeficiency virus [HIV] disease

507

590

26.50

307.65

2.6

3.2

27.79

121.19

u/l

0.62

501

516

Hernia of abdominal wall, postoperative

1810

4286

4.90

307.65

3.7

1.5

47.74

36.08

u/l

0.94

1594

3513

Alcohol use disorder, Swedish definition

4945

22139

2.22

307.65

3.8

2.5

79.04

41.43

u/l

1.41

4214

18911

Asthma, unspecified (mode)

4507

16731

2.09

307.65

2.7

2.4

36.06

51.86

u/l

1.80

3783

14220

Anxiety (asthma-related co-morbidities)

5671

20192

2.33

307.65

3.1

2.4

42.73

42.92

u/l

0.01

4841

17259

Personality disorders, excluding more controls

2311

9185

2.80

307.65

3.1

2.4

38.18

42.39

u/l

0.37

1949

7880

Persons encountering health services for specific procedures and health care

9772

30350

2.04

307.65

3.5

2.3

45.44

48.81

u/l

0.16

8349

25742

Covid-19 confirmed case

3445

16486

2.32

307.65

3.6

2.5

38.29

47.87

u/l

1.01

2864

13952

Disorders of gallbladder, biliary tract and pancreas

11582

26953

3.06

307.65

4.2

1.9

75.41

34.53

u/l

5.38

10169

22573

Other antidepressants

8214

24489

1.81

307.65

2.9

2.5

43.17

51.80

u/l

0.56

6946

20936

GASTRO-related operations

7645

11388

3.74

307.65

3.1

1.5

45.66

33.41

u/l

1.28

6605

9295

Any gastric operation

7645

11388

3.74

307.65

3.1

1.5

45.66

33.41

u/l

1.28

6605

9295

Symptoms and signs involving the digestive system and abdomen

9786

18288

2.96

307.65

3.2

2.0

49.05

46.86

u/l

0.08

8505

15125

Mental and behavioural disorders due to alcohol

4281

21763

2.02

307.65

3.5

2.6

51.80

46.25

u/l

0.19

3621

18618

Heart failure, not strict

5948

23160

1.85

307.65

3.8

2.4

53.37

49.54

u/l

0.11

5044

19655

Anxiety disorders

7875

30156

1.92

307.65

3.0

2.5

40.68

49.74

u/l

0.66

6698

25656

Other diseases of intestine

1554

5569

3.25

307.65

3.3

2.3

55.28

52.43

u/l

0.06

1364

4707

Benign neoplasm of colon, rectum, anus and anal canal

5311

25406

1.90

307.65

2.9

2.5

49.20

51.48

u/l

0.10

4521

21440

Adenocarcinoma and papilloma adenocarcinoma of rectum

1187

3210

4.71

307.65

2.1

2.2

32.32

55.37

u/l

0.87

1079

2666

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1220

3339

4.63

307.65

2.2

32.28

54.29

u/l

0.86

1111

2780

Solid cancers, including Hilmo

6721

22821

1.82

307.65

3.0

2.4

38.82

43.20

u/l

0.85

5821

19246

Acute pancreatitis (for exclusion)

2385

8068

3.60

307.65

6.8

2.4

187.57

33.21

u/l

4.98

2175

6839

Depression

8372

31277

1.91

307.65

3.0

2.5

41.04

50.55

u/l

0.73

7073

26670

5348

23903

2.11

307.65

3.7

2.5

75.58

42.34

u/l

1.31

4560

20429

Mental and behavioural disorders due to psychoactive substance use

5091

25162

2.00

307.65

3.4

2.5

53.61

46.69

u/l

0.26

4313

21519

Disorders of lipoprotein metabolism and other lipidaemias

7058

23137

1.99

307.65

2.9

2.5

38.49

50.93

u/l

1.59

6002

19657

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7659

24639

1.94

307.65

3.1

2.4

45.36

50.94

u/l

0.23

6505

20925

Intestinal adhesions without obstruction

1009

2789

4.53

307.65

3.8

2.3

38.94

58.87

u/l

0.58

912

2355

Adjustment and management of implanted device

1718

6748

2.92

307.05

2.8

2.3

37.13

47.72

u/l

0.79

1424

5671

Lower back pain or/and sciatica

8516

34424

1.61

305.25

2.9

2.5

48.60

47.85

u/l

0.04

7208

29285

Fall on same level

8903

30939

1.60

304.72

2.9

2.5

37.37

51.00

u/l

2.55

7501

26398

Oedema, not elsewhere classified

2714

12629

2.29

303.91

3.4

2.2

36.94

51.31

u/l

1.01

2319

10580

Neoplasms

5631

17117

1.81

302.85

3.0

2.3

36.66

44.40

u/l

1.39

4887

14481

Colectomy operation

1698

6743

2.95

301.10

3.5

2.5

40.52

45.99

u/l

0.33

1523

5686

Dorsalgia

7754

26008

1.66

300.95

2.9

2.5

39.07

46.92

u/l

1.16

6572

22196

Kidney transplant status

743

1832

5.71

298.27

9.8

2.6

59.52

68.19

u/l

0.11

690

1571

Medical observation and evaluation for suspected diseases and conditions

5045

14563

1.87

295.23

3.0

2.3

35.31

49.16

u/l

1.54

4292

12441

Erysipelas, including avohilmo

5645

25014

1.77

294.89

3.1

2.3

51.65

47.63

u/l

0.11

4741

21203

Care involving dialysis

921

2643

4.41

291.55

7.6

2.4

51.83

59.33

u/l

0.15

824

2255

Asthma (only as main-diagnosis), excluding more controls

5168

16437

1.83

289.64

2.7

2.4

33.98

54.62

u/l

2.73

4363

14014

Dyspnoea

7084

32631

1.65

284.27

3.0

2.5

40.23

49.86

u/l

1.06

6048

27637

Any death

5072

20887

1.83

283.41

3.5

2.4

41.66

56.39

u/l

1.50

4433

17534

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1497

5762

3.07

283.25

4.7

2.6

37.00

47.20

u/l

0.62

1326

4934

Need for other prophylactic measures

786

2097

5.08

281.81

3.7

2.6

37.85

64.09

u/l

0.60

678

1793

Asthma, hospital admission 2, infections

4819

27746

1.80

277.36

2.9

2.5

35.01

46.51

u/l

2.27

4078

23554

Asthma-related infections

4819

27746

1.80

277.36

2.9

2.5

35.01

46.51

u/l

2.27

4078

23554

Hypertensive diseases

5845

19937

1.74

276.27

3.4

2.4

47.45

48.92

u/l

0.05

4974

17056

Asthma (only as main-diagnosis)

5334

17560

1.79

276.14

2.7

2.4

33.94

53.61

u/l

2.80

4504

14949

Hypertension

5839

19927

1.74

275.26

3.4

2.4

47.47

48.93

u/l

0.05

4968

17048

Urinary track infection

4547

12742

1.90

275.12

2.7

2.2

34.67

47.37

u/l

1.16

3853

10673

Follow-up examination after treatment for conditions other than malignant neoplasms

3562

12558

2.02

273.79

2.8

2.3

57.52

47.73

u/l

0.19

2971

10708

Cholangitis (primary sclerosing, PSC), with reimbursement 202

396

621

12.60

272.89

7.3

2.5

40.70

110.35

u/l

0.42

385

516

Hernia

7185

30769

1.63

271.66

2.9

2.5

54.86

47.29

u/l

0.29

6185

26067

Asthma (diagnoses ohter than nonallergic)

6861

35647

1.63

270.70

2.7

2.5

34.85

49.61

u/l

3.42

5774

30288

Viral Sepsis

1919

8387

2.57

270.63

4.0

2.4

40.02

39.56

u/l

0.03

1654

7079

Implicit viral Sepsis

1916

8374

2.57

270.20

4.0

2.4

40.03

38.97

u/l

0.08

1653

7068

Care involving use of rehabilitation procedures

4893

26217

1.78

267.87

2.9

2.3

39.55

49.02

u/l

1.05

4124

22177

Other diseases of liver

1759

7472

2.70

267.75

3.4

2.4

38.86

38.25

u/l

0.07

1525

6330

Gastro-oesophageal reflux disease

5228

26692

1.75

267.17

2.9

2.4

36.46

49.71

u/l

2.04

4398

22602

Other pulmonary diagnosis

5841

17718

1.73

265.92

2.8

2.4

39.09

53.41

u/l

1.39

4929

15080

Benign neoplasm: Colon

4355

23798

1.84

265.24

2.9

2.5

52.53

52.16

u/l

0.01

3704

20104

Excluding asthma or asthma-COPD overlap

5833

17718

1.73

264.17

2.8

2.4

39.39

53.41

u/l

1.34

4922

15080

Cardiovascular diseases (excluding rheumatic etc)

4709

15538

1.83

263.68

3.4

2.2

46.76

42.36

u/l

0.17

4060

13266

Colitis, primary sclerosing

337

466

17.00

263.45

7.1

2.3

39.44

137.76

u/l

0.46

329

388

Other disorders of fluid, electrolyte and acid-base balance

2584

12014

2.21

262.72

4.1

2.4

44.86

52.49

u/l

0.28

2195

10129

Nonorganic sleeping disorders, excluding more controls

1766

7503

2.61

262.59

2.8

2.4

31.76

39.65

u/l

6.02

1521

6406

Irritable bowel syndrome

2251

10579

2.33

262.51

2.9

2.3

32.81

45.06

u/l

1.97

1923

8919

Functional dyspepsia

2343

11243

2.30

261.38

3.4

2.3

41.61

41.17

u/l

0.02

2022

9475

Other reaction to severe stress, and adjustment disorders

2955

15336

2.08

261.27

3.0

2.5

48.93

41.59

u/l

0.19

2503

13118

Malignant neoplasm of pancreas

790

2191

4.48

261.02

7.4

2.2

106.66

40.66

u/l

0.88

694

1799

COPD differential diagnosis

5806

17675

1.72

260.82

2.8

2.4

39.02

53.64

u/l

1.43

4900

15053

ILD differential diagnosis

5804

17674

1.72

260.38

2.8

2.4

39.02

53.64

u/l

1.43

4899

15052

Other headache syndromes

3514

19304

1.95

259.30

3.0

2.5

38.00

51.29

u/l

1.10

3007

16390

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4857

28739

1.76

259.06

3.3

2.5

76.72

44.30

u/l

1.07

4114

24348

Poisoning by drugs, medicaments and biological substances

2116

9835

2.39

256.93

3.5

2.6

35.13

44.36

u/l

0.95

1807

8382

Chronic kidney disease

2635

12747

2.17

256.52

4.9

2.5

47.12

45.12

u/l

0.11

2336

10725

COPD/asthma related infections

7553

24639

1.60

255.65

2.9

2.4

44.35

50.94

u/l

0.28

6399

20925

COPD/asthma/ILD related infections

7553

24639

1.60

255.65

2.9

2.4

44.35

50.94

u/l

0.28

6399

20925

Oral corticosteroids

8044

31400

1.57

254.98

2.9

2.5

42.09

46.03

u/l

0.35

6936

26525

Endocrine, nutritional and metabolic diseases

5829

18031

1.71

253.20

3.0

2.2

43.65

43.88

u/l

0.01

4897

15578

Dysphagia

1830

8052

2.48

248.80

3.1

1.9

33.70

39.99

u/l

3.81

1570

6622

Convulsions, not elsewhere classified

1919

8512

2.43

248.78

3.4

2.2

35.96

56.55

u/l

1.29

1634

7195

Other bacterial intestinal infections, including avohilmo

2061

9609

2.38

247.87

3.5

2.4

42.51

43.83

u/l

0.06

1772

8125

Diseases of arteries, arterioles and capillaries (FINNGEN)

1945

5889

2.50

247.63

3.7

2.3

44.52

44.78

u/l

0.02

1640

5040

Erysipelas

4254

21481

1.81

246.98

3.1

2.3

56.31

45.22

u/l

0.28

3591

18175

Poisoning by medicine

1940

8856

2.44

246.76

3.5

2.6

34.76

45.05

u/l

0.98

1660

7571

Personality disorders

2311

11282

2.25

246.16

3.1

2.6

38.18

44.11

u/l

0.43

1949

9656

Obesity, other/unspecified

2879

15231

2.05

243.45

2.6

2.5

57.53

40.43

u/l

0.48

2390

13060

Panic disorder

1357

5310

2.88

242.18

3.3

2.4

71.50

39.25

u/l

0.44

1149

4557

Other/unspecified dorsalgia

3080

16449

1.99

240.72

3.1

2.5

38.50

48.80

u/l

0.97

2560

13989

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

274

334

23.99

240.52

2.7

3.3

29.10

189.04

u/l

0.57

269

283

Cardiovascular diseases

4399

13479

1.82

240.50

3.1

2.1

49.94

42.12

u/l

0.31

3787

11489

Disorders of adult personality and behaviour

2404

12041

2.18

238.29

3.0

2.6

36.02

43.36

u/l

0.67

2017

10305

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1951

8750

2.39

237.60

3.6

2.3

48.98

46.88

u/l

0.08

1729

7338

Asthma, hospital admissions 3, pneumonia

3004

16158

2.00

237.57

3.0

2.5

37.09

51.52

u/l

1.45

2531

13685

Asthma-related pneumonia or sepsis

3004

16158

2.00

237.57

3.0

2.5

37.09

51.52

u/l

1.45

2531

13685

Autoimmune diseases related-to ILD

6528

35745

1.60

237.44

3.0

2.5

46.89

48.51

u/l

0.08

5628

30278

Dizziness and giddiness

5716

28233

1.66

237.10

2.8

2.5

37.24

50.80

u/l

1.97

4814

23981

Asthma-related pneumonia

2997

16123

2.00

236.93

3.0

2.5

37.11

51.55

u/l

1.45

2527

13657

Heartburn

978

3259

3.42

235.22

3.4

1.9

36.67

40.54

u/l

0.59

846

2695

Other heart diseases

3459

12352

1.93

234.94

3.3

2.2

37.31

40.52

u/l

0.68

2960

10540

Other dorsopathies, not elsewhere classified

7530

26055

1.56

231.53

2.8

2.5

34.25

46.89

u/l

3.19

6374

22235

Hypothyroidism (congenital or acquired)

1629

3663

2.65

230.37

2.6

1.8

34.28

42.59

u/l

2.27

1367

3156

Any reimbursement code in KELA

4159

11983

1.82

227.01

3.0

1.9

48.54

46.65

u/l

0.06

3560

10209

Unspecified human immunodeficiency virus [HIV] disease

257

311

24.08

226.75

2.7

3.3

29.25

46.68

u/l

0.65

252

262

Other external causes of accidental injury

5846

18463

1.65

226.56

2.7

2.4

47.22

48.97

u/l

0.07

4958

15695

Hypothyroidism and >3 levothyroxin purchases

1615

3651

2.64

226.49

2.6

1.8

34.13

42.67

u/l

2.35

1353

3145

Hypothyroidism, levothyroxine purchases

1615

3651

2.64

226.49

2.6

1.8

34.13

42.67

u/l

2.35

1353

3145

Alcohol dependence

2187

10791

2.22

226.38

3.8

2.6

40.89

48.26

u/l

0.43

1862

9241

Malignant neoplasm of colon, including Hilmo

1532

6562

2.60

223.06

2.7

2.3

39.58

42.32

u/l

0.24

1359

5478

Preparatory care for dialysis

589

1537

5.36

219.70

7.5

2.5

56.67

70.03

u/l

0.15

523

1297

Benign neoplasm of other and ill-defined parts of digestive system

1635

7343

2.54

219.58

3.6

2.5

75.77

46.55

u/l

0.92

1404

6194

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4442

27296

1.72

219.39

3.3

2.5

74.97

43.05

u/l

0.95

3760

23124

Mucosal proctocolitis

1248

4965

2.90

218.81

3.8

2.6

39.33

47.95

u/l

0.42

1133

4223

Bronchitis

8223

34076

1.50

217.82

3.0

2.5

38.25

50.46

u/l

1.44

7028

28888

Injuries to the head

8383

34491

1.50

217.15

2.9

2.5

48.32

47.94

u/l

0.01

7088

29323

Behavioural syndromes associated with physiological disturbances and physical factors

7137

32640

1.54

216.93

2.8

2.6

36.05

49.91

u/l

2.92

6090

27732

Unspecified jaundice

529

1255

5.23

214.86

6.9

1.9

42.21

46.09

u/l

0.26

483

1017

Other noninfective gastroenteritis and colitis

2105

10453

2.21

213.98

3.4

2.5

80.18

42.12

u/l

0.46

1816

8820

Alcohol abuse, main dg, excluding more controls

1267

5091

2.79

213.91

4.0

2.6

36.32

44.91

u/l

1.03

1089

4396

Syncope and collapse

3269

15396

1.88

213.74

3.0

2.2

34.48

50.63

u/l

2.19

2775

12938

L04AA Selective immunosuppressants

1959

9525

2.29

213.50

5.6

2.5

41.66

45.54

u/l

0.30

1758

8082

Heart failure and antihypertensive medication

1903

5699

2.37

212.59

3.3

2.4

36.04

57.74

u/l

0.81

1614

4922

Need for immunization against other single viral diseases

350

626

9.80

209.91

3.6

2.7

30.70

117.49

u/l

0.59

330

533

Specific personality disorders

1971

9636

2.25

209.20

3.0

2.6

36.63

44.80

u/l

0.59

1665

8249

Accidents

5756

18463

1.63

208.88

2.7

2.4

46.22

48.97

u/l

0.11

4889

15695

Symptoms and signs involving the urinary system

5716

28190

1.60

207.87

3.0

2.5

47.99

49.38

u/l

0.04

4890

23844

Other viral hepatitis, including avohilmo

753

2364

3.94

207.06

3.3

2.8

31.51

62.14

u/l

0.89

662

2052

Cholecystitis

1196

4758

2.83

206.65

4.2

1.8

54.20

33.04

u/l

1.10

1039

3970

Bacterial pneumonia, not elsewhere classified

2996

14698

1.91

206.44

3.0

2.4

36.08

46.16

u/l

1.35

2563

12435

Other symptoms and signs involving cognitive functions and awareness

3613

18896

1.80

206.43

2.7

2.5

40.42

49.53

u/l

0.56

3020

15997

Viral hepatitis, including avohilmo

831

2769

3.65

206.25

3.2

2.7

31.79

58.30

u/l

0.91

729

2394

Ulcer of lower limb, not elsewhere classified

1362

5821

2.68

204.88

3.8

2.5

35.47

47.93

u/l

0.83

1124

4944

3521

20633

1.80

203.57

3.0

2.6

34.22

43.19

u/l

1.68

2998

17562

Haemorrhage from respiratory passages

2597

12331

1.99

203.18

2.9

2.4

39.92

56.24

u/l

1.37

2235

10425

Infections of the skin and subcutaneous tissue

4520

28011

1.67

202.24

3.5

2.5

52.53

45.55

u/l

0.18

3815

23910

Falls/tendency to fall

7759

26728

1.51

202.12

2.9

2.5

43.64

51.01

u/l

0.45

6569

22819

Emotionally unstable personality disorder

1152

4574

2.87

201.42

2.9

2.4

39.91

48.66

u/l

0.29

969

3907

Bacterial pneumoniae

3115

15572

1.87

201.13

3.0

2.4

36.28

45.71

u/l

1.31

2659

13189

Other diseases of anus and rectum

2249

11593

2.08

200.46

2.9

2.3

39.23

53.56

u/l

0.98

1932

9729

Soft tissue disorders

7401

25894

1.52

200.20

2.8

2.5

43.97

44.27

u/l

0.01

6299

22060

Sleep disorders

6816

32000

1.53

199.16

2.7

2.6

36.62

50.18

u/l

2.67

5809

27195

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

659

1933

4.13

199.03

6.2

2.2

44.71

40.76

u/l

0.35

593

1588

Substance use, excluding alcohol

1689

7960

2.35

197.83

3.7

2.5

74.46

41.21

u/l

0.53

1452

6813

Other viral hepatitis

710

2214

3.98

197.53

3.3

2.7

31.25

63.48

u/l

0.88

625

1924

Generalized anxiety disorder

1385

5991

2.55

197.13

2.8

2.4

41.52

39.27

u/l

0.12

1175

5141

Speech therapy

2165

11226

2.12

196.46

2.9

2.5

39.76

43.60

u/l

0.21

1847

9482

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2346

12439

2.04

196.45

3.1

2.6

35.82

43.31

u/l

0.83

1993

10620

Nutritional anaemias

3803

22124

1.74

193.33

3.2

2.5

44.72

46.18

u/l

0.07

3244

18647

8295

29572

1.47

192.68

2.8

2.5

37.66

51.27

u/l

2.15

7036

25102

Viral hepatitis

782

2618

3.64

192.63

3.2

2.7

31.58

59.82

u/l

0.92

688

2261

Mycoses, including avohilmo

6894

36219

1.51

192.27

2.8

2.6

46.13

48.27

u/l

0.12

5866

30785

Venous thromboembolism

4041

24166

1.71

191.94

3.0

2.5

45.06

46.39

u/l

0.06

3456

20406

Chronic apical periodontitis

8199

32458

1.47

191.06

2.9

2.5

42.44

47.08

u/l

0.31

6934

27629

Conjunctivitis (acute, non atopic), including avohilmo

7425

31172

1.49

190.78

2.7

2.6

41.64

50.31

u/l

0.72

6352

26494

Alcoholic liver disease

966

3652

3.11

189.03

4.8

2.5

38.03

40.73

u/l

0.31

852

3124

Inflammatory bowel disease

2525

13886

1.96

188.95

3.5

2.6

41.53

43.14

u/l

0.15

2248

11804

888

3201

3.22

188.09

2.4

2.3

30.66

35.45

u/l

2.20

749

2713

Other specific joint derangements/joint disorders

5587

22970

1.58

187.67

2.7

2.5

40.44

45.87

u/l

0.53

4718

19588

Bipolar affective disorders

1521

7026

2.38

186.23

2.9

2.5

35.29

41.60

u/l

0.99

1281

6064

Suicide or other Intentional self-harm

1987

10160

2.14

186.21

3.3

2.6

37.00

44.95

u/l

0.69

1681

8668

Insomnia

6679

31986

1.51

186.11

2.8

2.6

37.07

50.15

u/l

2.50

5695

27182

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7240

31861

1.49

185.78

3.5

2.4

51.71

45.85

u/l

0.23

6283

26949

Caries of enamel

7095

32267

1.50

185.78

2.8

2.6

41.23

49.69

u/l

1.05

6029

27468

Myalgia

1978

10091

2.13

185.75

3.2

2.4

57.60

40.36

u/l

0.33

1698

8585

Chronic viral hepatitis

609

1803

4.26

184.37

3.2

2.7

31.24

68.63

u/l

0.82

531

1578

Alcohol-induced chronic pancreatitis

696

2248

3.87

183.82

8.2

2.5

288.28

40.34

u/l

1.36

611

1953

Autoimmune diseases excluding thyroid diseases

7680

29221

1.48

182.84

3.4

2.4

47.74

49.70

u/l

0.11

6603

24896

Antihypertensive medication - note that there are other indications

4253

13688

1.69

182.54

3.0

2.3

47.91

47.75

u/l

0.00

3604

11800

Ulcerative colitis

1994

10319

2.11

180.41

3.6

2.6

42.66

45.09

u/l

0.17

1786

8758

Budesonide

1301

5746

2.55

180.02

3.1

2.4

41.13

46.95

u/l

0.28

1141

4850

Unspecified kidney failure

979

3807

2.97

179.63

3.9

2.4

38.94

39.66

u/l

0.11

848

3194

Fibrosis and cirrhosis of liver

809

2878

3.41

179.48

4.1

2.4

34.96

39.38

u/l

1.05

723

2450

Autoimmune diseases excluding thyroid diseases, strict definition

7448

28384

1.48

179.28

3.4

2.4

48.47

50.02

u/l

0.08

6408

24196

Asthma, including avohilmo

8614

34130

1.44

178.92

2.6

38.38

50.26

u/l

1.65

7257

29066

Total colectomy

525

1449

4.80

178.84

3.7

2.6

45.22

73.23

u/l

0.40

489

1230

Total colectomy operation

525

1449

4.80

178.84

3.7

2.6

45.22

73.23

u/l

0.40

489

1230

Diseases of the skin and subcutaneous tissue

7089

24673

1.49

176.49

2.8

2.4

46.88

49.68

u/l

0.10

5995

21034

Gout

2189

10007

2.03

176.19

3.1

2.6

48.76

51.72

u/l

0.11

1895

8502

Other gastritis (incl. Duodenitis)

1760

8809

2.18

175.08

3.7

2.3

36.83

48.13

u/l

0.74

1521

7422

Conjunctivitis

5677

30991

1.54

175.03

2.6

45.49

48.56

u/l

0.16

4844

26284

Heart failure,strict

3766

16204

1.72

174.78

2.9

2.5

41.63

47.73

u/l

0.50

3173

13714

Benign neoplasms

6988

26444

1.49

174.70

2.9

2.5

38.55

46.45

u/l

1.25

5977

22466

Gout, idiopatic and unspecified

1939

10079

2.10

173.83

3.1

2.6

50.54

53.61

u/l

0.10

1676

8535

Other nutritional deficiencies

5006

30405

1.58

173.62

2.7

2.6

49.26

47.83

u/l

0.05

4136

25933

Migraine

3840

18594

1.69

173.60

2.7

2.5

39.05

43.38

u/l

0.31

3308

15797

Malignant neoplasm of colon

1230

5373

2.55

173.05

2.8

2.2

39.31

39.14

u/l

0.02

1091

4473

Alcohol-induced acute pancreatitis

467

1219

5.21

172.84

9.3

2.6

109.38

81.47

u/l

0.31

421

1046

Iron deficiency anaemia

3277

19475

1.75

172.50

3.1

2.5

46.28

46.11

u/l

0.01

2802

16420

Schizophrenia or delusion, excluding more controls

2128

11211

2.00

172.12

2.7

2.5

32.18

43.77

u/l

2.69

1805

9637

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1411

6559

2.39

171.95

3.5

2.6

34.74

45.60

u/l

0.76

1211

5622

Other CVD (FINNGEN)

974

2835

2.95

171.92

3.6

2.2

37.47

40.68

u/l

0.49

836

2421

Appendectomy

4764

29940

1.59

171.70

2.7

2.6

37.88

46.92

u/l

1.58

4094

25467

Other and unspecified iron deficiency

2682

15410

1.86

171.68

3.1

2.4

48.64

47.69

u/l

0.03

2290

12968

Chronic rhinitis, nasopharyngitis and pharyngitis

2574

14642

1.89

171.60

2.7

2.6

34.23

40.28

u/l

3.85

2177

12485

Disorders of conjunctiva

6192

33170

1.51

171.53

2.6

47.08

48.06

u/l

0.05

5275

28145

Other bacterial intestinal infections

1496

7125

2.32

170.53

4.0

2.4

46.89

45.39

u/l

0.05

1298

5994

Other heart diseases, wide

6554

27524

1.50

169.86

3.0

2.5

36.43

50.23

u/l

2.33

5559

23501

Genitourinary diseases

3848

11768

1.71

169.68

3.1

2.4

48.77

47.72

u/l

0.03

3326

10032

Cerebrovascular diseases (FINNGEN)

2200

8218

2.00

167.61

3.3

2.2

41.95

43.53

u/l

0.15

1872

7030

Gingivitis and periodontal diseases

7036

25483

1.48

166.88

2.7

2.5

38.16

52.68

u/l

2.12

5886

21752

Abnormal findings on examination of blood, without diagnosis

3443

19218

1.72

166.83

3.4

2.6

59.87

46.02

u/l

0.37

2957

16282

Dorsopathies

7314

26129

1.47

166.62

2.8

2.5

35.36

46.83

u/l

2.66

6192

22294

Superficial injury of head

1969

10462

2.04

163.56

3.1

2.5

35.17

44.52

u/l

0.99

1645

8880

External causes of morbidity and mortality

4523

14529

1.62

163.13

2.6

2.3

48.95

40.27

u/l

0.38

3828

12349

Type 2 diabetes, wide definition

5581

23936

1.53

162.53

3.0

2.3

31.31

41.40

u/l

1.83

4552

20460

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

4111

25503

1.62

162.23

2.5

37.55

48.14

u/l

1.67

3502

21636

Sciatica+with lumbago

3831

21557

1.65

162.15

3.0

2.5

49.74

47.16

u/l

0.10

3243

18383

Bacterial pneumonia (organism specified)

3268

18133

1.72

161.72

3.1

2.5

36.24

48.98

u/l

1.52

2793

15337

Any operation in hilmo

263

134

10.80

160.80

2.4

1.1

31.08

32.41

u/l

0.25

217

112

Factors influencing health status and contact with health services

1949

4897

2.10

160.51

2.8

2.1

63.92

43.55

u/l

0.39

1666

4160

Episodal and paroxysmal disorders

7794

28403

1.44

160.34

2.7

2.6

36.72

49.36

u/l

2.16

6650

24177

Chronic lower respiratory diseases

8625

33245

1.41

160.15

2.7

2.6

37.64

50.82

u/l

2.01

7289

28295

Gout, FINNGEN

2189

12058

1.94

159.23

3.1

2.6

48.76

51.25

u/l

0.09

1895

10244

IBD patients in KELA-register

1824

9577

2.07

157.96

3.6

2.5

42.31

44.43

u/l

0.14

1636

8134

Cardiac arrhythmias

4200

17336

1.62

157.62

2.8

2.3

36.05

49.74

u/l

1.72

3583

14934

Other and unspecified mood [affective] disorders

681

2336

3.38

157.42

3.0

2.4

27.77

37.35

u/l

4.14

577

1998

Symptoms and signs involving the skin and subcutaneous tissue

5278

34220

1.52

156.63

2.9

2.5

47.79

46.71

u/l

0.04

4510

28998

5-aminosalicylic acid

1704

8785

2.11

155.51

3.4

2.5

40.46

47.13

u/l

0.51

1518

7450

Nonorganic sleeping disorders

1766

9233

2.08

155.22

2.8

2.6

31.76

42.87

u/l

1.43

1521

7846

Cutaneous abscess, furuncle and carbuncle

2067

11360

1.96

155.10

3.8

2.5

34.27

43.77

u/l

1.32

1750

9692

ILD medications: azathioprine

1230

5637

2.42

154.82

3.8

2.3

50.73

47.43

u/l

0.09

1106

4764

Exposure to other specified factors

5887

35402

1.48

154.45

2.9

2.6

41.68

49.49

u/l

0.78

5035

30076

Injuries to the thorax

3422

21533

1.68

154.34

3.2

2.6

37.26

46.04

u/l

1.21

2922

18280

Abnormalities of heart beat

2560

14454

1.82

154.28

3.0

2.4

34.05

56.70

u/l

2.06

2164

12202

Obesity and other hyperalimentation

4674

29547

1.56

154.28

2.7

2.6

50.69

48.14

u/l

0.08

3840

25214

Disturbances of skin sensation

2179

12197

1.92

154.02

2.9

2.5

32.58

44.43

u/l

2.11

1883

10392

Obesity

4649

29440

1.56

153.28

2.7

2.6

50.79

45.32

u/l

0.20

3822

25126

Persistent mood disorders

1525

7604

2.19

153.24

3.0

2.4

35.60

41.62

u/l

1.09

1285

6463

Diseases of arteries, arterioles and capillaries

4717

23169

1.56

153.18

3.3

2.5

60.41

46.63

u/l

0.42

3997

19618

Gout, unspecified

1594

8114

2.16

152.26

3.2

2.6

45.19

55.30

u/l

0.39

1385

6852

COPD (mode)

2161

9295

1.93

151.74

3.0

2.4

45.69

49.89

u/l

0.13

1820

7880

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1406

6844

2.25

151.12

3.5

2.3

39.70

49.18

u/l

0.52

1247

5720

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

676

2374

3.34

150.93

3.6

2.8

26.25

40.15

u/l

5.19

583

2071

Allergic conjunctivitis

4231

26957

1.58

150.87

2.5

2.6

37.70

47.38

u/l

1.57

3607

22864

Memory loss

847

3375

2.94

149.68

2.6

2.5

34.74

42.01

u/l

1.02

700

2824

Acute upper respiratory infections of multiple and unspecified sites

5598

28364

1.49

149.55

3.1

2.5

33.78

47.85

u/l

4.02

4822

24083

Polyarthropathies

4840

20903

1.55

149.25

3.0

2.5

41.00

45.17

u/l

0.45

4118

17774

Noninfectious colitis NAS

1187

5462

2.43

148.91

3.7

2.4

38.35

46.62

u/l

0.43

1022

4585

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

500

1482

4.06

148.56

6.3

2.3

42.09

38.89

u/l

0.27

453

1209

Progressive vascular leukoencephalopathy

471

1367

4.45

148.22

2.4

32.19

39.46

u/l

2.33

395

1120

Inflammatory bowel disease, strict (require KELA)

1824

9791

2.02

147.83

3.6

2.6

42.31

44.63

u/l

0.16

1636

8332

Injuries to the abdomen, lower back, lumbar spine and pelvis

3068

18743

1.71

147.50

3.1

2.5

64.60

44.28

u/l

0.41

2609

15866

Hernia of abdominal wall

3320

21032

1.67

146.62

3.1

2.6

41.62

49.65

u/l

0.70

2881

17839

Other inflammation of eyelid, including avohilmo

3374

21433

1.66

146.35

2.5

2.6

37.32

43.66

u/l

1.42

2867

18209

Intracranial trauma

4125

18204

1.59

146.19

2.9

2.5

70.09

47.92

u/l

0.44

3485

15574

Sleep disorders (combined)

7826

29901

1.41

145.83

2.6

38.36

49.20

u/l

1.42

6609

25481

Cirrhosis of liver, NAS

588

1975

3.70

145.64

4.1

2.5

32.75

64.48

u/l

0.71

523

1671

Unspecified fall

3785

24242

1.61

145.22

3.0

2.5

38.39

46.29

u/l

1.16

3197

20552

Hypothyroidism, drug reimbursement

867

2310

2.81

145.18

2.5

1.8

40.07

44.13

u/l

0.37

735

1983

Other acute lower respiratory infections

3905

24390

1.60

145.08

3.1

2.5

42.18

45.95

u/l

0.16

3319

20714

Acute bronchitis

3033

18458

1.70

144.50

3.1

2.5

33.59

46.56

u/l

2.01

2573

15609

Atrial fibrillation and flutter

2117

7506

1.93

144.05

3.0

2.2

38.36

43.95

u/l

0.81

1804

6426

Cough

2862

16315

1.72

143.12

2.7

2.4

40.24

57.32

u/l

1.16

2423

13808

Gastroduodenal ulcer

1850

10014

1.97

142.94

3.6

2.4

80.38

46.88

u/l

0.59

1599

8438

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4755

28293

1.53

142.83

3.0

2.5

48.50

50.75

u/l

0.09

4106

23864

Heart failure, strict

4074

18636

1.60

142.79

2.9

2.6

41.14

51.79

u/l

0.93

3427

15772

Unspecified haematuria

3007

15105

1.71

142.75

2.9

2.6

40.30

47.86

u/l

0.65

2603

12822

Disorders of eyelid, lacrimal system and orbit

6214

32517

1.45

142.72

2.7

2.6

38.71

49.54

u/l

1.62

5262

27590

Continuous positive airway pressure

1343

5372

2.25

142.64

3.2

2.3

36.35

59.95

u/l

2.01

1126

4650

Azathioprine

1230

5828

2.34

142.58

3.8

2.5

50.73

47.15

u/l

0.10

1106

4931

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2942

11203

1.73

142.44

3.3

2.2

33.17

41.28

u/l

3.83

2545

9566

Mental and behavioural disorders due to sedatives or hypnotics

674

2465

3.24

140.83

3.9

2.6

31.72

39.99

u/l

1.54

571

2122

Nonalcoholic fatty liver disease

940

4043

2.67

140.22

3.1

2.6

35.16

52.10

u/l

0.80

819

3467

Chronic periodontitis, complicated

4061

26456

1.57

139.72

3.0

2.6

39.31

53.18

u/l

1.98

3446

22473

Ventral hernia

1822

9956

1.98

139.62

3.3

2.5

47.42

46.61

u/l

0.03

1595

8438

DVT of lower extremities and pulmonary embolism

3017

18813

1.69

139.58

3.0

2.5

46.70

48.38

u/l

0.06

2573

15872

Adenocarcinoma and ductal carcinoma of pancreas

398

1068

4.73

138.98

9.3

2.2

150.56

41.10

u/l

0.70

353

866

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

479

1444

3.99

138.84

5.1

2.3

35.00

39.24

u/l

0.53

423

1180

Assault

1118

5157

2.40

138.61

3.6

2.7

34.77

48.46

u/l

0.84

961

4455

Oesophageal varices

474

1446

4.20

138.31

5.3

2.5

32.34

76.69

u/l

0.73

427

1218

Problems related to lifestyle

874

3629

2.69

137.88

3.9

2.4

29.55

53.46

u/l

1.14

735

3094

Hypokalaemia

1007

4461

2.52

137.88

4.0

2.4

38.65

50.48

u/l

0.49

860

3763

Persons encountering health services for examination and investigation

4391

14566

1.57

137.66

2.8

2.3

48.51

49.17

u/l

0.02

3730

12442

Diseases of the respiratory system

4422

14702

1.56

137.16

2.6

2.4

46.30

52.23

u/l

0.19

3735

12470

Other diseases of hard tissues of teeth

3862

12913

1.61

137.13

2.7

2.4

37.80

51.51

u/l

1.48

3254

11021

Extracorporeal dialysis

612

2170

3.43

137.06

7.0

2.6

57.15

62.17

u/l

0.07

554

1847

Neurological diseases, wide definition

1991

5359

1.96

135.74

2.7

2.3

59.93

48.07

u/l

0.20

1679

4661

Migraine with aura

1892

10513

1.92

135.63

2.8

2.5

33.11

44.42

u/l

1.71

1640

8917

Alcohol abuse, main dg

1267

6211

2.25

134.53

4.0

2.7

36.32

49.66

u/l

0.88

1089

5328

Diseases of pulp and periapical tissues, including avohilmo

7281

27581

1.41

134.12

2.8

2.4

42.68

48.49

u/l

0.35

6153

23477

Bacterial intestinal infections, IBD co-morbidities

1469

7593

2.12

134.06

4.0

2.5

47.94

44.64

u/l

0.11

1273

6409

All-cause Heart Failure

3975

18349

1.58

134.05

2.9

2.6

41.33

50.71

u/l

0.77

3340

15533

Neurological diseases

5958

21188

1.46

132.58

2.7

2.5

43.05

47.26

u/l

0.20

5064

18101

Other and unspecified effects of external causes

2078

11975

1.86

132.57

2.8

2.6

67.61

42.58

u/l

0.33

1760

10173

Periodontitis

7010

32856

1.41

131.75

2.9

2.5

46.72

48.98

u/l

0.14

5932

27962

Chronic periodontitis, including avohilmo

6999

32835

1.41

131.75

2.9

2.5

46.73

49.00

u/l

0.14

5927

27946

Other and unspecified nonorganic psychotic disorders

1504

7875

2.07

131.34

2.7

30.27

46.97

u/l

1.93

1293

6763

Visual disturbances

3537

23340

1.59

129.91

2.9

2.5

45.19

47.25

u/l

0.07

3011

19769

Disorders of thyroid, IBD co-morbidities

1256

4092

2.24

129.44

2.6

2.3

42.56

45.15

u/l

0.21

1065

3556

Asthma, hospital admissions , main diagnosis only

5761

36136

1.43

127.93

2.7

2.6

33.69

49.40

u/l

4.16

4860

30692

Other specified and unspecified personality disorders

795

3297

2.75

127.61

3.3

2.5

29.51

54.13

u/l

1.03

680

2811

Pulmonary heart disease, diseases of pulmonary circulation

2323

13949

1.78

127.60

2.9

2.5

46.53

48.08

u/l

0.05

1980

11782

Early onset COPD, excluding more controls

1400

7206

2.09

126.87

3.3

2.4

50.67

49.43

u/l

0.02

1173

6165

Obesity related asthma

2530

15563

1.73

126.38

2.8

2.6

37.29

48.82

u/l

1.01

2110

13248

Phobic anxiety disorders

1011

4617

2.38

125.84

3.0

2.5

47.93

40.59

u/l

0.32

846

3986

Ulcerative colitis, NAS

1133

5468

2.29

125.45

3.8

2.5

45.24

46.42

u/l

0.04

1018

4643

Diseases of oral cavity, salivary glands and jaws

3849

13036

1.58

125.42

2.6

2.4

51.62

51.61

u/l

0.00

3228

11118

Pulmonary embolism

2158

12782

1.80

125.01

3.0

2.5

45.65

48.91

u/l

0.10

1837

10788

Used for control exclusion in common control thyroid runs

7314

27311

1.39

124.76

3.1

2.4

38.96

46.27

u/l

1.25

6215

23272

Overexertion and strenuous or repetitive movements

878

3854

2.59

124.54

2.7

2.6

58.98

51.57

u/l

0.09

741

3300

Visual disturbances and blindness

3759

25309

1.55

124.40

2.9

2.5

44.32

47.02

u/l

0.10

3191

21419

Injuries to the knee and lower leg

8352

34204

1.36

124.40

2.8

2.5

40.63

49.73

u/l

1.11

7065

29088

Pulmonary heart disease

2158

12811

1.80

123.98

3.0

2.5

45.65

48.86

u/l

0.10

1837

10814

Secondary hypertension

642

2377

3.00

123.83

6.4

2.3

39.08

38.90

u/l

0.03

584

2046

Undetermined asthma, excluding more controls

998

4576

2.38

123.82

2.6

2.3

30.19

52.14

u/l

1.41

830

3886

Atrial fibrillation and flutter with reimbursement

1714

5819

1.98

123.81

2.7

2.3

38.79

44.43

u/l

0.61

1455

4975

Concussion

3528

18006

1.58

123.81

3.0

2.5

61.59

48.12

u/l

0.23

2980

15399

Hyperkinetic disorders, excluding more controls

865

3450

2.52

123.25

2.6

2.3

30.54

38.78

u/l

2.55

738

2979

Migraine without aura

1510

8065

2.01

122.88

2.7

2.4

48.93

43.45

u/l

0.14

1297

6859

Retention of urine

2359

11485

1.76

122.86

3.1

2.5

64.82

49.87

u/l

0.21

2017

9743

Spondylosis

3778

19798

1.56

122.83

2.7

2.5

63.07

48.61

u/l

0.27

3158

16879

Gout, strict definition

1368

7125

2.10

122.38

3.1

2.6

47.52

57.81

u/l

0.33

1179

6024

Other disorders of skin and subcutaneous tissue

5112

30729

1.46

122.31

3.1

2.5

34.46

49.88

u/l

3.34

4262

26101

Acute alcohol intoxication

1826

10370

1.88

122.18

3.7

2.6

35.14

48.48

u/l

1.13

1567

8835

Other inflammatory liver diseases

630

2400

3.10

122.16

4.8

2.4

108.95

39.63

u/l

0.47

558

2041

Acetic acid derivatives and related substances

1889

5349

1.92

122.14

2.6

2.8

35.31

40.16

u/l

0.90

1571

4589

Other disorders of eye and adnexa

1177

5833

2.23

121.66

3.5

2.5

34.32

46.33

u/l

0.76

1001

4932

Acute alcohol intoxication, ICD10

1533

8295

2.00

121.34

3.9

2.6

36.01

47.18

u/l

1.00

1325

7093

Calculus of kidney and ureter

2125

12638

1.79

121.21

2.7

2.6

34.24

51.86

u/l

1.81

1849

10706

Other disorders of veins

3015

19203

1.63

121.16

2.5

35.52

43.69

u/l

2.01

2536

16223

Autoimmune diseases

7704

29366

1.37

120.02

3.2

2.4

38.48

49.67

u/l

1.77

6538

25019

Candidiasis, including avohilmo

2282

13873

1.75

119.76

3.0

2.5

39.12

42.09

u/l

0.23

1942

11749

Injury, poisoning and certain other consequences of external causes

3585

11729

1.59

119.44

2.6

2.3

51.03

40.17

u/l

0.37

3036

9994

Hyperlipidaemia, other/unspecified

2594

14543

1.69

119.37

2.9

2.5

49.58

51.25

u/l

0.04

2190

12303

Mental and behavioural disorders due to use of other stimulants, including caffeine

348

950

4.70

119.32

3.1

2.8

26.04

34.49

u/l

5.46

300

825

Abnormal serum enzyme levels

2103

12071

1.79

119.15

3.0

2.6

54.63

48.89

u/l

0.13

1833

10262

Acute upper respiratory infections

7287

32733

1.37

119.04

2.8

2.5

45.61

49.07

u/l

0.18

6194

27737

Non-selective monoamine reuptake inhibitors

2508

14934

1.70

118.91

3.0

2.4

34.26

52.72

u/l

1.73

2065

12686

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

6386

36794

1.39

118.79

2.7

2.6

44.98

48.38

u/l

0.19

5467

31218

Dialysis

420

1302

4.03

118.56

8.9

2.4

41.70

40.77

u/l

0.08

373

1101

Colon adenocarcinoma

912

4127

2.44

118.01

2.8

2.2

41.94

38.50

u/l

0.33

792

3438

Subjective visual disturbances

1943

11391

1.83

117.43

2.9

2.5

35.79

43.31

u/l

0.88

1660

9628

Adverse effects, not elsewhere classified

1506

8193

1.99

117.27

2.8

2.5

34.29

43.30

u/l

0.85

1278

6934

Spondylopathies

5265

22216

1.45

116.54

2.8

2.5

51.02

47.29

u/l

0.16

4445

18951

Invasive ventilation

659

2630

2.91

115.68

3.4

2.5

41.53

59.07

u/l

0.44

569

2217

STROKE

3785

17220

1.54

115.58

3.0

2.4

42.66

50.82

u/l

0.69

3205

14705

All influenza

1857

10765

1.84

115.32

3.5

2.5

33.45

46.64

u/l

1.93

1607

9168

Injuries to the ankle and foot

5093

31283

1.44

114.93

3.0

2.6

48.30

45.05

u/l

0.12

4281

26718

Undetermined asthma

998

4716

2.31

114.92

2.6

2.3

30.19

51.88

u/l

1.45

830

4002

Urolithiasis

2244

13730

1.74

114.56

2.8

2.6

34.05

51.03

u/l

1.93

1954

11622

Mental and behavioural disorders due to opioids

405

1247

3.97

114.56

3.3

2.7

26.91

34.11

u/l

3.98

347

1071

Infections with a predominantly sexual mode of transmission, including avohilmo

2788

16362

1.64

113.99

2.7

2.6

36.26

44.14

u/l

1.11

2393

14003

KRA_PSY_EATING, excluding more controls

603

2261

2.91

113.42

2.8

2.1

31.91

38.19

u/l

1.28

501

1932

Liquid cancers

1901

10515

1.81

113.22

2.7

2.3

37.85

46.73

u/l

0.88

1622

8803

Hypertensive heart and/or renal disease

1734

7127

1.89

112.49

3.0

2.4

45.56

52.96

u/l

0.24

1450

6079

Dental caries, including avohilmo

4911

17741

1.46

112.41

2.7

2.4

47.61

56.23

u/l

0.32

4122

15137

Benign neoplasm: Colon, unspecified

1851

10853

1.83

112.24

3.0

2.5

59.52

51.25

u/l

0.19

1539

9189

Other intervertebral disc disorders

5550

23985

1.42

112.11

2.7

2.5

46.97

46.79

u/l

0.01

4676

20503

Soft tissue disorders related to use, overuse and pressure

2015

12058

1.78

111.96

2.8

2.5

45.61

42.75

u/l

0.13

1701

10225

Fracture of rib(s), sternum and thoracic spine

2215

13613

1.73

111.16

3.4

2.5

36.51

49.54

u/l

1.23

1907

11577

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1255

6562

2.09

110.72

3.7

2.6

43.19

48.37

u/l

0.26

1131

5596

Outcome of delivery

1228

3774

2.17

110.48

2.1

2.6

36.14

37.89

u/l

0.18

1030

3188

Polyuria

1614

9136

1.90

110.03

2.9

2.5

33.84

45.42

u/l

1.41

1352

7708

Infections with a predominantly sexual mode of transmission

2148

13087

1.73

109.88

2.8

2.6

36.04

42.01

u/l

0.72

1851

11193

Alcohol withdrawal state with delirium

613

2426

2.95

109.82

5.2

2.6

33.58

61.82

u/l

0.82

528

2094

Osteopathies and chondropathies

3971

25263

1.50

109.68

3.3

2.5

37.19

49.49

u/l

1.65

3391

21355

Diseases of pulp and periapical tissues and dental caries

4416

15744

1.49

109.50

2.6

2.4

49.41

53.06

u/l

0.11

3715

13435

Other disorders of kidney and ureter

1046

5196

2.24

108.15

3.9

2.6

57.82

48.91

u/l

0.21

927

4393

Dermatitis and eczema

7770

35266

1.34

108.14

2.8

2.5

37.55

50.23

u/l

2.65

6603

29953

Implicit fungal Sepsis, including avohilmo

644

2623

2.83

108.05

3.6

2.3

35.45

41.04

u/l

0.88

544

2209

Other maltreatment syndromes

347

1011

4.33

107.90

3.9

2.6

38.53

85.72

u/l

0.51

308

877

Other Crohn's disease

612

2441

2.88

106.86

3.6

2.5

40.01

56.08

u/l

0.37

553

2076

Ulcerative colitis (strict definition, require KELA)

1276

6790

2.04

106.69

3.7

2.6

42.96

47.87

u/l

0.25

1147

5791

Fenamates

1071

3533

2.22

106.59

2.5

2.8

68.03

42.62

u/l

0.36

899

3031

Glomerular disorders in diseases classified elsewhere

928

4433

2.34

106.39

7.6

2.5

50.21

49.30

u/l

0.02

797

3768

Non-allergic asthma (mode), excluding more controls

1276

6699

2.01

105.68

2.6

2.3

32.86

52.01

u/l

1.68

1083

5696

Faecal incontinence

656

2710

2.68

104.21

2.7

1.8

36.59

40.44

u/l

0.45

553

2197

Sequelae of external causes of morbidity and mortality

1884

11316

1.78

104.03

3.4

2.5

62.81

42.67

u/l

0.58

1594

9596

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1214

6425

2.07

103.80

2.9

2.5

78.63

39.38

u/l

0.50

1057

5453

Hypo-osmolality and hyponatraemia

1260

6689

2.01

102.63

4.1

2.4

52.73

46.81

u/l

0.11

1062

5644

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1340

7330

1.98

102.63

3.6

2.6

42.65

47.38

u/l

0.26

1200

6255

Other specified and unspecified disorders of eye and adnexa

398

1304

3.76

102.55

3.6

2.5

41.63

38.50

u/l

0.13

334

1098

Intracranial injury

4004

26320

1.47

102.16

2.9

2.5

59.49

48.94

u/l

0.20

3351

22392

Diseases of appendix

5050

33099

1.41

101.99

2.7

2.6

37.72

48.57

u/l

2.21

4319

28170

Cardiomyopathy

1234

6577

2.02

101.79

2.7

2.5

75.95

61.70

u/l

0.20

1052

5651

Heart failure and bmi 25plus

2207

9072

1.71

101.66

2.9

2.6

38.97

60.16

u/l

0.93

1850

7634

Acute appendicitis

4726

31860

1.42

101.63

2.7

2.6

38.04

48.27

u/l

1.92

4039

27114

Appendicitis, broad definition

5007

32912

1.41

101.62

2.7

2.6

37.69

47.94

u/l

2.05

4281

28012

Hypertensive Heart Disease

1559

6661

1.88

101.54

2.9

2.3

45.19

53.53

u/l

0.25

1294

5673

Diseases of the eye and adnexa

5321

19395

1.41

101.21

2.9

2.4

35.50

46.51

u/l

2.66

4510

16643

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6514

31141

1.36

101.21

2.9

2.5

47.75

45.34

u/l

0.08

5587

26401

Mental disorders, not otherwise specified

696

3021

2.60

100.71

3.0

2.5

31.96

54.08

u/l

0.78

597

2575

Abnormalities of gait and mobility

977

4869

2.23

100.21

2.8

2.5

51.39

40.05

u/l

0.51

809

4085

Viral pneumonia

992

4949

2.19

99.91

3.2

2.4

37.45

50.61

u/l

0.67

847

4216

Liquid cancers, including Hilmo

2234

12363

1.67

99.56

2.8

2.3

37.34

45.34

u/l

0.95

1907

10356

Diabetes, varying definitions

6931

30661

1.35

99.50

3.5

2.4

44.27

46.29

u/l

0.10

5676

26387

Autoimmune hepatitis, wide definition

463

1676

3.30

99.27

4.2

2.3

32.92

66.96

u/l

0.63

412

1420

Mixed and other personality disorders

671

2887

2.63

99.21

3.7

2.5

33.54

57.18

u/l

0.80

563

2485

Trochanteric bursitis

1132

5933

2.08

99.21

2.7

2.3

44.14

41.03

u/l

0.10

945

4978

Statin medication

4430

17728

1.45

99.12

3.1

2.5

47.86

48.20

u/l

0.01

3729

15261

Coxibs

1800

5444

1.81

98.76

2.5

2.8

38.39

40.00

u/l

0.19

1503

4670

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1320

7283

1.97

98.73

2.9

2.6

84.86

38.86

u/l

0.66

1147

6189

Diabetes mellitus

6953

30685

1.34

98.61

3.5

2.4

44.42

46.23

u/l

0.08

5685

26412

Symptoms and signs involving speech and voice

2344

15062

1.64

97.80

2.7

2.5

51.17

48.40

u/l

0.06

1988

12729

Disorders resulting from impaired renal tubular function

384

1272

3.76

97.67

5.9

2.5

65.36

79.72

u/l

0.13

345

1063

Crohn disease

998

5041

2.17

97.45

3.6

2.5

41.16

48.34

u/l

0.32

892

4272

Shoulder lesions

4982

21772

1.41

97.31

2.8

2.5

38.49

43.72

u/l

0.82

4177

18567

Benign neoplasm: Rectum, anus and anal canal

1467

8410

1.88

96.63

2.8

2.5

36.31

46.04

u/l

0.89

1246

7090

Non-allergic asthma (mode)

1276

6898

1.95

96.59

2.6

2.3

32.86

51.25

u/l

1.64

1083

5853

Collagenous colitis

782

3638

2.42

96.51

3.2

2.4

150.33

49.90

u/l

0.45

679

3055

Chronic sinusitis

2942

19832

1.55

96.49

2.6

43.42

44.09

u/l

0.03

2449

16899

Open wound of head

3709

24502

1.47

96.49

3.0

2.6

36.92

51.24

u/l

2.71

3125

20884

Caries of dentine, including avohilmo

5222

19555

1.41

96.00

2.7

2.4

46.42

56.23

u/l

0.41

4368

16706

Other arrhythmias

4292

23011

1.44

95.76

2.6

2.5

34.79

52.48

u/l

2.66

3618

19601

Explicit bacterial Sepsis, including avohilmo

827

3917

2.32

95.65

3.5

2.3

39.34

38.99

u/l

0.03

695

3316

Benign neoplasm: Rectum

1334

7468

1.94

95.64

2.8

2.5

34.88

46.07

u/l

0.96

1140

6293

Unspecified mental disorder

2720

18115

1.57

95.21

2.8

2.6

33.85

44.20

u/l

2.18

2274

15501

Gastric ulcer

1219

6614

1.98

94.97

3.7

2.3

99.63

40.32

u/l

0.76

1046

5591

Post-traumatic stress disorder

649

2780

2.57

94.95

3.0

2.3

100.13

38.47

u/l

0.41

564

2375

Somatoform disorder

1170

6277

2.01

94.87

3.2

2.4

35.36

38.27

u/l

0.45

987

5320

Vascular disorders of the intestines

526

2055

2.88

94.49

3.7

2.2

53.23

44.07

u/l

0.41

468

1719

Hepatocellular carcinoma, including Hilmo

289

809

4.39

94.38

4.5

2.2

33.55

36.33

u/l

0.37

253

651

Diseases of the musculoskeletal system and connective tissue

3590

12352

1.50

94.26

2.7

2.4

50.63

42.72

u/l

0.25

3044

10580

COPD

2966

16275

1.55

94.15

3.0

2.6

43.19

55.03

u/l

0.58

2501

13811

Voice disturbances

1903

11765

1.72

93.84

2.7

2.5

55.16

42.79

u/l

0.29

1611

9936

Glomerular diseases

1304

7282

1.94

93.75

6.3

2.6

56.70

45.29

u/l

0.39

1137

6200

Migraine with aura and triptan purchases

1172

6313

2.00

93.61

2.8

2.5

32.90

44.32

u/l

0.85

1011

5371

Other dialysis

331

1033

4.09

93.41

9.3

2.5

43.10

87.17

u/l

0.46

292

874

Hypotension

1281

7120

1.94

93.14

3.3

2.4

35.95

38.68

u/l

0.59

1099

5982

Transport accidents

3005

16950

1.53

92.61

2.9

2.4

61.50

43.95

u/l

0.34

2571

14440

Type 2 diabetes

6638

29460

1.34

92.14

3.2

2.4

44.69

45.75

u/l

0.05

5448

25346

Malignant neoplasm of stomach

421

1491

3.22

91.71

4.7

2.3

36.93

41.11

u/l

0.47

377

1217

Streptococcal septicaemia, including avohilmo

705

3198

2.45

91.30

3.6

2.3

39.07

38.72

u/l

0.02

594

2697

Coagulation defects, purpura and other haemorrhagic conditions

1411

8121

1.87

91.15

3.1

2.5

47.44

44.64

u/l

0.07

1222

6865

Malignant neoplasm of stomach, including Hilmo

467

1761

3.00

90.23

4.6

2.2

38.37

40.86

u/l

0.25

418

1439

Fracture of skull and facial bones

1526

8987

1.81

90.07

3.0

2.6

37.07

45.96

u/l

0.80

1321

7693

Polyneuropathies and other disorders of the peripheral nervous system

1537

9095

1.81

90.03

3.7

2.6

50.77

53.23

u/l

0.05

1295

7742

Pain and other conditions associated with female genital organs and menstrual cycle

1433

6861

1.85

89.93

2.6

2.4

39.29

36.81

u/l

0.15

1214

5799

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1849

11292

1.71

89.87

2.9

2.5

31.95

42.05

u/l

1.58

1543

9633

Adenocarcinoma of pancreas

286

827

4.23

89.03

9.1

2.2

62.79

35.91

u/l

0.85

253

665

Acute appendicitis, no complications

3701

26297

1.45

88.74

2.7

2.6

38.34

46.63

u/l

1.16

3151

22433

Superficial injury of lower leg

1870

11652

1.70

88.56

2.7

2.5

52.03

43.65

u/l

0.25

1580

9892

Other CVD

1436

8373

1.84

88.40

3.3

2.4

35.53

44.94

u/l

0.89

1228

7031

Migraine without aura and triptan purchases

1183

6504

1.95

88.38

2.7

2.5

36.29

44.58

u/l

0.51

1019

5533

Viral and other specified intestinal infections, including avohilmo

1862

11108

1.69

88.23

3.4

2.4

61.23

40.59

u/l

0.38

1608

9425

Malignant neoplasm of liver and intrahepatic bile ducts

293

865

4.08

87.92

4.6

2.2

34.72

40.80

u/l

0.48

253

696

Vocal cord dysfunction

906

3968

2.14

87.91

2.8

2.2

38.43

44.51

u/l

0.48

761

3417

Malignant neoplasm of skin, including Hilmo

3241

15009

1.50

87.64

2.6

2.3

42.95

44.85

u/l

0.09

2775

12542

Other chronic obstructive pulmonary disease

2820

15677

1.54

87.29

3.0

2.5

43.30

55.55

u/l

0.57

2371

13299

Other viral diseases, including avohilmo

2572

17063

1.56

87.26

3.1

2.6

40.64

41.77

u/l

0.06

2192

14564

Schizophrenia or delusion

2128

13736

1.63

86.50

2.7

2.6

32.18

45.49

u/l

2.30

1805

11736

Ischaemic heart disease, wide definition

5019

23040

1.38

86.25

3.0

2.6

39.10

51.47

u/l

1.78

4271

19528

Other diseases of upper respiratory tract

7374

30052

1.31

85.93

2.6

46.99

49.08

u/l

0.09

6217

25567

Explicit bacterial Sepsis

789

3824

2.26

85.90

3.4

2.3

39.62

38.96

u/l

0.05

664

3236

Cerebrovascular diseases

4817

24857

1.39

85.63

2.9

2.6

42.20

53.73

u/l

1.14

4080

21038

Abnormal findings on diagnostic imaging of lung

3202

21279

1.48

85.40

2.9

2.5

49.32

49.05

u/l

0.01

2780

17919

Mental and behavioural disorders due to cannabinoids

307

954

3.88

85.32

3.1

2.7

180.74

38.45

u/l

0.46

270

836

Cellulitis

1572

9488

1.76

84.92

3.7

2.5

85.50

46.06

u/l

0.40

1306

8091

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1452

7414

1.80

84.61

2.5

2.6

36.02

46.77

u/l

0.56

1223

6373

Schizophrenia, schizotypal and delusional disorders

2126

13789

1.62

84.57

2.7

2.6

32.24

45.43

u/l

2.28

1802

11784

Non-ischemic cardiomyopathy

2090

10638

1.64

84.46

2.9

2.5

42.79

51.25

u/l

0.47

1760

9028

Paracetamol or NSAID medication

1012

2547

2.09

84.20

2.5

82.24

39.74

u/l

0.43

850

2202

Second line medication for Crohn's disease

3877

28182

1.42

84.01

3.0

2.6

41.18

49.23

u/l

0.79

3392

23870

Other disorders of lacrimal gland

2530

17072

1.55

83.83

2.8

2.5

40.35

45.91

u/l

0.40

2167

14410

Other diseases of blood and blood-forming organs, wide

1556

9427

1.76

83.46

3.3

2.5

34.55

44.30

u/l

1.17

1368

7982

Agoraphobia

307

963

3.77

83.34

2.9

2.4

44.01

42.54

u/l

0.05

270

812

Lung cancer and mesothelioma

1245

5946

1.89

83.22

2.8

2.3

34.05

42.40

u/l

4.46

1083

5017

Paroxysmal tachycardia

1412

6829

1.81

83.14

2.6

2.2

37.87

43.34

u/l

0.78

1174

5806

Dermatophytosis, including avohilmo

4431

32292

1.39

82.82

2.7

2.6

43.88

48.12

u/l

0.28

3771

27500

Allergic asthma (mode), excluding more controls

1480

8584

1.76

82.52

2.5

2.3

34.19

50.82

u/l

1.80

1259

7343

Later onset COPD, excluding more controls

1335

5838

1.85

82.35

2.7

2.3

36.73

46.07

u/l

1.16

1125

4891

Other diseases of gallbladder

389

1410

3.21

82.28

3.2

1.8

43.04

33.14

u/l

0.44

341

1172

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

561

2424

2.61

82.23

3.4

2.5

32.36

59.08

u/l

0.73

477

2048

Streptococcal septicaemia

671

3120

2.38

81.72

3.4

2.3

39.33

37.94

u/l

0.10

565

2635

Pain in thoracic spine

1110

6157

1.93

80.90

3.3

2.4

33.30

50.70

u/l

1.39

944

5269

Inflammatory diseases of female pelvic organs

4177

20996

1.41

80.68

2.6

2.4

37.53

44.72

u/l

0.84

3526

17641

Fracture of lumbar spine and pelvis

1576

9633

1.73

80.30

3.1

2.5

38.68

44.32

u/l

0.40

1340

8115

Insulin, intermediate and long-acting

3599

25132

1.43

80.15

4.7

2.4

71.54

45.02

u/l

0.51

2809

21549

Obsessive-compulsive disorder

508

2111

2.65

79.56

2.6

2.4

32.98

38.91

u/l

0.79

439

1793

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

715

2327

2.32

79.55

3.0

2.4

36.85

48.12

u/l

1.07

640

2019

Chronic hepatitis, not elsewhere classified

342

1189

3.49

79.51

4.0

2.3

34.44

38.28

u/l

0.79

303

998

Other diseases of stomach and duodenum

527

2256

2.64

78.95

4.4

2.3

41.65

39.41

u/l

0.25

462

1894

Ulcerative ileocolitis

368

1333

3.26

78.54

4.0

2.5

36.61

73.77

u/l

0.52

338

1138

Spinal stenosis

3267

17086

1.46

78.35

2.8

2.5

59.10

49.65

u/l

0.33

2752

14510

Asthma and allergy, excluding more controls

867

4408

2.07

78.09

2.5

2.3

34.14

50.34

u/l

0.85

735

3784

Syphilis

276

857

4.03

78.06

3.5

2.7

36.59

95.12

u/l

0.54

252

741

Syphilis, including avohilmo

276

857

4.03

78.06

3.5

2.7

36.59

95.12

u/l

0.54

252

741

Other inflammation of eyelid

1064

5912

1.95

77.93

2.6

2.5

39.78

48.18

u/l

0.47

905

4979

Disorder of lipoprotein metabolism, unspecified

887

4638

2.07

77.91

3.1

2.5

40.03

66.34

u/l

0.77

746

3916

Allergic asthma (mode)

1480

8724

1.73

77.72

2.5

2.3

34.19

50.54

u/l

1.80

1259

7461

Exclusions for E4_PCOS_CONSORTIUM

4786

22473

1.37

77.49

2.6

2.5

37.21

41.32

u/l

0.78

4064

19044

Hard cardiovascular diseases

5399

24387

1.35

77.32

3.2

2.5

39.64

49.67

u/l

1.41

4608

20717

Asthma and allergy

867

4425

2.06

77.15

2.5

2.3

34.14

50.11

u/l

0.84

735

3790

Other arthrosis

3546

17104

1.44

77.08

2.7

2.6

42.91

46.97

u/l

0.30

3016

14552

Hepatic failure, not elsewhere classified

352

1262

3.34

77.02

5.2

2.4

35.77

42.99

u/l

0.86

312

1071

Malignant neoplasm of skin

3018

14291

1.48

76.82

2.6

2.3

43.23

45.12

u/l

0.09

2576

11932

Fracture of lower leg, including ankle

3689

26504

1.41

76.74

3.0

2.6

37.52

49.35

u/l

1.64

3082

22494

Lumbar disc prolapse

4157

22806

1.39

76.48

2.8

2.5

47.17

47.39

u/l

0.01

3504

19491

Other and unspecified polyneuropathies, also in other diseases

1330

7917

1.80

76.40

3.7

2.6

54.28

54.58

u/l

0.01

1112

6736

Other chronic obstructive pulmonary disease, including avohilmo

3456

20500

1.44

76.39

2.9

2.6

42.34

51.37

u/l

0.51

2909

17356

Right hemicolectomy

484

2032

2.74

76.37

3.7

2.4

42.37

40.40

u/l

0.11

433

1690

Fissure and fistula of anal and rectal regions

1492

9103

1.72

76.24

2.6

2.4

40.51

56.65

u/l

0.78

1272

7689

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6198

28682

1.31

75.83

3.7

2.4

57.53

45.94

u/l

0.36

5023

24701

Type 2 diabetes, definitions combined

6250

28390

1.31

75.75

2.8

2.4

44.72

46.19

u/l

0.06

5171

24430

Other special examinations and investigations of persons without complaint or reported diagnosis

3954

14565

1.41

75.28

3.0

2.3

52.75

49.17

u/l

0.09

3356

12442

Cervicalgia

1418

8594

1.75

75.08

2.9

2.4

36.70

48.92

u/l

1.09

1199

7319

Sequelae with surgical and medical care as external cause

1433

8751

1.75

74.64

3.5

2.5

50.08

44.59

u/l

0.23

1205

7414

Major coronary heart disease event excluding revascularizations

3905

18964

1.41

74.30

2.9

2.6

64.19

53.57

u/l

0.22

3318

16018

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1423

7048

1.75

74.28

2.8

2.3

34.51

42.52

u/l

1.37

1225

5888

Volume depletion

675

3257

2.25

74.09

4.3

2.4

46.01

56.50

u/l

0.27

581

2726

Type 2 diabetes, strict (exclude DM1)

6271

28587

1.31

73.94

2.8

2.4

44.98

46.11

u/l

0.05

5185

24599

Other joint disorders

5828

23518

1.32

73.80

2.6

2.5

48.39

45.70

u/l

0.08

4923

20037

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

218

599

4.56

73.70

9.7

2.1

57.33

37.10

u/l

1.72

208

479

Social phobias

597

2745

2.36

73.64

3.0

2.5

56.29

38.49

u/l

0.51

494

2352

Ulcerative colitis (strict definition, all Crohn cases excluded)

1019

5682

1.93

73.43

3.5

2.6

42.76

47.54

u/l

0.21

911

4843

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3605

20685

1.42

73.26

3.0

2.5

39.73

53.35

u/l

1.36

2965

17667

Assault by bodily force

599

2782

2.38

73.24

3.6

2.7

34.32

55.70

u/l

0.67

518

2402

Other complications of surgical and medical care, not elsewhere classified

741

3734

2.18

73.21

3.1

2.3

36.34

51.60

u/l

0.61

650

3136

Symptoms and signs concerning food and fluid intake

729

3631

2.16

72.80

3.2

2.1

34.39

53.94

u/l

0.81

611

3013

Disorders of lacrimal system

2957

20730

1.46

72.68

2.8

2.5

41.05

51.97

u/l

0.79

2515

17517

Insulin medication

3917

24120

1.39

72.64

4.7

2.4

68.46

44.31

u/l

0.51

3076

20739

Umbilical hernia

1765

11373

1.63

72.54

2.9

2.6

41.63

51.47

u/l

0.66

1522

9679

Speech and linguistic disorders, excluding more controls

525

2149

2.48

72.10

2.6

2.3

28.93

38.44

u/l

2.66

454

1833

Rotator cuff syndrome

3939

20094

1.39

71.70

2.7

2.5

36.22

44.35

u/l

2.62

3295

17134

Ovarian cyst

2219

8430

1.57

71.61

2.6

2.4

36.00

40.92

u/l

0.71

1859

7123

Heart failure and coronary heart disease

2727

13347

1.49

71.25

2.9

2.6

38.83

51.89

u/l

1.36

2320

11291

Type 2 diabetes, definitions combined, including avohilmo

6254

28448

1.30

71.20

2.8

2.4

45.18

46.01

u/l

0.03

5171

24498

Fall on and from stairs and steps

1798

11695

1.62

71.17

2.9

2.6

34.88

42.81

u/l

1.14

1512

9932

Injuries to the wrist and hand

6772

35764

1.28

71.12

2.7

2.6

52.41

47.25

u/l

0.19

5768

30374

Inflammatory disease of uterus

979

5444

1.93

71.10

2.7

2.3

33.77

35.82

u/l

0.44

812

4550

Disease of hard tissues of teeth, NOS

3348

12553

1.44

70.99

2.6

2.4

37.88

52.07

u/l

1.47

2830

10729

Other viral diseases

1911

12537

1.59

70.87

3.4

2.6

44.08

42.82

u/l

0.05

1640

10689

Injuries to unspecified part of trunk, limb or body region

779

4045

2.11

70.77

3.1

2.5

39.47

50.61

u/l

0.40

674

3417

Benign neoplasm: Pancreas

289

985

3.67

70.48

5.1

2.4

227.27

36.59

u/l

1.49

262

820

Vascular diseases of the intestine

347

1294

3.13

69.85

3.8

2.4

57.48

36.18

u/l

0.83

318

1065

Colon adenocarcinoma, helper endpoint

912

5004

1.98

69.84

2.8

2.5

41.94

39.91

u/l

0.17

792

4215

Peripheral artery disease

2696

14949

1.48

69.77

3.5

2.5

65.80

45.37

u/l

0.34

2237

12639

Coronary atherosclerosis

4121

19452

1.38

69.69

3.0

2.5

45.12

53.39

u/l

0.48

3476

16439

Cerebral palsy and other paralytic syndromes

812

4292

2.06

69.64

3.3

2.6

30.69

50.03

u/l

1.05

700

3625

Other sexually transmitted chlamydial diseases, including avohilmo

707

3547

2.15

69.50

2.4

2.5

30.20

48.84

u/l

0.77

625

3040

Personal history of malignant neoplasm

682

3416

2.21

69.16

2.2

2.3

52.94

39.22

u/l

0.31

582

2829

Asthma/COPD (KELA code 203)

6273

33211

1.29

68.84

2.6

36.81

50.85

u/l

2.71

5279

28270

Finngen Rheumatological endpoints

6318

28354

1.29

68.64

2.7

2.6

39.01

43.56

u/l

0.98

5370

24156

Cardiomyopathy, other and unspecified

580

2735

2.35

68.62

2.7

2.5

44.02

59.73

u/l

0.42

492

2350

Diabetes medication

6867

32065

1.28

68.35

3.5

2.4

55.08

45.47

u/l

0.32

5584

27582

COPD, hospital admissions

2806

16822

1.46

68.07

3.0

2.5

43.41

52.55

u/l

0.40

2356

14244

COPD, early/later onset

2835

16974

1.46

67.80

3.0

2.5

43.19

52.40

u/l

0.41

2384

14377

Abscess of anal and rectal regions

597

2849

2.29

67.66

3.2

2.5

41.30

56.05

u/l

0.40

520

2464

Emotional disorders starting during childhood or adolecense, excluding more controls

304

1019

3.19

67.49

2.6

2.2

27.99

33.77

u/l

2.15

247

865

Other viral diseases, not elsewhere classified, including avohilmo

1771

11524

1.60

67.38

3.0

2.6

43.28

43.10

u/l

0.01

1489

9831

Myocardial infarction, without ST-elevation

2509

15855

1.49

67.21

2.9

2.6

40.96

49.22

u/l

0.62

2096

13450

Rash and other nonspecific skin eruption

721

3725

2.12

66.57

2.7

2.4

36.44

52.10

u/l

0.62

620

3124

Abnormal spermatozoa

110

4742

0.22

66.09

2.3

2.7

58.47

55.60

u/l

0.04

4054

L04AX Other immunosuppressants

3659

27387

1.38

65.97

2.9

2.6

41.45

49.01

u/l

0.68

3189

23200

Atopic dermatitis

3933

23571

1.37

65.94

2.6

2.5

37.76

43.43

u/l

1.10

3348

20112

Delirium, not induced by alcohol and other psychoactive substances

879

4839

1.95

65.60

3.3

2.5

37.39

49.97

u/l

0.65

738

4092

Injuries to the hip and thigh

3175

20832

1.41

65.37

2.8

2.5

45.70

46.73

u/l

0.04

2652

17611

Enterocolitis due to Clostridium difficile

771

4090

2.05

65.35

4.9

2.5

41.49

50.94

u/l

0.35

672

3446

Fibromyalgia

679

3449

2.14

65.24

2.9

2.2

35.66

41.14

u/l

0.48

566

2898

Diabetes, insulin treatment (Kela reimbursement)

6586

31370

1.28

65.22

3.6

2.4

56.45

45.35

u/l

0.37

5324

26964

Malignant neoplasm of small intestine, including Hilmo

266

892

3.55

65.18

3.6

2.2

41.90

42.59

u/l

0.03

242

731

Paralytic ileus

303

1086

3.21

65.09

4.5

2.3

31.96

38.59

u/l

1.55

270

907

Adenomyosis (Endometriosis of uterus)

927

5208

1.91

64.86

2.6

2.4

37.27

42.81

u/l

0.40

780

4387

Other and unspecified injuries of head

576

2770

2.30

64.81

3.4

2.4

41.21

56.34

u/l

0.36

499

2339

Acute peritonitis

496

2254

2.47

64.81

5.6

2.5

90.99

61.77

u/l

0.24

430

1898

Malignant neoplasm of urinary organs, including Hilmo

722

3746

2.08

64.77

2.9

2.2

57.77

53.16

u/l

0.08

644

3116

COPD, hospital admission 2, with asthma infections

2019

11752

1.55

64.68

3.2

2.5

32.57

52.03

u/l

1.98

1703

9952

Ischemic heart diseases

5280

24557

1.31

64.38

3.2

2.5

39.27

50.47

u/l

1.66

4515

20812

Arthropathies

5911

23555

1.30

64.14

2.7

2.5

36.75

45.67

u/l

2.00

5041

20066

Insulin, combination of fast acting with intermediate-acting or long-acting

3918

26921

1.36

64.02

4.7

2.4

68.46

44.81

u/l

0.50

3077

23046

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

328

1247

3.09

63.99

2.7

2.6

34.53

79.58

u/l

0.60

280

1049

Crohn's disease NAS

500

2291

2.44

63.78

3.8

2.4

37.78

56.93

u/l

0.44

446

1946

Dental pulpitis, including avohilmo

6012

30639

1.29

63.51

2.9

2.6

34.96

48.23

u/l

3.49

5104

26110

Basal cell carcinoma, including Hilmo

2697

12962

1.46

63.51

2.5

2.3

44.97

44.21

u/l

0.03

2295

10819

In situ neoplasms

2593

18515

1.46

63.44

2.6

2.5

63.95

41.77

u/l

0.37

2174

15546

Monoamine oxidase A inhibitors

791

4267

2.00

63.44

2.7

2.4

45.36

39.52

u/l

0.43

663

3637

Amiodarone users

710

3716

2.10

63.39

2.7

2.5

41.26

39.51

u/l

0.18

608

3126

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2777

13372

1.45

63.33

2.5

2.3

44.46

45.50

u/l

0.04

2366

11160

Abnormal involuntary movements

968

5568

1.87

63.20

3.1

2.5

34.67

48.17

u/l

0.87

813

4706

Other embolism and thrombosis

896

5042

1.91

62.88

3.2

2.5

137.81

52.07

u/l

0.42

756

4252

Myocardial infarction

3085

15725

1.42

62.86

3.0

2.6

72.12

51.27

u/l

0.39

2617

13293

Other and unspecified coagulation defects

420

1805

2.65

62.85

3.5

2.5

29.64

65.20

u/l

0.73

359

1516

Non-small cell lung cancer, including Hilmo

904

4750

1.89

62.58

2.9

2.2

33.31

40.57

u/l

2.36

783

3932

Fracture of shoulder and upper arm

2398

16902

1.47

62.55

2.9

2.5

41.67

49.32

u/l

0.44

2041

14316

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

260

890

3.57

62.38

2.3

2.0

32.30

36.44

u/l

0.80

220

730

Hepatocellular carcinoma

202

586

4.14

62.32

3.9

2.3

34.34

35.69

u/l

0.17

178

469

Injuries to the shoulder and upper arm

5635

34527

1.29

62.27

2.8

2.6

46.56

48.72

u/l

0.12

4762

29371

Stomatitis and related lesions

1359

8556

1.68

62.26

2.9

2.5

32.55

43.42

u/l

1.21

1151

7222

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2497

17508

1.46

62.22

2.8

2.5

34.44

40.90

u/l

1.63

2083

14995

Atherosclerosis, excluding cerebral and coronary sclerosis

2502

13907

1.47

61.96

3.3

2.5

67.93

42.76

u/l

0.41

2082

11742

Benign neoplasm: Sigmoid colon

1272

7919

1.71

61.47

2.7

2.5

31.98

45.80

u/l

1.56

1090

6704

Other metabolic disorders

898

5081

1.89

61.40

2.8

2.3

40.79

47.98

u/l

0.30

775

4259

Benign neoplasm: Stomach

717

3810

2.07

61.40

3.2

2.5

46.27

52.20

u/l

0.13

605

3205

Ocular pain

654

3362

2.14

61.39

3.7

2.4

30.18

52.73

u/l

0.93

561

2841

Viral pneumonia (unknown virus, not influenza)

520

2457

2.35

61.38

3.4

2.6

37.38

60.89

u/l

0.63

450

2076

Personal history of other diseases and conditions

780

4209

1.98

61.28

3.0

2.2

42.66

48.54

u/l

0.14

666

3503

Hydronephrosis

777

4213

1.99

61.26

3.0

2.4

37.18

39.32

u/l

0.42

692

3538

Primary biliary cholangitis, wide definition

240

795

3.74

61.14

5.8

2.2

40.80

96.95

u/l

0.44

221

662

Polycystic kidney disease

256

879

3.56

61.13

4.5

2.6

42.76

89.70

u/l

0.41

240

747

Enlarged lymph nodes

980

5684

1.82

60.77

3.0

2.2

34.62

48.17

u/l

0.91

834

4772

Other diseases of lip and oral mucosa

2755

20038

1.43

60.42

2.9

2.6

46.43

46.92

u/l

0.02

2304

17006

6-mercaptopurine

310

1176

3.04

60.10

4.0

2.3

35.50

80.67

u/l

0.57

280

1009

Persons with potential health hazards related to communicable diseases

2374

16678

1.46

59.95

3.2

2.6

34.19

41.36

u/l

1.48

2083

14227

Postprocedural disorders of digestive system, not elsewhere classified

297

1112

3.15

59.79

4.4

2.2

34.27

33.79

u/l

0.07

262

924

Kela-code for severe mental illness

2276

16041

1.47

59.72

2.7

33.61

44.62

u/l

1.98

1893

13736

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

4127

28960

1.33

59.65

2.8

2.6

37.35

46.06

u/l

1.76

3571

24640

COPD related to multimorbidity

2418

14512

1.46

59.54

3.1

2.5

44.99

49.65

u/l

0.16

2026

12299

Portal vein thrombosis

182

517

4.54

59.48

7.1

2.5

830.74

43.37

u/l

0.79

167

434

Haemorrhage, not elsewhere classified

307

1162

3.01

59.39

4.0

2.3

105.87

84.73

u/l

0.10

275

956

Other sexually transmitted chlamydial diseases

470

2154

2.39

59.20

2.5

2.6

28.31

57.06

u/l

0.71

419

1846

Obesity due to excess calories

3050

22600

1.39

59.11

2.8

2.6

52.95

43.68

u/l

0.24

2496

19350

Anogenital herpesviral [herpes simplex] infection, including avohilmo

779

4285

1.95

58.59

2.6

2.4

32.32

48.35

u/l

0.79

681

3652

Other diseases of pleura

2793

17716

1.42

58.47

3.1

2.6

45.05

47.91

u/l

0.12

2386

14975

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3311

23959

1.37

58.30

2.7

2.6

43.03

47.21

u/l

0.24

2830

20441

Acute sinusitis

3363

22961

1.37

58.27

2.9

2.5

45.07

42.96

u/l

0.17

2829

19568

Anogenital herpesviral [herpes simplex] infection

485

2273

2.36

58.24

2.7

2.5

33.42

57.95

u/l

0.60

427

1923

Fracture of foot, except ankle

1629

10823

1.58

58.24

3.2

2.5

69.15

40.76

u/l

0.47

1386

9219

Disorders of tooth development and eruption

1055

5091

1.77

58.21

2.9

2.3

40.75

45.54

u/l

0.40

898

4384

Attention to artificial openings

329

1306

2.87

58.17

2.7

2.3

30.90

41.91

u/l

1.78

291

1098

Malignant neoplasm of bronchus and lung, including Hilmo

1220

6278

1.70

58.08

2.8

2.3

34.45

39.70

u/l

1.89

1054

5216

Ductal carcinoma of pancreas

112

226

7.44

58.04

9.6

2.1

372.60

35.41

u/l

0.59

100

184

COPD, hospital admissions 3, with asthma pneumonia sepsis

1675

9554

1.57

57.92

3.2

2.5

32.09

48.89

u/l

1.50

1417

8076

Volvulus

234

777

3.52

57.86

4.0

2.3

40.24

38.67

u/l

0.09

200

657

Chondrocostal junction syndrome [Tietze]

337

1367

2.87

57.79

3.9

2.3

30.27

39.13

u/l

3.05

300

1145

Fungal Sepsis

348

1428

2.79

57.64

4.2

2.3

34.08

38.29

u/l

0.93

296

1217

Cardiodefibrillation

2158

15148

1.48

57.50

2.5

2.6

37.07

50.80

u/l

1.54

1831

12878

Non-small cell lung cancer, adenocarcinoma

424

1890

2.48

57.25

2.8

2.2

32.93

39.19

u/l

1.09

363

1559

Eating disorder

606

3089

2.12

57.03

2.8

2.3

32.04

50.79

u/l

0.62

504

2584

Superficial injury of wrist and hand

1389

8956

1.63

56.99

2.9

2.6

33.53

42.84

u/l

1.00

1203

7615

Oter anti-inflammatory and antirheumatic agents, non-steroids

1276

4299

1.70

56.90

2.7

2.8

36.50

40.55

u/l

0.93

1068

3673

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

457

2112

2.39

56.74

2.7

2.2

39.29

62.75

u/l

0.48

393

1750

Basal cell carcinoma

2557

12514

1.44

56.57

2.6

2.3

44.53

44.43

u/l

0.00

2167

10444

Early onset COPD

1400

9077

1.63

56.51

3.3

2.6

50.67

55.46

u/l

0.09

1173

7733

Idiopathic gout

650

3431

2.07

56.33

3.0

2.6

61.04

53.50

u/l

0.11

554

2881

Cystic kidney disease

289

1107

3.09

55.95

4.2

2.5

42.43

78.80

u/l

0.40

270

940

Benign neoplasm: Small intestine

342

1424

2.81

55.77

3.9

2.5

49.74

41.95

u/l

0.33

308

1190

Open wound of lower leg

1029

6225

1.76

55.35

3.1

2.5

34.51

46.04

u/l

0.84

881

5288

Postprocedural endocrine and metabolic disorders, not elsewhere classified

819

4653

1.88

55.27

2.8

2.3

42.13

49.26

u/l

0.26

710

3902

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

621

3236

2.07

55.15

2.9

2.2

61.69

55.78

u/l

0.09

549

2684

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2617

12852

1.43

55.14

2.5

2.3

44.31

44.29

u/l

0.00

2221

10726

Zoster [herpes zoster], including avohilmo

3341

24451

1.36

55.12

2.7

2.5

47.30

49.79

u/l

0.08

2850

20619

Malignant neoplasm of respiratory system and intrathoracic organs

1215

6295

1.68

55.00

2.8

2.3

34.49

39.62

u/l

1.80

1047

5240

Early syphilis

146

379

5.20

54.74

2.2

3.1

32.21

43.73

u/l

0.47

141

325

Endometriosis

2052

8245

1.50

54.70

2.5

2.4

44.45

41.20

u/l

0.21

1739

6964

Phlebitis and thrombophlebitis (not including DVT)

1477

9759

1.59

54.58

3.2

2.5

36.12

44.89

u/l

0.57

1269

8312

Cystic kidney disease, including avohilmo

304

1208

2.95

54.53

4.1

2.5

41.89

79.95

u/l

0.47

283

1024

Carcinoma in situ of other and unspecified digestive organs

368

1597

2.66

54.52

2.6

2.5

45.36

39.90

u/l

0.33

306

1349

Percutaneous Coronary Intervention

4935

23759

1.29

54.36

3.1

2.5

38.70

50.77

u/l

1.81

4240

20136

Other eating disorders

364

1554

2.58

54.05

2.9

2.3

33.18

34.14

u/l

0.13

307

1284

Epilepsy

1924

13347

1.49

53.95

3.0

2.6

49.23

49.16

u/l

0.00

1640

11310

Other and unspecified dermatitis

3374

25718

1.35

53.75

2.9

2.5

38.81

50.37

u/l

1.48

2891

21807

Elevated blood glucose level

605

3168

2.08

53.70

4.8

2.5

115.78

39.62

u/l

0.45

491

2684

Eating disorders

699

3822

1.95

53.17

2.8

2.4

31.97

49.05

u/l

0.74

584

3226

Duodenal ulcer

687

3742

1.96

53.15

3.5

2.4

44.67

41.67

u/l

0.16

603

3154

Diseases of peritoneum

700

3855

1.97

53.09

5.0

2.5

76.29

51.67

u/l

0.31

607

3236

Emergency coronary revascularization (for ACS)

5353

25902

1.28

52.87

3.1

2.6

38.49

52.66

u/l

2.08

4588

21921

Use of disulfiram, acamprosate or naltrexone

625

3329

2.05

52.82

3.8

2.9

34.33

54.39

u/l

0.79

529

2893

Systemic connective tissue disorders

2238

16109

1.44

52.46

2.6

2.5

47.89

42.76

u/l

0.21

1897

13536

Early syphilis, including avohilmo

154

427

4.68

52.23

2.2

3.0

31.90

42.31

u/l

0.48

146

364

Other (not insulin) diabetes medications

6275

30040

1.25

52.22

2.8

2.4

46.00

46.25

u/l

0.01

5146

25822

Cervicocranial syndrome

734

4110

1.91

52.18

3.0

2.3

33.83

53.28

u/l

0.99

635

3489

Fentanyl

624

3299

2.01

52.14

4.1

2.1

37.02

39.05

u/l

0.12

548

2780

Urticaria and erythema

2311

16723

1.43

52.12

2.7

2.5

73.42

42.17

u/l

0.40

1953

14221

Cardiomyopathy (excluding other)

793

4543

1.86

52.03

2.6

69.23

67.85

u/l

0.01

673

3900

Coronary revascularization (ANGIO or CABG)

4919

23770

1.29

51.99

3.1

2.5

38.75

50.77

u/l

1.79

4223

20144

Viral infections characterized by skin and mucous membrane lesions

2691

19957

1.39

51.72

3.0

2.6

59.07

46.37

u/l

0.39

2326

16953

Congenital malformations of the urinary system, including avohilmo

465

2254

2.29

51.69

3.6

2.5

42.43

61.47

u/l

0.42

424

1897

Benign neoplasm: Ascending colon

956

5799

1.77

51.66

2.9

2.5

46.22

47.45

u/l

0.03

824

4889

Erosion of teeth , including avohilmo

1723

11861

1.51

51.63

3.1

2.6

36.65

43.26

u/l

0.78

1479

10104

Procreative management

2107

12319

1.46

51.62

2.7

2.8

35.76

46.28

u/l

1.38

1849

10540

Lung transplantation

109

239

6.80

51.53

2.9

2.7

44.15

32.02

u/l

2.15

100

197

Congenital malformations, deformations and chromosomal abnormalities

3670

26937

1.33

51.37

2.8

2.6

37.33

46.03

u/l

1.60

3191

22924

Congenital malformations of the urinary system

440

2097

2.34

51.19

3.7

2.5

42.90

60.39

u/l

0.35

402

1767

Cardiomyopathies, Primary/intrinsic

760

4321

1.88

51.17

2.5

2.6

70.32

70.65

u/l

0.00

646

3712

Myocardial infarction, strict

2814

14806

1.39

51.05

2.9

2.6

50.69

51.92

u/l

0.04

2384

12528

Pleural effusion

994

6089

1.73

51.04

3.0

2.5

34.72

39.72

u/l

1.72

851

5118

Implicit fungal Sepsis

318

1326

2.74

50.98

4.0

2.3

34.41

38.88

u/l

0.91

268

1126

Disturbance of activity and attention

828

4695

1.82

50.87

2.5

2.6

30.58

46.25

u/l

0.89

703

4027

Event of undetermined intent

481

2372

2.23

50.78

3.0

2.6

35.19

60.62

u/l

0.67

408

2014

Lung transplant status

108

238

6.76

50.75

2.9

2.7

44.32

31.89

u/l

2.22

196

Covid-19 suspected case

1366

9007

1.59

50.65

2.9

2.5

32.20

42.87

u/l

1.27

1201

7647

Purpura and other haemorrhagic conditions

898

5375

1.78

50.63

3.0

2.6

33.98

47.78

u/l

0.87

778

4515

Other diseases of oesophagus

621

3339

2.00

50.33

3.6

2.4

43.23

41.21

u/l

0.11

537

2815

Migraine, single triptan purchase ok & required. ICD-code if available is included

4803

25964

1.28

50.11

2.6

35.01

47.39

u/l

2.41

4059

22120

Triptan medication for migraine, single purchase ok

4803

25964

1.28

50.11

2.6

35.01

47.39

u/l

2.41

4059

22120

Hyperkinetic disorders

873

5048

1.78

49.84

2.6

30.49

45.09

u/l

0.89

743

4324

Sequelae of injuries, of poisoning and of other consequences of external causes

1498

10140

1.55

49.16

3.1

2.6

67.22

41.52

u/l

0.37

1261

8663

Malignant neoplasm of other and unspecified parts of biliary tract

151

426

4.38

49.16

10.2

2.0

58.82

33.56

u/l

1.63

146

342

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

497

2509

2.17

49.15

3.5

2.6

40.93

58.55

u/l

0.43

448

2134

Recurrent aphthous stomatitis , including avohilmo

966

5937

1.73

49.13

3.0

2.5

31.62

47.27

u/l

1.22

816

4973

Other coagulation defects

540

2807

2.10

49.11

3.3

2.5

69.16

55.40

u/l

0.13

468

2362

Sleep disorders, other/unspecified

301

1243

2.75

49.06

2.8

2.4

32.45

76.27

u/l

0.57

254

1029

Malignant neoplasm of urinary organs

592

3160

2.01

48.90

3.0

2.2

62.17

56.49

u/l

0.08

530

2617

Non-Hodgkin lymphoma, all, including Hilmo

767

4427

1.84

48.88

2.6

2.2

36.29

50.04

u/l

0.65

653

3686

Non-small cell lung cancer

611

3248

1.98

48.72

2.8

2.2

33.59

39.26

u/l

1.33

527

2667

Conjunctivitis (acute, non atopic)

1772

12337

1.49

48.70

2.9

2.6

54.53

44.02

u/l

0.22

1525

10477

Maternal care for other conditions predominantly related to pregnancy

1281

8185

1.60

48.55

2.5

2.4

36.56

37.73

u/l

0.15

1091

6959

Hyperkalaemia

400

1864

2.35

48.49

5.3

2.5

31.77

63.86

u/l

0.66

346

1564

Striking against or struck by other objects

2106

15166

1.44

48.41

2.7

36.48

48.91

u/l

1.24

1828

12949

Dermatitis

3968

30603

1.30

48.34

2.9

2.5

38.32

49.85

u/l

1.83

3380

25935

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

15.45

48.28

2.6

2.7

30.39

28.54

u/l

0.25

Other obstetric conditions, not elsewhere classified

1852

8129

1.49

48.28

2.5

2.4

34.93

38.50

u/l

0.66

1586

6913

Other and unspecified visual disturbances

743

4287

1.87

48.20

3.2

2.5

31.80

51.92

u/l

1.11

633

3615

Cytomegalovirus infection, IBD co-morbidity

211

742

3.42

48.16

6.2

2.4

40.04

107.26

u/l

0.52

195

628

Other local infections of skin and subcutaneous tissue

716

4087

1.88

48.08

3.7

2.5

33.65

49.65

u/l

0.75

623

3468

Other general symptoms and signs

358

1581

2.45

48.02

3.1

2.1

37.80

71.00

u/l

0.52

302

1311

Crohn disease (strict definition, require KELA, min 2 HDR)

467

2329

2.21

47.88

3.5

2.6

41.43

60.58

u/l

0.43

420

1983

Sequelae of injuries of lower limb

649

3606

1.95

47.86

3.0

2.6

109.71

40.45

u/l

0.45

545

3080

Other viral diseases, not elsewhere classified

1166

7505

1.63

47.69

3.3

2.6

50.25

43.85

u/l

0.19

978

6387

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

160

480

4.12

47.65

2.8

1.9

47.05

35.78

u/l

0.34

136

393

Malignant neoplasm of small intestine

198

673

3.50

47.64

3.4

2.1

35.86

45.81

u/l

0.68

176

547

Injuries to the elbow and forearm

4601

31625

1.28

47.64

2.8

2.5

37.65

48.88

u/l

1.90

3899

26840

Decubitus ulcer and pressure area

446

2189

2.24

47.59

3.4

2.4

31.56

37.83

u/l

1.33

351

1819

Other infectious diseases

530

2769

2.09

47.42

3.9

2.5

37.87

56.76

u/l

0.53

464

2323

Disorders of other endocrine glands

2774

20610

1.37

47.37

3.1

2.5

39.45

43.56

u/l

0.43

2382

17487

Superficial injury of abdomen, lower back and pelvis

1028

6461

1.68

47.36

3.2

2.5

37.72

46.37

u/l

0.53

875

5468

Injury of unspecified body region

558

2971

2.05

47.33

3.1

2.5

36.63

55.28

u/l

0.57

487

2499

Carcinoma in situ of skin of other and unspecified parts of face

590

3197

2.01

47.30

2.8

2.4

32.56

41.49

u/l

2.70

507

2640

Disorders of vitreous body and globe

3232

23575

1.34

47.21

3.3

2.5

42.80

52.26

u/l

0.81

2705

19928

Insulin, fast-acting

2207

16106

1.42

47.19

5.6

2.4

69.47

40.01

u/l

0.39

1685

13817

Abnormal findings on diagnostic imaging of other body structures

979

6105

1.71

47.17

3.4

2.4

53.85

47.90

u/l

0.19

836

5131

Other disorders of bone

1252

8239

1.60

47.14

3.2

2.5

33.76

46.15

u/l

1.25

1077

7009

Herpesviral [herpes simplex] infections, including avohilmo

1641

11392

1.50

47.12

2.7

2.5

34.05

42.20

u/l

1.16

1410

9658

Crohn disease (strict definition, require KELA)

470

2364

2.19

47.05

3.5

2.6

41.32

60.12

u/l

0.43

423

2014

Crohn's disease of large intestine

381

1774

2.39

46.89

3.8

2.4

39.78

64.41

u/l

0.44

343

1508

Other cataract

2768

15467

1.37

46.83

3.3

2.5

47.46

44.47

u/l

0.13

2300

13123

Urticaria

1877

13362

1.46

46.76

2.8

2.5

80.64

41.75

u/l

0.40

1590

11368

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1803

7909

1.49

46.70

2.4

35.15

38.66

u/l

0.62

1541

6736

Primary_lymphoid and hematopoietic malignant neoplasms

1487

10162

1.53

46.67

2.8

2.5

38.60

51.18

u/l

0.80

1270

8587

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

621

3430

1.96

46.60

3.3

2.4

65.45

52.55

u/l

0.14

548

2881

Hemiplegia

370

1705

2.41

46.59

3.4

2.5

30.09

40.42

u/l

2.39

324

1435

Failure and rejection of transplanted organs and tissues

142

404

4.45

46.11

8.1

2.3

47.09

151.23

u/l

0.43

128

348

Intestinal malabsorption

363

1675

2.43

45.99

6.3

2.4

36.54

67.88

u/l

0.55

296

1400

Other and unspecified local infections of skin and subcutaneous tissue

675

3839

1.89

45.96

3.7

2.5

33.11

50.59

u/l

0.78

586

3253

Dental operations

3867

15537

1.31

45.85

2.6

2.4

41.08

52.51

u/l

1.11

3277

13217

Biomechanical lesions, not elsewhere classified

389

1849

2.36

45.80

2.9

2.4

36.29

40.89

u/l

0.41

332

1552

Disorders of vitreous body

3144

23091

1.33

45.69

3.3

2.5

43.17

52.64

u/l

0.79

2634

19517

Benign neoplasm: Duodenum

233

892

3.13

45.60

4.0

2.5

54.85

40.74

u/l

0.46

213

744

Biguanides

6083

30296

1.24

45.59

2.7

2.5

45.88

48.46

u/l

0.11

4973

25968

Medical abortion

3910

16611

1.31

45.59

2.5

2.4

33.29

41.80

u/l

3.54

3297

13935

Gonococcal infection

281

1173

2.77

45.35

2.3

2.6

28.78

83.02

u/l

0.73

246

993

Malignant neoplasm of kidney, except renal pelvis

540

2869

2.02

45.35

2.9

2.2

65.29

58.16

u/l

0.09

478

2380

Other/unspecified cytomegaloviral diseases

188

644

3.56

45.20

6.6

2.4

41.33

109.85

u/l

0.44

172

543

Other infectious diseases, including avohilmo

608

3374

1.94

44.92

3.9

2.5

76.69

53.13

u/l

0.24

528

2834

Certain disorders involving the immune mechanism

1193

7863

1.60

44.88

3.0

2.6

38.76

44.91

u/l

0.46

1020

6680

Crohn's disease of small intestine

486

2514

2.11

44.75

3.4

2.4

42.87

56.34

u/l

0.30

434

2123

Other disorders starting during childhood or adolecense, excluding more controls

275

1066

2.66

44.45

2.4

2.3

28.64

33.30

u/l

1.71

229

903

Propionic acid derivatives

1642

5641

1.51

44.44

2.4

2.8

67.18

39.64

u/l

0.45

1369

4829

Other specified/unspecified arthritis

1701

12013

1.47

44.38

2.9

2.5

39.13

46.93

u/l

0.84

1418

10187

Cytomegaloviral disease

214

793

3.21

44.32

6.1

2.4

39.89

101.10

u/l

0.51

198

681

Laparoscopic left hemicolectomy

173

574

3.75

44.26

3.1

2.4

35.47

42.83

u/l

0.41

155

486

Diseases of salivary glands

2050

14962

1.42

44.22

2.8

2.6

43.14

43.06

u/l

0.00

1734

12695

Oesophagitis

385

1841

2.31

44.14

4.8

2.3

45.75

40.45

u/l

0.16

333

1552

Benign neoplasm: Adrenal gland

555

3025

2.01

44.12

2.8

2.6

44.67

56.54

u/l

0.29

484

2548

Unstable angina pectoris

2211

12764

1.41

44.02

2.8

2.5

46.97

52.55

u/l

0.18

1859

10793

Major coronary heart disease event

5187

25294

1.25

43.92

3.1

2.6

39.29

50.13

u/l

1.65

4448

21403

Ptosis of eyelid

748

4442

1.81

43.81

2.7

2.4

34.70

39.40

u/l

1.25

631

3742

Missing teeth due to accident, extraction or parodontitis

3886

27619

1.29

43.73

3.0

2.5

61.95

48.57

u/l

0.26

3295

23346

Gonococcal infection, including avohilmo

295

1278

2.63

43.67

2.3

2.6

28.71

79.02

u/l

0.74

260

1083

Cytomegaloviral disease, including avohilmo

215

805

3.17

43.63

6.1

2.4

39.85

99.76

u/l

0.51

199

693

Adenocarcinoma and papillary adenocarcinoma of stomach

211

771

3.09

43.63

5.0

2.2

36.21

34.21

u/l

0.30

190

618

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

16.58

43.60

2.7

30.92

28.95

u/l

0.23

Triptan medication for migraine, min. 3 purchases

3489

20413

1.31

43.57

2.5

36.69

41.82

u/l

0.75

2954

17411

Autoimmune hepatitis

116

302

5.20

43.47

4.1

2.3

39.51

30.75

u/l

2.27

103

251

Fall on same level involving ice and snow

3664

29002

1.29

43.45

2.7

2.6

34.74

49.08

u/l

2.72

3079

24613

Disorders of lens

4127

20393

1.28

43.37

3.4

2.5

40.49

45.47

u/l

0.79

3481

17354

Diabetic nephropathy, excluding more controls

966

4958

1.69

43.30

7.4

2.8

45.36

41.01

u/l

0.17

798

4120

Cyst of kidney

506

2693

2.06

43.24

3.0

2.5

60.48

40.27

u/l

0.36

444

2267

Follow-up examination after treatment for malignant neoplasms

648

3696

1.87

43.18

2.7

2.3

38.86

40.85

u/l

0.22

536

3110

Stroke, excluding SAH

3592

20390

1.30

43.16

2.9

2.6

42.11

54.38

u/l

0.94

3010

17268

Disorders of skin appendages

3114

24067

1.32

43.04

3.0

2.5

38.17

46.28

u/l

1.20

2639

20488

Misadventures to patients during surgical and medical care

923

5803

1.68

42.79

3.6

2.4

80.61

47.12

u/l

0.46

811

4890

Malignant melanoma, including Hilmo

976

6204

1.65

42.65

2.8

2.3

34.91

46.90

u/l

0.85

833

5180

Other shoulder lesions

640

3657

1.87

42.63

3.1

2.4

32.99

40.26

u/l

2.26

529

3104

Malignant melanoma

882

5481

1.69

42.45

2.9

2.3

34.78

48.13

u/l

0.83

757

4576

Malignant neoplasm of bronchus and lung

1028

5495

1.63

42.35

2.8

2.2

34.83

40.11

u/l

1.59

890

4551

Secondary uncertain malignant neoplasm

759

4543

1.76

42.25

2.9

2.2

35.66

49.45

u/l

0.68

649

3793

Anti-inflammatory and antirheumatic products, non-steroids

1628

5642

1.49

42.16

2.4

2.8

67.34

39.64

u/l

0.45

1363

4830

Other extrapyramidal and movement disorders in other diseases

1555

10934

1.48

42.02

2.7

2.5

33.98

43.47

u/l

1.32

1295

9256

Nerve, nerve root and plexus disorders

6764

34111

1.21

41.88

2.9

2.5

46.55

45.43

u/l

0.05

5677

29060

Non-invasive ventilation

474

7597

0.52

41.87

3.2

2.2

36.43

64.71

u/l

1.54

425

6581

Unspecified/other endometriosis

571

3093

1.92

41.81

2.4

52.55

37.20

u/l

0.46

487

2619

Aortic aneurysm

1330

8889

1.53

41.76

2.6

39.17

44.71

u/l

0.40

1139

7546

Stroke, including SAH

3787

21599

1.29

41.67

2.9

2.6

42.59

53.53

u/l

0.85

3179

18289

Angina pectoris

3391

17623

1.31

41.67

2.8

2.5

43.90

54.55

u/l

0.55

2855

14876

All influenza (not pneumonia)

902

5663

1.67

41.59

3.2

2.5

31.13

50.32

u/l

1.60

776

4861

Enthesopathies of lower limb, excluding foot

1403

9689

1.51

41.36

2.7

2.5

92.64

48.76

u/l

0.32

1187

8264

Emotional disorders and disorders of social functioning with onset specific to childhood

343

1566

2.33

41.19

2.5

2.4

28.37

63.19

u/l

0.58

280

1305

Disorders of the thyroid gland

5926

31976

1.22

41.17

2.6

37.76

46.87

u/l

2.07

4945

27249

Bulimia nervosa (incl. atypical)

250

1024

2.72

41.11

2.6

2.3

35.09

32.97

u/l

0.24

208

840

Other disorders of eyelid

2696

19509

1.34

41.03

2.6

2.5

38.88

52.63

u/l

1.19

2264

16421

Ischaemic Stroke, excluding all haemorrhages

3344

19321

1.31

40.97

2.9

2.6

42.53

50.69

u/l

0.61

2790

16352

Other disorders of glucose regulation and pancreatic internal secretion

564

3153

1.93

40.70

5.2

2.6

28.98

54.38

u/l

1.00

443

2669

Superficial injury of thorax

970

6241

1.64

40.60

3.2

2.5

33.19

47.47

u/l

1.15

817

5301

Other disorders involving the immune mechanism, not elsewhere classified

256

1077

2.73

40.57

3.8

2.7

38.83

83.62

u/l

0.51

235

922

Insulin, fast-acting or short human

2221

16623

1.38

40.39

5.6

2.5

69.33

42.79

u/l

0.34

1697

14211

ILD, hospital admission 2, with pulmonary infections

605

3454

1.87

40.33

3.3

2.3

36.94

56.01

u/l

0.75

546

2918

Extrapyramidal and movement disorders

2355

17808

1.37

40.21

2.6

2.5

34.66

48.93

u/l

1.98

1966

15031

Other systemic involvement of connective tissue (FG)

1625

11375

1.46

40.17

2.5

2.4

52.62

44.75

u/l

0.24

1377

9542

Mixed disorders of conduct and emotions, excluding more controls

155

496

3.50

40.11

2.4

2.3

24.22

32.91

u/l

4.31

122

425

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2088

15542

1.39

39.78

2.7

2.6

91.82

44.23

u/l

0.58

1772

13187

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

241

999

2.78

39.49

3.9

2.7

39.37

87.53

u/l

0.51

221

859

Disorders of psychological development

724

4028

1.75

39.43

2.4

2.6

29.54

48.21

u/l

0.91

614

3407

Disorders of choroid and retina

4999

28806

1.24

39.43

3.4

2.5

41.03

51.08

u/l

0.92

4151

24480

Ulcerative enterocolitis

242

1004

2.74

39.28

4.6

2.5

53.37

82.04

u/l

0.25

223

852

Acute pharyngitis

942

5989

1.63

39.26

2.8

2.6

31.17

41.04

u/l

2.49

790

5137

Other arthritis (FG)

1932

14249

1.40

38.95

2.9

2.6

38.28

45.93

u/l

1.02

1607

12070

Other and unspecified diseases of blood and blood-forming organs

219

877

2.90

38.71

2.8

2.4

35.98

35.48

u/l

0.05

188

734

Poisoning by narcotics and psychodysleptics [hallucinogens]

157

531

3.56

38.40

3.4

2.7

27.44

124.18

u/l

0.56

133

456

Malignant neoplasm of bladder, including Hilmo

617

3532

1.81

38.27

2.7

2.2

39.30

38.80

u/l

0.06

523

2911

Other specified/unspecified hearing loss

617

3612

1.84

38.17

2.7

2.5

33.75

41.27

u/l

2.36

522

3041

Symptoms and signs involving emotional state

239

999

2.70

38.04

3.4

2.4

31.12

85.03

u/l

0.58

213

842

Candidiasis

923

5969

1.63

38.00

3.3

2.4

34.93

45.86

u/l

0.72

791

5031

Disorders of vestibular function (Vertigo)

2881

21952

1.31

37.95

2.8

2.5

41.96

51.52

u/l

0.66

2413

18516

Rheumatism, unspecified

833

5262

1.67

37.87

3.1

2.3

32.05

40.52

u/l

3.20

681

4409

Other ulcerative colitis

399

2046

2.13

37.84

3.9

2.4

40.85

61.72

u/l

0.42

369

1739

Other neurological diseases

4405

27925

1.25

37.83

2.9

2.5

36.36

51.26

u/l

2.53

3706

23636

Suppurative and necrotic conditions of lower respiratory tract

383

1940

2.17

37.73

3.9

2.6

39.45

39.30

u/l

0.01

336

1647

Benign neoplasm of other and unspecified endocrine glands

857

5468

1.66

37.69

2.7

2.5

68.70

48.97

u/l

0.30

746

4608

Toxic effect of other and unspecified substances

129

394

4.01

37.41

4.8

2.6

24.04

150.96

u/l

0.53

114

334

Other diseases of arteries and capillaries

583

3373

1.85

37.40

4.1

2.5

32.65

52.14

u/l

0.76

499

2845

Amputation

626

3703

1.80

36.87

4.3

2.5

37.77

38.39

u/l

0.05

495

3138

Cervicobrachial syndrome

1322

9230

1.49

36.82

2.9

2.4

108.61

49.37

u/l

0.44

1123

7879

Other orthopaedic follow-up care

386

1974

2.13

36.78

2.9

2.3

31.23

66.75

u/l

0.83

318

1666

Other retinal disorders

3909

24058

1.26

36.58

3.6

2.5

42.87

51.98

u/l

0.60

3227

20399

Other and unspecified drugs and medicaments

573

3329

1.85

36.49

3.3

2.5

67.92

53.56

u/l

0.15

511

2800

Clear cell adenocarcinoma of kidney

308

1457

2.33

36.42

3.1

2.3

44.57

41.56

u/l

0.18

273

1200

Senile cataract

3731

18235

1.27

36.30

3.3

2.5

40.37

45.55

u/l

0.74

3135

15508

Other surgical follow-up care

259

1145

2.53

36.25

4.2

2.3

35.59

39.54

u/l

0.29

228

975

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

643

3861

1.78

36.23

3.1

2.5

183.85

51.79

u/l

0.61

543

3256

Traumatic subdural haemorrhage

803

4729

1.66

36.21

2.9

2.5

42.16

57.03

u/l

0.46

674

4057

Toxic liver disease

147

497

3.59

36.19

5.0

2.3

592.57

33.90

u/l

0.51

133

415

Viral and other specified intestinal infections

1196

7999

1.51

36.18

3.7

2.4

37.05

43.43

u/l

0.49

1030

6819

Zoster [herpes zoster]

1157

7929

1.53

35.99

2.9

2.5

70.75

44.89

u/l

0.39

997

6691

Schizoaffective disorder

495

2766

1.93

35.87

2.6

27.95

58.29

u/l

1.09

408

2366

malignant neoplasm of female genital organs, including Hilmo

1005

6368

1.57

35.86

2.3

2.2

126.73

40.38

u/l

0.50

843

5283

Temporomandibular joint disorders, including avohilmo

2749

20850

1.31

35.69

2.7

2.5

35.38

41.60

u/l

1.51

2351

17693

Intentional self-harm by unspecified means

134

432

3.78

35.68

3.7

2.5

29.76

30.92

u/l

0.21

103

355

Other specified/unspecified bacterial intestinal infections

455

2489

1.99

35.64

2.9

2.4

34.89

59.01

u/l

0.67

378

2108

Malignant melanoma of skin, including Hilmo

796

5036

1.66

35.62

3.0

2.3

36.41

49.05

u/l

0.68

681

4203

Benign neoplasm: Caecum

697

4297

1.74

35.59

3.0

2.5

66.31

40.11

u/l

0.43

614

3626

Other acute viral hepatitis

132

425

3.87

35.54

4.1

2.6

26.68

142.51

u/l

0.52

116

364

Malignant neoplasm of other and unspecified female genital organs

152

532

3.49

35.41

2.5

2.0

33.34

36.58

u/l

0.36

128

430

Diabetic nephropathy

973

6393

1.59

35.38

7.4

2.9

45.35

57.72

u/l

0.33

803

5253

Malignant neoplasm of oesophagus, including Hilmo

237

1019

2.58

35.14

2.8

2.2

326.69

42.31

u/l

0.48

206

836

Sequelae of other external causes

397

2087

2.07

35.08

3.1

2.5

110.61

63.76

u/l

0.26

342

1763

Thoracic aortic aneurysm

860

5577

1.63

35.03

2.5

2.6

42.11

47.91

u/l

0.24

731

4782

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

304

1451

2.30

34.97

2.7

2.1

34.78

38.85

u/l

0.78

255

1184

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1046

6858

1.55

34.85

3.1

2.6

43.63

43.95

u/l

0.01

925

5807

Gastrointestinal stromal tumor and sarcoma

113

333

4.20

34.73

3.0

1.9

40.64

37.04

u/l

0.18

104

268

Carcinoma in situ of colon

233

1012

2.65

34.70

2.6

2.5

47.03

41.57

u/l

0.21

194

850

Exposure to other and unspecified inanimate mechanical forces

511

2914

1.88

34.62

3.4

2.6

29.93

55.95

u/l

0.94

447

2481

Other systemic involvement of connective tissue

1665

12237

1.41

34.59

2.5

52.02

42.27

u/l

0.33

1412

10266

Endocarditis

256

1149

2.48

34.54

3.2

2.6

33.00

86.58

u/l

0.70

224

978

Malignant neoplasm of mesothelium and soft tissue

266

1213

2.42

34.41

2.6

2.2

42.48

36.58

u/l

0.27

226

990

Other degenerative diseases of the nervous system

1678

8933

1.41

34.23

2.5

2.4

53.61

50.91

u/l

0.06

1381

7590

Thrombocytopenia, unspecified

473

2648

1.93

34.23

3.0

2.5

32.59

57.96

u/l

0.77

393

2221

IgA nephropathy (IgA glomerulonephritis)

196

792

2.87

34.10

3.3

2.5

40.56

95.39

u/l

0.45

179

683

Secondary and unspecified malignant neoplasm of lymph nodes

487

2745

1.89

33.98

2.7

2.3

36.55

38.61

u/l

0.28

412

2289

Peripheral arterial reconstruction

975

6531

1.56

33.89

2.8

2.5

109.11

39.42

u/l

0.46

808

5514

Cluster headache, strict

269

1244

2.40

33.79

3.0

2.6

31.19

40.89

u/l

2.18

232

1072

Disorders of breast

2981

20887

1.29

33.49

2.4

37.43

44.80

u/l

0.87

2539

17525

Other and unspecified disorders of vitreous body

2558

19614

1.31

33.36

2.6

2.5

44.81

52.74

u/l

0.50

2143

16514

Benign neoplasm: Transverse colon

692

4329

1.71

33.30

3.3

2.5

70.06

51.06

u/l

0.26

604

3652

Haemorrhoids and perianal venous thrombosis

1794

13273

1.38

33.29

2.8

2.3

35.32

52.07

u/l

1.78

1504

11144

Pruritus

734

4642

1.67

33.29

3.4

2.3

37.94

49.25

u/l

0.51

628

3888

DVT of lower extremities

1133

7848

1.51

33.26

3.1

2.5

63.95

47.24

u/l

0.34

980

6662

Emotional disorders starting during childhood or adolescence

310

1500

2.21

33.18

2.5

2.3

28.22

64.96

u/l

0.59

253

1248

Fracture at wrist and hand level

2082

15839

1.35

33.15

3.0

2.6

71.30

43.73

u/l

0.38

1776

13520

Valvular heart disease excluding rheumatic fever

2675

14965

1.31

33.15

2.8

2.5

52.75

59.17

u/l

0.20

2260

12694

Other infective otitis externa

414

2249

2.00

33.14

2.7

2.4

29.10

61.83

u/l

0.88

345

1892

Transient ischemic attack

3042

19327

1.28

33.12

2.8

2.5

38.35

50.61

u/l

1.54

2544

16346

Injuries to the neck

1395

10030

1.44

33.06

3.2

2.6

32.97

43.59

u/l

1.40

1181

8538

Non-small cell lung cancer, adenocarcinoma, helper endpoint

424

2324

1.98

32.97

2.8

2.5

32.93

39.12

u/l

1.26

363

1946

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

977

6382

1.55

32.93

3.2

2.6

42.70

44.58

u/l

0.08

865

5408

Malignant melanoma of skin

670

4149

1.70

32.92

2.9

2.2

36.67

38.95

u/l

0.34

579

3454

Hypoglycaemia, other or unspecified

446

2481

1.94

32.87

5.3

2.6

29.40

58.61

u/l

0.87

354

2099

Other inflammation of vagina/vulva

277

1311

2.34

32.85

2.3

2.2

33.35

36.46

u/l

0.46

228

1085

Toxic effects of substances chiefly nonmedicinal as to source

710

4472

1.68

32.81

3.5

2.6

38.53

49.42

u/l

0.39

607

3802

Neuroendocrine tumor and carcinoma of pancreas

196

5.58

32.58

4.4

2.0

145.90

31.09

u/l

1.20

157

Peripheral artery operations in Hilmo

734

4659

1.65

32.44

3.9

2.5

138.00

48.16

u/l

0.43

595

3936

Otitis externa

1386

9993

1.44

32.43

2.9

2.6

34.79

45.08

u/l

1.17

1159

8497

Other protozoal intestinal diseases, including avohilmo

180

712

2.89

32.42

2.1

2.4

31.23

37.58

u/l

1.05

162

601

Conduction disorders

1693

10036

1.39

32.30

2.6

2.5

34.25

52.37

u/l

1.45

1418

8535

Diseases of spleen

155

574

3.18

32.17

5.4

2.6

37.65

42.50

u/l

0.24

139

478

Manic episode

221

961

2.57

32.16

2.5

30.30

37.76

u/l

0.87

178

823

Allergic urticaria

530

3119

1.81

32.07

3.1

2.5

34.59

53.62

u/l

0.65

446

2638

ILD, hospital admissions 3, with pneumonia sepsis

511

2975

1.83

32.00

3.2

2.4

35.80

42.92

u/l

2.07

458

2510

Irregular menses

2896

17304

1.29

31.95

2.7

2.3

65.62

38.37

u/l

0.44

2430

14643

Acute and transient psychotic disorders

711

4509

1.66

31.92

2.9

2.6

29.80

51.75

u/l

1.38

608

3861

Fibroblastic disorders

1321

9460

1.44

31.90

2.9

2.5

37.79

40.99

u/l

0.29

1113

8004

Fitting and adjustment of other devices

1084

13670

0.68

31.89

2.7

2.3

48.38

47.32

u/l

0.03

869

11502

Other symptoms and signs involving general sensations and perceptions

294

1439

2.25

31.89

3.6

2.4

29.48

69.43

u/l

0.63

258

1216

Excessive, frequent and irregular menstruation

2167

8800

1.35

31.88

2.7

2.4

32.74

40.54

u/l

1.86

1775

7430

Cramp and spasm

334

1715

2.14

31.86

3.6

2.5

32.82

68.28

u/l

0.68

284

1446

Disorders of synovium and tendon

3150

21489

1.27

31.84

2.7

2.5

44.80

43.88

u/l

0.04

2620

18322

Dissociative [conversion] disorders

255

1178

2.37

31.79

3.4

2.2

34.76

39.14

u/l

0.30

230

967

Radiculopathy

928

6231

1.55

31.77

2.9

2.4

33.61

49.11

u/l

1.29

771

5310

Crushed, pushed or stepped on by crowd or human stampede

478

2736

1.86

31.77

2.6

2.7

31.01

56.93

u/l

0.85

420

2333

Malignant neoplasm, without specification of site, including Hilmo

286

1378

2.24

31.71

3.0

2.3

38.11

76.30

u/l

0.53

246

1125

Mycoses

1679

12522

1.39

31.70

3.2

2.6

34.31

44.55

u/l

1.69

1446

10611

Fracture of femur

1601

10648

1.40

31.70

2.8

2.5

36.67

43.29

u/l

0.73

1330

8948

Primary biliary cholangitis (PBC)

185

754

2.85

31.69

4.5

2.2

46.02

37.35

u/l

0.84

172

625

Speech and linguistic disorders

535

3021

1.80

31.64

2.6

2.5

28.79

50.77

u/l

0.77

462

2542

Cluster headache, wide

279

1344

2.29

31.55

3.0

2.6

30.99

40.33

u/l

2.23

240

1151

Other enthesopathies

1737

13012

1.37

31.48

2.8

2.5

38.11

41.05

u/l

0.44

1458

11077

Excessive attrition of teeth

3716

30219

1.24

31.45

2.7

2.6

39.14

44.46

u/l

0.82

3163

25708

Reimbursement for rheumatic diseases

3413

27656

1.25

31.30

3.0

2.5

49.76

48.58

u/l

0.04

2947

23361

Dementia in Alzheimer disease

423

6207

0.55

31.24

2.2

2.4

44.60

39.27

u/l

0.17

340

5179

Malignant neoplasm of other connective and soft tissue, including Hilmo

268

1276

2.31

31.15

2.8

2.2

45.20

80.23

u/l

0.42

230

1046

Benign neoplasm: Liver/bile ducts

207

892

2.64

31.13

3.3

2.5

32.29

39.31

u/l

1.16

171

748

Hypothyroidism, other/unspecified

5406

30086

1.20

31.12

2.6

2.5

37.44

46.73

u/l

1.97

4495

25621

Superficial injury of ankle and foot

768

4980

1.62

31.09

3.2

2.5

48.89

38.79

u/l

0.24

642

4240

Noninflammatory disorders of female genital tract

2289

8821

1.33

31.07

2.4

34.49

40.51

u/l

1.15

1893

7443

Non-rheumatic valve diseases

2646

14893

1.30

31.06

2.8

2.5

52.99

59.30

u/l

0.20

2235

12633

Unspecified acute lower respiratory infection

922

6216

1.55

31.06

3.2

2.7

69.77

50.43

u/l

0.21

781

5306

Colonic or urogenital fistula

1587

11781

1.39

30.95

2.6

40.33

45.32

u/l

0.30

1360

10032

Laparoscopic right hemicolectomy

394

2165

2.00

30.83

2.8

2.4

35.96

38.45

u/l

0.33

339

1805

Superficial injury of hip and thigh

922

6225

1.55

30.77

2.9

2.5

39.14

46.44

u/l

0.34

764

5249

Agranulocytosis

693

4416

1.66

30.74

3.5

2.5

33.43

49.57

u/l

0.83

603

3714

Nephrotic syndrome

229

1037

2.49

30.64

4.3

2.6

45.15

86.63

u/l

0.43

206

879

Campylobacter enteritis

211

923

2.59

30.63

3.1

2.6

96.84

42.31

u/l

0.44

194

788

Carcinoma in situ of skin

545

3281

1.78

30.62

2.8

2.5

32.18

41.07

u/l

3.08

461

2727

Pyothorax

296

1479

2.20

30.49

3.6

2.5

41.98

39.21

u/l

0.14

257

1247

Congenital malformations of gallbladder, bile ducts and liver

103

314

4.17

30.47

6.9

2.2

46.40

31.57

u/l

1.57

255

Amputation of toe

445

2534

1.89

30.41

4.4

2.6

38.44

36.95

u/l

0.09

358

2133

Hypothyroidism, strict autoimmune

4395

24028

1.22

30.28

2.5

2.4

37.80

44.53

u/l

1.03

3646

20413

Barrett oesophagus

331

1724

2.10

30.21

4.1

2.4

34.21

43.08

u/l

1.18

276

1474

Diseases of inner ear

3252

25335

1.26

30.13

2.7

2.6

41.26

49.84

u/l

0.68

2732

21420

Biological medication for rheuma

1062

7410

1.49

30.01

3.0

2.6

40.86

46.72

u/l

0.37

928

6325

Benign paroxysmal vertigo

1769

13413

1.36

29.99

2.9

2.5

44.11

45.94

u/l

0.07

1477

11327

Sacrococcygeal disorders, not elsewhere classified

222

997

2.47

29.96

2.7

2.2

139.77

43.72

u/l

0.49

185

848

Other aneurysm

342

1807

2.05

29.67

3.2

2.5

81.54

65.29

u/l

0.13

294

1512

Myocarditis

284

1399

2.18

29.66

2.9

2.3

36.83

40.09

u/l

0.44

250

1218

Other and unspecified paralytic syndromes

126

436

3.44

29.66

3.8

2.5

28.94

45.09

u/l

0.86

107

360

General examination and investigation of persons without complaint and reported diagnosis

3453

14541

1.25

29.61

3.1

2.3

65.29

49.16

u/l

0.41

2925

12421

Open wound of ankle and foot

635

3998

1.68

29.40

3.9

2.5

36.52

39.51

u/l

0.37

530

3388

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1732

13115

1.36

29.30

2.6

36.88

44.34

u/l

0.91

1471

11202

Malignant neoplasm of head and neck, including Hilmo

528

3170

1.75

29.25

2.8

2.3

86.96

55.31

u/l

0.28

448

2647

Neuromuscular dysfunction of bladder

533

3217

1.76

29.22

2.9

2.5

32.94

55.95

u/l

0.88

455

2739

Late syphilis, including avohilmo

143

537

3.15

29.02

4.2

2.5

39.34

124.90

u/l

0.47

118

453

Late syphilis

121

416

3.50

28.93

4.7

2.7

40.44

150.90

u/l

0.48

104

356

Atypical facial pain

361

1969

2.00

28.76

3.3

2.4

31.70

40.24

u/l

1.70

316

1658

Other congenital malformations of the digestive system, including avohilmo

334

1758

2.05

28.73

4.3

2.4

41.05

62.77

u/l

0.36

294

1454

Presence of other devices

726

10768

0.64

28.56

2.6

2.4

54.97

46.41

u/l

0.17

584

9026

Other/unspecified enthesopathies of lower limb, excluding foot

454

2642

1.83

28.54

2.8

2.3

29.61

58.75

u/l

0.97

384

2266

Anosmia

130

434

3.12

28.54

3.4

1.7

32.21

38.28

u/l

0.91

114

364

Abnormal blood-pressure reading, without diagnosis

301

1544

2.11

28.44

3.1

2.2

35.07

72.52

u/l

0.64

244

1311

Diseases of external ear

2100

16400

1.32

28.36

2.8

2.6

36.51

47.97

u/l

1.35

1770

13923

Other and unspecified tonsillitis

1917

12235

1.33

28.31

2.7

2.6

41.76

43.78

u/l

0.10

1637

10536

Pericarditis

242

1151

2.31

28.30

3.9

2.5

32.16

86.17

u/l

0.70

201

977

Disorders of mineral metabolism

505

3033

1.77

28.24

4.1

2.4

40.70

55.39

u/l

0.43

428

2551

AV-block

993

5874

1.50

28.23

2.6

2.4

36.89

61.27

u/l

1.00

824

5013

Osteoporosis

1598

11055

1.37

28.13

3.2

2.4

41.06

47.12

u/l

0.44

1387

9240

Osteonecrosis

421

2421

1.88

28.13

2.7

2.5

35.46

42.13

u/l

0.80

350

2043

Hordeolum and other deep inflammation of eyelid

404

2291

1.90

28.12

2.6

2.5

38.07

60.33

u/l

0.52

351

1956

Other noninflammatory disorders of vulva and perineum

581

3616

1.69

28.11

2.6

2.4

33.82

38.63

u/l

1.68

493

3036

Malignant neoplasm of retroperitoneum and peritoneum

217

4.72

28.04

2.8

2.1

34.93

34.31

u/l

0.04

181

Chronic hepatitis NAS

119

415

3.47

27.90

3.5

2.5

33.76

33.80

u/l

0.00

106

346

Acidosis

161

651

2.82

27.80

5.1

2.7

43.17

42.56

u/l

0.02

146

552

Uterine polyps

1611

7029

1.38

27.76

2.4

37.13

42.17

u/l

0.57

1334

5944

Premature rupture of membranes

583

6543

0.61

27.73

2.3

2.5

47.13

39.13

u/l

0.32

491

5593

Hypothyreosis and Thyroxine purchase for inclusion criteria

5588

31370

1.18

27.70

2.6

2.5

37.20

48.19

u/l

1.99

4642

26700

Diplopia

787

5271

1.57

27.67

3.1

2.5

36.36

49.37

u/l

0.72

664

4449

Malignant neoplasm of head and neck

443

2577

1.82

27.66

2.9

2.3

97.10

59.21

u/l

0.29

380

2142

Specific development disorders of scholastic skills

283

1403

2.14

27.65

2.5

30.85

68.16

u/l

0.55

244

1174

COPD, hospital admissions 1, only main diagnosis

1909

12661

1.33

27.63

3.0

2.5

34.36

50.24

u/l

1.57

1604

10705

Iron deficiency anaemia secondary to blood loss (chronic)

941

6524

1.50

27.59

3.4

2.4

34.41

45.85

u/l

0.86

810

5496

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

636

4016

1.63

27.31

2.6

2.1

34.17

38.13

u/l

0.91

528

3327

Meniscus derangement

3262

17713

1.25

27.31

2.7

2.6

70.81

46.48

u/l

0.43

2738

15070

Diffuse large B-cell lymphoma

288

1478

2.11

27.25

2.4

2.3

39.39

39.08

u/l

0.02

254

1200

Diffuse large B-cell lymphoma, including Hilmo

288

1478

2.11

27.25

2.4

2.3

39.39

39.08

u/l

0.02

254

1200

Diffuse large B-cell lymphoma, helper endpoint

288

1478

2.11

27.25

2.4

2.3

39.39

39.08

u/l

0.02

254

1200

Pregnancy examination and test

868

3620

1.54

27.18

2.3

2.6

35.72

37.16

u/l

0.19

725

3066

Other and unspecified abdominal hernia

277

1410

2.16

27.14

4.0

2.3

38.62

41.45

u/l

0.12

246

1178

Emphysema

441

2583

1.82

27.13

3.2

2.5

36.10

40.86

u/l

0.51

386

2174

Dilated cardiomyopathy

679

4430

1.62

27.12

2.5

2.6

38.97

50.94

u/l

0.55

576

3789

Vitamin B12 deficiency anaemia

602

3814

1.66

27.10

3.7

2.4

38.32

52.12

u/l

0.52

509

3183

Nonsuppurative otitis media, including avohilmo

1865

12433

1.33

27.05

2.9

2.5

59.07

40.08

u/l

0.34

1590

10589

Immunodeficiencies

314

1670

2.05

27.04

2.9

2.5

33.78

68.08

u/l

0.62

272

1404

Glomerulonephritis

582

3669

1.68

27.01

3.8

2.6

76.75

51.70

u/l

0.40

519

3110

Type 1 diabetes

1419

10547

1.38

26.99

6.1

2.4

42.92

41.22

u/l

0.07

1078

9115

Degeneration of macula and posterior pole

2804

17505

1.26

26.97

2.5

44.70

49.08

u/l

0.19

2340

14748

Arthrosis

4217

19337

1.21

26.95

2.6

38.06

45.70

u/l

1.24

3570

16471

Oxicams

1187

4794

1.44

26.87

2.5

2.8

77.33

39.92

u/l

0.44

990

4106

malignant neoplasm of female genital organs

854

5711

1.53

26.84

2.3

2.2

144.21

40.88

u/l

0.51

712

4734

Other protozoal intestinal diseases

125

455

3.22

26.79

2.0

2.4

29.47

36.31

u/l

1.15

112

390

Plantar fascial fibromatosis

596

3780

1.66

26.78

2.8

2.3

44.76

42.38

u/l

0.09

509

3186

Salpingitis and oophoritis

1012

7161

1.47

26.72

2.8

2.3

38.41

37.54

u/l

0.07

847

6008

Necrosis of pulp, including avohilmo

3504

28758

1.23

26.65

2.9

2.6

48.32

44.62

u/l

0.10

2995

24555

Other necrotizing vasculopathies (FG)

380

2153

1.90

26.54

2.6

2.4

33.65

64.61

u/l

0.77

331

1822

Amenorrhoea

390

2213

1.86

26.50

3.0

2.3

30.43

37.32

u/l

2.18

325

1869

Psychotic depression

328

1766

1.97

26.39

2.8

2.4

43.30

36.40

u/l

0.37

270

1520

Postmenopausal bleeding

1536

5995

1.39

26.34

2.4

2.5

57.79

43.92

u/l

0.43

1266

5056

Anorexia (incl.atypical)

349

1921

1.93

26.33

2.4

32.32

60.54

u/l

0.57

304

1596

Localized swelling, mass and lump of skin and subcutaneous tissue

1869

14522

1.32

26.31

2.9

2.5

58.69

48.88

u/l

0.20

1590

12307

Benign neoplasm of mouth and pharynx

654

4263

1.62

26.30

2.8

2.5

36.65

49.87

u/l

0.60

550

3605

Other salmonella infections, including avohilmo

278

1431

2.11

26.15

3.4

2.3

34.37

73.30

u/l

0.62

240

1225

Personal history of risk-factors, not elsewhere classified

125

462

3.18

26.08

3.4

2.2

32.31

138.96

u/l

0.50

110

384

Symptoms and signs involving the nervous and musculoskeletal systems

3439

28577

1.23

26.08

3.0

2.5

45.87

47.91

u/l

0.09

2919

24198

Other congenital malformations, including avohilmo

752

5046

1.56

26.05

2.6

2.5

31.16

47.55

u/l

1.05

648

4271

Malignant neoplasm of bladder

341

1868

1.92

25.82

2.6

2.2

42.39

39.71

u/l

0.24

283

1505

Other specified/unspecified dorsopathies

233

1133

2.25

25.77

2.5

2.2

30.91

43.06

u/l

1.77

188

970

Other respiratory diseases principally affecting the interstitium

1021

7279

1.46

25.73

3.1

2.5

44.85

45.71

u/l

0.03

903

6107

Other congenital malformations of the digestive system

283

1464

2.08

25.72

4.6

2.5

40.80

67.96

u/l

0.38

246

1210

Superficial injury of forearm

616

3975

1.63

25.67

2.8

2.5

33.96

49.31

u/l

0.68

526

3359

Other necrotizing vasculopathies

448

2687

1.79

25.61

2.6

2.5

35.13

57.25

u/l

0.65

380

2254

Weight loss

624

4050

1.63

25.60

3.0

2.5

34.27

51.49

u/l

0.80

525

3395

Polyp of the female genital tract

1685

7253

1.35

25.53

2.4

36.82

42.33

u/l

0.68

1394

6130

Deviated nasal septum

1855

14435

1.32

25.50

2.6

2.7

37.94

50.46

u/l

1.35

1576

12353

Malignant neoplasm of anus and anal canal, including Hilmo

105

357

3.48

25.47

2.5

1.9

30.56

37.67

u/l

1.03

293

Benign neoplasm: Liver

179

792

2.55

25.40

3.1

2.5

32.70

39.52

u/l

0.93

147

669

Neuroendocrine tumor and carcinoma of small intestine

112

395

3.32

25.40

3.0

2.2

34.38

34.46

u/l

0.01

323

Alzheimer’s disease (Late onset), excluding more controls

843

3722

1.53

25.38

2.1

2.4

67.14

60.78

u/l

0.07

683

3167

Pneumonitis due to solids and liquids

482

2942

1.73

25.33

3.1

2.5

33.47

56.01

u/l

0.75

414

2472

Sleep apnoea

5775

31495

1.17

25.28

2.5

2.6

44.15

48.67

u/l

0.32

4810

26873

Diagnoses used for exclusion with ILD

1430

10774

1.37

25.26

3.0

2.6

36.72

50.39

u/l

1.02

1205

9134

Other pleural conditions

593

3811

1.64

25.25

3.1

2.5

40.52

39.17

u/l

0.11

510

3210

Other and/or unspecified nontoxic goitre

513

3196

1.71

25.22

2.7

2.4

43.37

40.97

u/l

0.12

424

2676

D07AA Corticosteroids, weak (group I)

882

6136

1.49

25.10

3.0

2.5

36.61

45.55

u/l

0.53

755

5192

Cluster headache, strict, including avohilmo

326

1795

1.96

25.08

2.9

2.6

32.20

67.81

u/l

0.73

282

1528

Scar conditions and fibrosis of skin

283

1491

2.07

25.08

2.5

2.2

31.40

37.61

u/l

1.46

248

1246

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

123

457

3.07

25.04

3.4

2.1

43.92

33.56

u/l

0.64

103

367

Other symptoms and signs involving the urinary system

598

3858

1.63

24.99

2.9

2.5

32.39

53.15

u/l

1.00

515

3279

L01XE Protein kinase inhibitors

341

1914

1.94

24.96

3.0

2.5

71.35

40.23

u/l

0.39

310

1613

Charcot foot

143

579

2.85

24.84

9.4

2.6

44.09

37.54

u/l

0.33

118

499

Other menopausal disorders

1524

6395

1.37

24.75

2.4

2.5

38.94

43.73

u/l

0.51

1275

5413

Squamous cell neoplasms and carcinomas of the skin

513

3188

1.68

24.73

2.5

2.1

34.09

37.71

u/l

0.64

424

2620

Infection of intervertebral disc (pyogenic)

116

425

3.22

24.68

2.8

2.3

28.50

144.39

u/l

0.53

366

Presence of cardiac and vascular implants and grafts

2532

15037

1.27

24.65

2.7

2.5

40.80

45.97

u/l

0.45

2129

12722

Acute gastritis

430

2568

1.77

24.64

3.6

2.4

36.36

39.05

u/l

0.31

362

2159

Ulcerative proctitis

383

2220

1.84

24.63

3.0

2.4

52.38

59.62

u/l

0.12

337

1872

Chondropathies

886

6210

1.49

24.63

3.2

2.6

34.24

46.01

u/l

0.84

768

5292

Deforming dorsopathies

1568

11997

1.34

24.61

2.6

2.4

37.51

46.88

u/l

1.25

1308

10179

Disorders of sclera, cornea, iris and ciliary body

3252

27046

1.23

24.61

3.0

2.6

54.05

46.02

u/l

0.29

2761

22996

Malignant neoplasm of rectosigmoid junction, including Hilmo

180

805

2.47

24.54

2.3

2.1

32.78

41.95

u/l

0.80

161

654

Exposure to other and unspecified animate mechanical forces

226

1110

2.24

24.50

2.6

2.5

30.31

83.96

u/l

0.66

192

932

Traumatic subarachnoid haemorrhage

245

1237

2.15

24.37

2.7

2.4

33.14

39.82

u/l

0.76

206

1053

Other spirochaetal diseases, including avohilmo

1993

15781

1.30

24.24

2.3

2.6

37.21

49.25

u/l

1.36

1691

13396

Otalgia

531

3369

1.67

24.11

2.9

2.5

30.70

53.41

u/l

0.92

448

2821

Disorders of parathyroid gland

1201

8783

1.40

24.09

3.4

2.4

45.98

44.24

u/l

0.07

1042

7335

Hypertensive Renal Disease

217

1049

2.23

24.06

3.5

2.3

44.83

37.73

u/l

0.44

188

883

Other and unspecified iridocyclitis

318

1763

1.95

24.06

2.5

36.82

68.33

u/l

0.59

271

1496

Other disorders of the musculoskeletal system and connective tissue

867

6088

1.49

23.99

2.8

2.5

38.94

47.41

u/l

0.48

736

5146

Artrosis, including avohilmo

4977

23362

1.18

23.96

2.6

2.7

40.77

45.97

u/l

0.53

4213

20008

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

792

5455

1.51

23.96

2.8

2.3

36.07

48.33

u/l

0.74

673

4566

Maternal care for known or suspected fetal abnormality and damage

911

5433

1.47

23.95

2.5

35.83

39.54

u/l

0.53

757

4652

Other predominantly sexually transmitted diseases, not elsewhere classified

949

6758

1.45

23.93

2.8

2.6

39.66

45.01

u/l

0.26

809

5784

Discitis, unspecified

131

518

2.90

23.81

2.9

2.3

28.71

125.23

u/l

0.54

110

447

Other bursitis of hip

161

702

2.59

23.67

2.9

2.1

37.01

42.30

u/l

0.53

139

597

Psoriasis

1643

12739

1.33

23.67

3.0

2.6

35.93

44.53

u/l

1.21

1420

10834

Other spirochaetal diseases

1964

15579

1.29

23.56

2.3

2.6

37.23

49.45

u/l

1.36

1667

13232

Malignant neoplasm of oesophagus

168

743

2.50

23.52

2.6

2.3

34.29

43.48

u/l

0.67

149

602

Pneumothorax

415

2490

1.77

23.51

3.3

2.6

42.37

61.59

u/l

0.42

362

2099

Immunodeficiency with predominantly antibody defects

188

878

2.40

23.44

2.8

2.6

35.15

96.71

u/l

0.57

157

730

Alcoholic gastritis

116

436

3.09

23.40

6.1

2.4

26.35

43.94

u/l

1.06

102

371

Dissocial personality disorder

127

500

2.93

23.37

3.0

27.95

137.09

u/l

0.62

111

440

Spirochaetal infections, other/unspecified, including avohilmo

1959

15550

1.29

23.37

2.3

2.6

37.27

49.48

u/l

1.36

1659

13214

Other diseases of blood and blood-forming organs

426

2583

1.76

23.37

2.7

2.6

35.39

58.08

u/l

0.65

373

2206

Behavioural disorders, excluding more controls

128

498

2.81

23.25

3.2

2.3

28.70

36.84

u/l

1.87

106

439

Other disorders of bladder

640

4255

1.57

23.22

2.6

2.5

33.65

52.44

u/l

0.99

536

3635

Open wound of forearm

574

3734

1.61

23.17

2.8

2.5

31.85

50.78

u/l

0.84

499

3161

Malignant neoplasm of breast, HER2-negative, including Hilmo

2263

11611

1.28

23.16

2.2

40.87

39.45

u/l

0.17

1916

9680

Malignant neoplasm of breast, including Hilmo

2263

11611

1.28

23.14

2.2

40.87

39.45

u/l

0.17

1916

9680

Hyperparathyroidism

1061

7667

1.42

23.12

3.5

2.4

47.50

45.21

u/l

0.08

916

6411

Hypertension, portal

7.09

23.08

5.6

2.5

30.77

31.97

u/l

0.07

severe traumatic brain injury, does not include concussion

1235

9231

1.38

23.08

2.8

2.6

78.90

38.77

u/l

0.51

1031

7841

Lyme disease, including avohilmo

1943

15436

1.29

23.03

2.3

2.6

37.36

49.55

u/l

1.34

1646

13113

Lyme disease

1943

15436

1.29

23.03

2.3

2.6

37.36

49.55

u/l

1.34

1646

13113

Cluster headache, wide,, including avohilmo

336

1917

1.88

22.99

3.0

2.6

32.01

65.69

u/l

0.75

290

1633

Left hemicolectomy

164

732

2.53

22.91

4.2

2.5

42.06

35.33

u/l

0.30

144

606

Haemolytic anaemias

232

1180

2.16

22.90

3.8

2.4

39.42

79.01

u/l

0.47

208

989

Abrasion of teeth

2121

17035

1.28

22.83

2.5

2.6

38.12

44.48

u/l

1.04

1802

14491

Pacemaker

1998

14788

1.29

22.80

2.6

2.5

38.41

51.25

u/l

1.24

1688

12487

Open wound of abdomen, lower back and pelvis

212

1045

2.23

22.73

3.8

2.7

30.06

86.72

u/l

0.67

174

892

Abnormal weight loss

564

3681

1.62

22.65

3.1

2.5

33.80

52.88

u/l

0.82

473

3084

Other superficial mycoses, including avohilmo

639

4273

1.56

22.64

2.8

2.5

78.78

49.41

u/l

0.26

548

3627

Viral warts, including avohilmo

1262

9494

1.37

22.60

2.8

2.6

37.51

43.20

u/l

0.50

1074

8079

Benign neoplasm: Descending colon

436

2687

1.73

22.55

2.9

2.5

33.47

40.10

u/l

1.71

373

2270

Shigellosis, including avohilmo

211

4.23

22.48

2.5

2.2

27.92

30.17

u/l

0.55

172

Helminthiases, including avohilmo

268

1437

2.02

22.45

2.7

2.4

32.31

70.77

u/l

0.58

226

1192

Vitreous haemorrhage

596

3943

1.59

22.43

6.7

2.5

39.79

51.68

u/l

0.46

501

3341

Previous suicide attempt

346

3.36

22.37

3.6

2.3

32.72

30.51

u/l

0.13

282

Crohn disease (strict definition, all UC cases excluded)

321

1823

1.89

22.30

3.3

2.5

36.19

64.63

u/l

0.54

289

1542

Hepatomegaly and splenomegaly, not elsewhere classified

219

3.96

22.28

3.8

1.9

31.60

60.06

u/l

0.76

182

Benign neoplasm: Endocrine pancreas

216

4.42

22.28

3.2

2.6

231.33

32.61

u/l

0.55

176

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1122

8307

1.39

22.23

2.7

2.5

41.53

42.86

u/l

0.06

947

7128

ILD, hospital admissions 1, main diag only

768

5352

1.50

22.21

3.0

2.5

36.17

48.87

u/l

0.77

690

4502

Schizophrenia

891

6368

1.45

22.16

2.5

2.7

33.05

50.29

u/l

1.26

741

5474

Restless leg syndrome

849

6034

1.47

22.02

2.5

32.15

47.16

u/l

1.17

708

5075

Intestinal helminthiases, other/unspecified, including avohilmo

7.71

21.94

3.5

3.2

30.09

27.38

u/l

0.36

Tumor necrosis factor alpha inhibitors

920

6628

1.44

21.86

3.0

2.7

41.43

45.36

u/l

0.21

805

5662

Toxic effect of ethanol

252

1338

2.04

21.77

4.1

2.7

29.70

75.41

u/l

0.70

205

1147

Disorders of muscles

589

3905

1.58

21.72

3.0

2.4

77.31

40.13

u/l

0.51

500

3307

Alcohol induced polyneuropathy

309

3.51

21.72

4.9

2.7

29.94

34.97

u/l

0.68

267

Disorders of calcium metabolism

375

2239

1.78

21.65

3.8

2.5

42.78

60.72

u/l

0.38

324

1877

Lactose intolerance

203

1002

2.21

21.62

2.6

2.4

35.98

86.29

u/l

0.52

171

842

ILD, hospital admissions

848

6044

1.46

21.60

3.0

2.5

36.78

47.47

u/l

0.71

761

5097

Open wound of wrist and hand

2583

20545

1.24

21.59

2.9

2.7

49.72

46.45

u/l

0.13

2209

17598

Other and unspecified immunodeficiencies with predominantly antibody defects

105

393

3.16

21.59

2.7

2.6

33.42

33.46

u/l

0.00

326

Gangrene, not elsewhere classified

201

4.17

21.58

2.3

2.1

64.08

31.01

u/l

0.58

163

Diabetic neuropathy

646

4365

1.55

21.58

5.1

3.1

32.00

65.51

u/l

0.99

513

3578

Viral pneumonia (known virus, not influenza)

196

960

2.26

21.56

2.9

2.6

48.65

39.81

u/l

0.18

171

798

Osteomyelitis

384

2313

1.77

21.55

5.2

2.6

37.73

62.80

u/l

0.62

314

1962

Malignant neoplasm of oral cavity, including Hilmo

257

1376

2.01

21.51

2.9

2.3

134.20

40.27

u/l

0.47

215

1132

Malignant neoplasm, without specification of site

186

886

2.26

21.47

3.2

2.2

36.50

39.72

u/l

0.21

160

701

Reactive arthropathies

502

3226

1.64

21.43

2.8

2.5

40.55

54.36

u/l

0.42

434

2738

Non-follicular lymphoma

541

3549

1.61

21.25

2.5

38.19

52.86

u/l

0.53

462

2975

Malignant neoplasm of breast, HER2-negative

2205

11473

1.27

21.24

2.2

41.02

39.42

u/l

0.19

1856

9557

Malignant neoplasm of breast

2208

11488

1.27

21.24

2.2

40.99

39.54

u/l

0.17

1858

9571

Viral agents as the cause of diseases classified to other chapters, including avohilmo

178

846

2.34

21.21

3.1

2.4

32.01

34.28

u/l

0.47

148

713

Metatarsalgia

560

3694

1.59

21.21

2.9

2.3

34.53

41.23

u/l

1.24

462

3105

Unspecified lump in breast

909

6580

1.44

21.18

2.5

2.4

34.95

38.34

u/l

0.57

757

5502

Follicular cysts of skin and subcutaneous tissue

1055

7814

1.40

21.16

2.9

2.6

39.24

47.20

u/l

0.57

891

6646

Arterial embolism and thrombosis

328

1897

1.84

21.15

2.9

2.5

47.96

37.61

u/l

0.30

291

1577

Other and unspecified glaucoma

429

2674

1.70

21.11

3.1

2.5

44.45

55.97

u/l

0.25

350

2234

Algoneurodystrophy

217

1110

2.14

21.06

2.8

2.4

30.64

41.25

u/l

1.44

183

935

Adhesive capsulitis of shoulder

923

6694

1.43

21.04

2.8

2.5

33.55

40.96

u/l

3.20

765

5689

Unspecified event, undetermined intent

181

869

2.31

21.02

3.5

2.5

34.06

98.00

u/l

0.60

156

733

Enteropathic arthropathies

163

750

2.41

21.00

3.0

2.5

47.35

102.58

u/l

0.41

142

640

Malignant neoplasm of ovary, including Hilmo

363

2170

1.78

20.99

2.1

2.2

280.76

39.21

u/l

0.50

303

1815

Contact with sharp object, undetermined intent

176

836

2.34

20.99

2.5

2.8

37.15

95.96

u/l

0.52

146

722

Other interstitial pulmonary diseases

854

6125

1.45

20.97

3.0

2.5

36.71

47.36

u/l

0.72

765

5161

Injury of intra-abdominal organs

171

802

2.36

20.96

3.3

2.7

435.44

101.37

u/l

0.38

149

680

Abnormal findings in nipple discharge synovial fluid wound secretions

122

499

2.83

20.93

4.6

2.4

41.08

37.61

u/l

0.19

103

413

Acne, including avohilmo

1208

7348

1.36

20.90

2.9

2.4

32.13

42.24

u/l

0.87

1043

6252

Diseases of the ear and mastoid process

7094

31510

1.14

20.88

2.8

2.6

42.91

48.84

u/l

0.34

6031

26836

Other diseases of pericardium

275

1521

1.94

20.87

3.3

2.5

29.90

75.64

u/l

0.83

223

1298

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

309

1724

1.86

20.84

2.5

2.4

28.15

62.10

u/l

0.64

261

1445

Interstitial lung disease endpoints

854

6134

1.45

20.80

3.0

2.5

36.71

47.27

u/l

0.71

765

5165

Interstitial lung disease

854

6134

1.45

20.80

3.0

2.5

36.71

47.27

u/l

0.71

765

5165

Cervical disc disorders

1970

15850

1.27

20.73

2.9

2.5

86.56

49.41

u/l

0.40

1669

13506

Diseases of the myoneural junction and muscle

698

4843

1.50

20.66

3.2

2.5

71.43

48.36

u/l

0.32

584

4088

Ulcerative rectosigmoiditis

471

3011

1.65

20.65

3.2

2.5

47.10

53.67

u/l

0.14

409

2558

Tinnitus

1393

10777

1.33

20.62

2.6

35.86

44.68

u/l

1.16

1180

9153

Chronic nephritic syndrome

242

1294

2.03

20.61

3.6

2.6

94.65

42.51

u/l

0.46

209

1099

Bacterial, viral and other infectious agents, including avohilmo

530

3482

1.60

20.60

3.3

2.8

42.58

53.23

u/l

0.30

449

3008

Carcinoma in situ of skin of trunk

219

1137

2.12

20.52

2.7

2.5

33.38

37.73

u/l

0.86

178

928

Dislocation, sprain and strain of joints and ligaments of knee

3547

27263

1.19

20.52

2.7

2.6

36.52

48.12

u/l

2.25

3045

23282

Protozoal diseases, including avohilmo

209

1069

2.16

20.48

3.4

2.5

36.70

36.45

u/l

0.03

183

907

Persons encountering health services in other circumstances

2160

17368

1.25

20.44

3.4

2.3

41.62

51.98

u/l

0.65

1842

14679

Personal history of allergy to drugs, medicaments and biological substances

100

375

3.11

20.38

2.8

2.0

52.41

34.40

u/l

0.63

310

Maltreatment syndromes

310

1786

1.85

20.37

2.9

2.6

30.36

64.74

u/l

0.70

259

1529

Other and unspecified urticaria

1100

8245

1.38

20.32

2.8

2.5

112.35

44.54

u/l

0.42

937

6969

Tubulo-interstitial nephritis, not specified as acute or chronic

386

2359

1.73

20.29

3.6

2.3

37.15

38.29

u/l

0.11

330

1949

Carcinoma in situ of skin of scalp and neck

190

946

2.23

20.13

2.9

2.4

33.62

37.10

u/l

0.57

169

785

Fracture of forearm

3302

25124

1.20

20.10

2.8

2.5

37.34

47.77

u/l

1.55

2771

21272

Internal derangement of knee

2129

17154

1.25

20.05

2.6

117.41

46.31

u/l

0.74

1776

14592

Malignant neoplasm of breast, ER-positive, including Hilmo

1727

10178

1.29

19.99

2.2

44.99

39.59

u/l

0.40

1440

8448

Protozoal diseases

202

1031

2.17

19.96

3.5

2.5

37.01

36.14

u/l

0.10

177

875

Poisoning by medicine, drug-induced

108

427

2.95

19.92

3.4

2.7

44.26

35.54

u/l

0.24

101

356

Female infertility, cervical, vaginal, other or unspecified origin

1385

6803

1.33

19.91

2.3

2.4

33.87

37.29

u/l

0.88

1181

5748

Malignant neoplasm of breast, HER-positive

1722

10163

1.29

19.91

2.2

45.06

39.60

u/l

0.40

1436

8436

COPD-related respiratory insufficiency

635

4358

1.52

19.85

3.2

2.5

30.41

39.55

u/l

4.54

538

3673

Viral agents as the cause of diseases classified to other chapters

156

724

2.41

19.83

3.2

2.4

32.19

34.26

u/l

0.37

130

612

Somnolence, stupor and coma

257

1413

1.95

19.82

4.4

2.5

30.68

74.26

u/l

0.69

223

1188

Sequelae of cerebrovascular disease

1965

13541

1.27

19.80

2.8

2.5

38.30

53.01

u/l

1.29

1625

11436

Thyrotoxicosis

1439

11235

1.32

19.78

2.6

2.5

100.85

41.94

u/l

0.49

1211

9467

Valvular operations

728

5122

1.47

19.71

2.7

2.6

41.84

65.06

u/l

0.76

638

4412

Papulosquamous disorders

2249

18469

1.24

19.66

2.8

2.6

38.41

48.05

u/l

1.05

1919

15657

Small fibre neuropathy

204

1051

2.14

19.64

3.8

2.5

36.88

40.14

u/l

0.27

176

880

Maternal care for (suspected) damage to fetus from alcohol

106

6.12

19.62

3.4

2.6

28.68

29.08

u/l

0.04

Thyrotoxicosis, other and/or unspecified

1154

8765

1.36

19.51

2.7

2.4

116.26

43.61

u/l

0.48

976

7417

Gonarthrosis

3673

17673

1.19

19.49

2.5

2.6

58.45

46.72

u/l

0.25

3085

15023

Carcinoma in situ of rectum

109

439

2.92

19.49

2.0

2.5

38.20

32.14

u/l

1.12

373

Other disorders of white blood cells

330

1967

1.80

19.46

2.9

2.5

33.92

64.79

u/l

0.67

288

1657

Abnormal findings on antenatal screening of mother

135

2901

0.45

19.39

2.3

63.14

34.26

u/l

0.50

118

2455

malignant neoplasm of male genital organs, including Hilmo

1343

6179

1.33

19.36

2.4

2.5

35.98

51.92

u/l

1.18

1113

5237

Molar incisor enamel hypoplasia, with caries

224

3.76

19.34

3.3

2.1

40.48

29.17

u/l

0.77

181

Other and unspecified psoriasis

406

2552

1.69

19.34

3.1

2.5

34.62

59.16

u/l

0.71

343

2165

Prurigo nodularis

170

824

2.29

19.33

3.6

2.3

31.79

38.62

u/l

1.05

143

690

Melanocytic naevi

1763

14135

1.28

19.31

2.9

2.6

34.74

48.03

u/l

1.43

1522

12016

Other symptoms and signs involving the digestive system and abdomen

732

5162

1.46

19.24

3.0

1.9

33.43

42.04

u/l

3.63

620

4229

Lactose intolerance, other/unspecified

180

889

2.21

19.23

2.7

2.4

36.63

91.30

u/l

0.49

153

745

Adalimumab

576

3912

1.54

19.09

3.4

2.6

39.38

51.95

u/l

0.50

501

3337

Herpesviral [herpes simplex] infections

674

4717

1.49

19.07

3.0

2.5

35.83

49.32

u/l

0.71

580

3993

Lung diseases due to external agents

737

5232

1.46

19.06

3.2

2.5

33.85

48.32

u/l

0.91

631

4419

Abnormal results of function studies

525

3504

1.57

19.02

3.8

2.5

35.88

52.66

u/l

0.64

451

2973

Intentional self-harm by sharp object

174

853

2.23

19.01

3.7

2.4

26.39

89.71

u/l

0.58

141

716

Mixed disorders of conduct and emotions

155

726

2.33

18.95

2.4

2.3

24.22

34.13

u/l

4.42

122

604

Sleep apnoea, including avohilmo

6027

32247

1.14

18.93

2.5

2.6

45.90

48.06

u/l

0.12

5032

27508

Pneumocystosis

140

638

2.49

18.83

3.9

2.6

38.89

35.64

u/l

0.37

126

534

Pneumocystosis, including avohilmo

140

638

2.49

18.83

3.9

2.6

38.89

35.64

u/l

0.37

126

534

Non-Hodgkin lymphoma, all

236

1282

1.96

18.82

2.4

2.2

37.90

38.99

u/l

0.08

201

1043

Other enthesopathy of foot (+metatarsalgia)

595

4075

1.52

18.81

2.9

2.3

34.34

40.65

u/l

1.27

495

3426

Atopic dermatitis, strict definition with reimbursement

1679

12893

1.28

18.61

2.8

2.5

36.41

43.46

u/l

0.95

1434

10984

Spondyloarthritis

960

7140

1.38

18.59

2.8

2.5

73.79

45.24

u/l

0.35

807

6039

Other arterial embolism and thrombosis

175

866

2.20

18.58

3.0

2.4

63.54

35.30

u/l

0.47

152

721

Oesophageal obstruction

213

1130

2.04

18.52

3.2

2.3

41.55

40.37

u/l

0.06

182

939

Other congenital malformations

483

3181

1.59

18.51

2.9

2.5

30.34

52.87

u/l

0.85

432

2678

Congenital malformation of biliary tract

6.94

18.36

8.0

3.4

60.19

29.55

u/l

1.27

Diseases of male genital organs

2721

11411

1.22

18.32

3.1

2.9

37.46

60.14

u/l

2.00

2338

9917

Other mycoses, not elsewhere classified/unspecified, including avohilmo

139

638

2.46

18.31

3.4

2.4

30.60

34.65

u/l

0.64

117

527

Reactive arthropathies, FINNGEN

412

2630

1.65

18.29

2.8

2.6

41.66

59.28

u/l

0.45

357

2243

Dependence on enabling machines and devices, not elsewhere classified

360

3.03

18.28

4.9

2.3

44.05

29.59

u/l

1.51

293

Complications of internal orthopaedic prosthetic devices, implants and grafts

1223

9451

1.33

18.22

2.8

2.4

49.37

43.89

u/l

0.17

980

7931

Female infertility

1483

6961

1.31

18.21

2.3

2.4

33.56

37.11

u/l

1.01

1262

5879

Suggestive for eosinophilic asthma

516

3467

1.56

18.11

2.6

2.5

33.89

53.78

u/l

0.80

434

2940

Carbimazole or st.post thyroidectomy, condition for graves disease

1179

9080

1.34

18.10

2.6

2.5

40.07

43.24

u/l

0.20

993

7670

Multiple myeloma, including Hilmo

241

1338

1.92

18.02

2.9

2.3

45.40

42.06

u/l

0.16

201

1078

Gestational diabetes (for exclusion)

1925

10733

1.26

17.99

2.4

36.92

38.66

u/l

0.20

1602

9126

Other problems related to primary support group, including family circumstances

602

4048

1.50

17.96

3.2

2.5

34.62

48.15

u/l

0.56

494

3430

Inguinal or femoral hernia, bilateral

554

3777

1.53

17.93

2.6

41.50

53.35

u/l

0.39

483

3224

Neuralgia and neuritis, unspecified

311

1866

1.77

17.80

2.8

2.3

53.27

42.28

u/l

0.26

260

1585

Childhood asthma (age<16), excluding more controls

637

3448

1.48

17.78

2.6

2.3

31.08

60.75

u/l

1.16

538

2973

Vasomotor and allergic rhinitis

2114

17024

1.24

17.62

2.3

2.6

36.66

41.30

u/l

1.09

1772

14527

Hypoplasia of dental enamel

249

3.47

17.60

3.5

2.5

40.25

29.71

u/l

0.75

204

Macular pucker

893

6652

1.39

17.55

2.6

2.5

37.33

51.60

u/l

0.70

750

5619

Dislocation, sprain and strain of joints and ligaments at neck level

854

6308

1.40

17.47

3.3

2.5

33.05

46.17

u/l

0.98

729

5383

Pedestrian injured in transport accident

410

2645

1.63

17.44

3.3

2.5

43.55

56.83

u/l

0.29

352

2249

Sensorineural hearing loss

3411

26427

0.85

17.42

2.6

49.82

51.27

u/l

0.05

2866

22361

Carcinoma in situ of skin of lower limb, including hip

154

751

2.29

17.42

2.6

2.3

30.20

33.43

u/l

0.73

130

621

Bacterial, viral and other infectious agents

481

3213

1.57

17.39

3.4

2.8

43.93

54.75

u/l

0.28

406

2777

Use of pramipexole

1218

9479

1.32

17.33

3.0

2.5

35.90

44.15

u/l

0.83

1028

8016

Type 1 diabetes, wide definition, subgroup 1

1093

8359

1.34

17.33

6.1

2.2

27.07

32.77

u/l

6.05

798

7216

Childhood asthma (age<16)

638

3474

1.47

17.29

2.6

2.3

31.03

60.03

u/l

1.14

539

2995

Molar incisor enamel hypoplasia

215

1114

1.97

17.21

2.7

2.3

32.67

29.83

u/l

0.45

177

904

Pneumonia due to other infectious organisms, not elsewhere classified

201

1073

2.02

17.19

4.1

2.2

37.17

87.13

u/l

0.58

179

913

Other disorders of breast

776

5672

1.42

17.12

2.4

2.3

35.07

37.76

u/l

0.37

669

4724

Hallux valgus (acquired)

1866

10860

1.25

17.01

2.3

2.5

36.68

45.30

u/l

0.98

1572

9160

Alzheimer disease, excluding more controls

947

4565

1.38

17.00

2.1

2.4

69.30

58.22

u/l

0.14

762

3875

Arthropathies in other diseases classified elsewhere

223

1237

1.94

16.96

7.0

2.5

38.39

77.45

u/l

0.50

181

1049

Atrophic disorders of skin

914

6862

1.38

16.95

2.6

2.4

32.89

46.10

u/l

1.15

754

5794

Procedures for purposes other than remedying health state

160

796

2.20

16.90

2.6

2.1

32.34

39.35

u/l

1.06

138

667

Other sleep disorders

625

4411

1.47

16.85

3.0

2.5

58.17

49.04

u/l

0.15

532

3756

Benign neoplasm: Other and unspecified parts of small intestine

119

532

2.55

16.81

3.7

2.4

38.35

34.10

u/l

0.30

104

437

Cardiac arrest

323

1665

1.72

16.81

3.3

2.3

63.94

40.73

u/l

0.39

279

1441

Inguinal hernia, bilateral

539

3704

1.51

16.79

2.6

41.73

53.44

u/l

0.38

470

3166

Other disorders of penis

537

3686

1.52

16.77

3.0

2.9

37.63

59.38

u/l

0.88

450

3222

Malignant neoplasm of oral cavity

194

1031

2.03

16.75

2.9

2.3

168.04

40.99

u/l

0.48

162

850

Other salmonella infections

214

1175

1.96

16.74

3.7

2.3

35.60

80.24

u/l

0.57

189

1003

Inflammatory diseases of the central nervous system

470

3151

1.56

16.73

2.8

2.6

69.93

55.32

u/l

0.18

411

2674

Senility

241

3.23

16.73

2.5

2.0

31.85

34.09

u/l

0.21

195

Hallux rigidus

766

5612

1.41

16.64

2.3

2.5

45.73

48.48

u/l

0.09

642

4732

Hypoplasia of dental enamel , including avohilmo

204

1058

1.98

16.63

2.8

2.4

33.04

29.85

u/l

0.49

169

858

malignant neoplasm of male genital organs

1291

6052

1.31

16.58

2.4

2.5

35.97

52.27

u/l

1.18

1067

5126

Explicit fungal Sepsis

201

3.72

16.54

5.4

2.3

28.73

33.22

u/l

0.52

169

Other/unspecified disorders of vestibular function

258

1507

1.84

16.52

2.7

2.4

30.47

38.68

u/l

2.70

224

1268

Excessive vomiting in pregnancy

449

2987

1.57

16.51

2.5

2.3

34.14

37.57

u/l

0.32

384

2506

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1009

7704

1.35

16.43

2.7

2.3

35.17

35.83

u/l

0.12

868

6456

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

521

3584

1.53

16.42

2.8

2.5

36.97

52.78

u/l

0.55

422

3037

Dysplasia of cervi uteri

1217

6650

1.32

16.39

2.4

36.69

37.90

u/l

0.13

1013

5621

Gonarthrosis [arthrosis of knee](FG)

4365

21978

1.16

16.28

2.6

64.99

44.47

u/l

0.59

3652

18670

Amputation of foot

169

871

2.13

16.28

4.9

2.5

35.08

35.14

u/l

0.00

137

737

Explicit fungal Sepsis, including avohilmo

203

3.67

16.27

5.4

2.3

28.73

33.17

u/l

0.52

170

Malignant neoplasm of rectosigmoid junction

105

447

2.61

16.24

2.3

2.1

31.95

35.24

u/l

0.57

356

Benign thyroid growths and nodules

1845

14069

1.24

16.22

2.5

2.4

40.57

45.70

u/l

0.47

1524

11858

Malignant neoplasm of other connective and soft tissue

148

726

2.22

16.16

2.5

2.1

51.37

34.20

u/l

0.48

119

595

Asthma and opportunity respiratory infection

278

1668

1.79

16.15

2.4

2.3

33.31

37.71

u/l

0.73

239

1409

Contusion of other and unspecified parts of foot

309

1897

1.72

16.15

3.3

2.4

29.12

40.89

u/l

3.48

262

1593

Benign neoplasm: Kidney

223

1259

1.92

16.14

2.4

38.82

37.49

u/l

0.09

198

1065

Exclusions for E4_PCOS_BROAD

947

7187

1.36

16.11

3.1

2.6

60.87

44.20

u/l

0.28

809

6111

475

3215

1.54

16.10

4.5

2.6

48.24

55.49

u/l

0.18

435

2732

Atopic dermatitis, strict definition

1610

12743

1.26

16.10

2.7

2.6

36.47

41.64

u/l

0.61

1374

10859

Other/unspecified synovitis and tenosynovitis

620

4409

1.46

16.02

2.8

2.4

33.44

41.75

u/l

2.92

514

3729

Acquired haemolytic anaemia

156

786

2.18

16.00

3.9

2.4

40.33

96.10

u/l

0.44

141

660

Other and unspecified disorders of white blood cells

242

1401

1.86

15.99

3.0

2.5

35.55

75.12

u/l

0.59

210

1166

Pedestrian injured in collision with pedal cycle

192

1037

2.00

15.95

3.1

2.5

53.58

87.26

u/l

0.29

165

869

Other puerperal infections

413

2719

1.59

15.89

2.2

2.3

36.38

34.94

u/l

0.09

353

2275

Hypermobility syndrome

307

1892

1.72

15.86

2.4

2.3

30.96

37.08

u/l

1.79

244

1560

Melanocytic naevi of trunk

678

4911

1.43

15.84

2.8

2.5

35.43

49.06

u/l

0.73

588

4141

Entropion and trichiasis of eyelid

455

3063

1.55

15.81

2.6

2.4

35.55

40.60

u/l

0.90

379

2562

Arthropathy in ulcerative colitis

400

2.73

15.80

2.8

2.4

56.15

152.56

u/l

0.37

339

Other disorders starting during childhood or adolescence

276

1634

1.76

15.80

2.4

28.53

61.93

u/l

0.57

230

1353

Assault by other specified means

317

2.98

15.79

3.3

2.4

30.96

29.82

u/l

0.19

266

Burns and corrosions

748

5504

1.40

15.78

2.9

2.7

38.41

50.03

u/l

0.61

631

4723

L04AC Interleukin inhibitors

379

2460

1.62

15.76

3.1

2.6

35.82

59.06

u/l

0.64

327

2118

UC patients in KELA-register (code 208), prior to 1994

255

1505

1.82

15.76

3.8

2.6

49.09

43.29

u/l

0.16

232

1278

Pyoderma gangrenosum

257

3.30

15.71

3.4

2.6

42.31

29.77

u/l

0.78

210

Contact with and exposure to communicable diseases

1030

13233

0.76

15.70

2.6

33.06

42.21

u/l

1.56

885

11302

Benign neoplasm: Rectosigmoid junction

248

1456

1.83

15.67

2.7

2.4

35.07

37.84

u/l

0.48

204

1227

Other renal tubulo-interstitial diseases

145

714

2.21

15.66

3.2

2.4

33.68

37.53

u/l

0.48

121

588

Diseases of tongue

334

2105

1.67

15.62

2.8

2.4

31.92

40.96

u/l

2.03

278

1796

Chronic conjunctivitis

186

1002

2.01

15.59

2.9

2.4

104.82

40.58

u/l

0.42

164

836

Inguinal hernia

3159

18030

1.18

15.58

2.7

61.35

47.23

u/l

0.28

2713

15384

Later onset COPD

1452

9348

1.28

15.56

2.6

2.4

35.87

48.73

u/l

0.93

1223

7870

Gingival hyperplasia

225

1287

1.88

15.54

4.0

2.4

40.34

38.96

u/l

0.09

193

1079

Recurrent dislocation and subluxation of joint

380

2470

1.61

15.53

2.5

2.6

32.28

58.11

u/l

0.74

330

2135

Adenocarcinoma and Papillary adenocarcinoma of kidney

333

2.89

15.38

2.8

2.3

41.95

50.29

u/l

0.25

265

Heart failure and hypertrophic cardiomyopathy

125

591

2.36

15.33

2.6

33.10

34.22

u/l

0.15

108

493

Unspecified visual impairment (binocular)

109

487

2.50

15.27

2.9

2.4

30.12

31.77

u/l

0.15

397

Cystic disease of liver

229

3.47

15.26

6.4

2.4

40.53

32.23

u/l

0.78

186

Malignant neoplasm of ovary

265

1591

1.77

15.23

2.1

2.2

375.71

35.88

u/l

0.52

219

1320

Periapical abscess

2631

22441

1.19

15.21

2.9

2.6

39.05

46.07

u/l

0.84

2211

19123

Malignant neoplasm of prostate, including Hilmo

1258

5826

1.30

15.16

2.3

2.4

36.24

44.58

u/l

1.34

1044

4914

Other and unspecified medical devices associated with adverse incidents

183

3.91

15.15

3.8

2.8

48.30

31.53

u/l

0.40

146

Chronic lymphocytic leukaemia

162

839

2.08

15.15

2.1

2.2

33.85

38.34

u/l

0.68

143

675

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

162

839

2.08

15.15

2.1

2.2

33.85

38.34

u/l

0.68

143

675

Chronic lymphocytic leukaemia, helper endpoint

162

839

2.08

15.15

2.1

2.2

33.85

38.34

u/l

0.68

143

675

Retinal detachments and breaks

1947

16199

1.23

15.05

2.9

2.5

37.46

50.34

u/l

1.52

1648

13764

Contact with heat and hot substances

310

1943

1.69

15.01

2.9

2.6

33.75

65.29

u/l

0.69

256

1650

Assault by blunt object

103

453

2.54

14.94

3.3

2.8

26.87

146.55

u/l

0.60

391

Respiratory insufficiency

388

2542

1.58

14.93

2.7

2.3

31.93

61.75

u/l

0.91

333

2119

Blepharochalasis

1586

12949

1.25

14.92

2.6

2.5

36.49

53.11

u/l

1.61

1323

10882

Malignant neoplasm of tongue, including Hilmo

148

748

2.14

14.90

3.1

2.3

41.33

42.92

u/l

0.06

126

606

Acute posthaemorrhagic anaemia

200

1115

1.92

14.90

5.2

2.4

29.54

35.85

u/l

2.31

169

927

Other neurotic disorders

267

1616

1.75

14.88

3.4

2.4

31.81

41.20

u/l

1.69

219

1362

Ehlers-Danlos syndrome, including avohilmo

412

2.64

14.84

3.0

2.4

31.10

31.80

u/l

0.07

337

Other hearing loss

1621

12843

1.25

14.82

2.6

2.5

37.31

52.20

u/l

1.30

1344

10810

Injury of eye and orbit

754

5612

1.38

14.72

3.3

2.6

39.01

47.53

u/l

0.46

657

4812

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

430

2905

1.54

14.67

2.5

2.6

32.26

54.65

u/l

0.76

371

2502

Keratitis

2002

16742

1.22

14.60

3.0

2.6

42.83

46.76

u/l

0.19

1682

14265

Disorder of the sleep-wake schedule

123

588

2.31

14.54

2.7

2.5

24.61

31.95

u/l

4.38

499

Short Achilles tendon (acquired)

939

0.19

14.54

1.5

2.1

57.43

38.41

u/l

0.30

797

Olecranon bursitis

337

2169

1.63

14.53

3.1

2.6

61.40

41.47

u/l

0.33

283

1857

Malignant neoplasm of other and ill-defined sites, including Hilmo

425

2.54

14.53

3.3

2.1

42.82

33.31

u/l

0.51

337

Operations 2 for CAVS

1525

11951

1.25

14.53

2.6

2.5

61.14

50.07

u/l

0.25

1276

10051

Calcific aortic valvular stenosis, diagnosis (helper)

1525

11951

1.25

14.53

2.6

2.5

61.14

50.07

u/l

0.25

1276

10051

Assault by unspecified means

136

675

2.20

14.51

3.5

2.7

34.55

108.29

u/l

0.54

117

590

Menorrhagia

1740

7941

1.24

14.47

2.7

2.4

35.12

41.68

u/l

1.11

1435

6707

Calcific aortic valvular stenosis, including rheumatic fever

1531

11996

1.25

14.46

2.6

2.5

61.25

49.97

u/l

0.26

1279

10089

Thyroiditis, ILD-related definition

628

4562

1.43

14.45

2.8

2.4

34.52

48.14

u/l

0.67

524

3807

Macular cyst

198

1118

1.92

14.44

2.7

2.4

31.79

40.07

u/l

1.14

164

947

Calcific aortic valvular stenosis, operated

1526

11970

1.25

14.42

2.6

2.5

61.14

50.08

u/l

0.25

1276

10067

Calcific aortic valvular stenosis

1526

11970

1.25

14.42

2.6

2.5

61.14

50.08

u/l

0.25

1276

10067

Urethritis and urethral syndrome

133

655

2.20

14.39

4.3

2.4

30.85

44.68

u/l

1.16

118

550

Dislocation, sprain and strain of joints and ligaments of thorax

211

1211

1.86

14.35

3.4

2.4

33.44

81.99

u/l

0.65

189

1028

Otitis externa, unspecified

627

4560

1.42

14.33

3.0

2.6

33.69

48.64

u/l

0.78

526

3870

Vitamin deficiency

277

1709

1.72

14.33

3.7

2.5

36.09

39.57

u/l

0.34

239

1454

Vitamin deficiency, wide

277

1709

1.72

14.33

3.7

2.5

36.09

39.57

u/l

0.34

239

1454

Carcinoma in situ of skin of upper limb, including shoulder

167

898

2.04

14.31

3.1

2.3

31.51

34.00

u/l

0.57

139

735

Infarction of spleen

199

3.53

14.21

6.3

2.7

35.18

32.88

u/l

0.14

161

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

432

2954

1.53

14.09

3.5

2.4

36.62

55.06

u/l

0.57

370

2483

Benign neoplasm of urinary organs

277

1720

1.71

14.09

2.5

2.4

38.02

38.21

u/l

0.01

244

1438

Foreign body entering into or through eye or natural orifice

434

2967

1.53

14.08

2.4

2.7

44.31

55.06

u/l

0.25

367

2547

Postmenopausal atrophic vaginitis

1394

6097

1.28

14.05

2.3

2.5

38.74

43.71

u/l

0.53

1172

5139

Conduct disorder

132

654

2.18

14.04

3.2

2.5

28.54

35.97

u/l

1.64

110

557

Scoliosis

446

3061

1.51

14.04

2.4

2.2

36.00

55.64

u/l

0.65

366

2572

244

3.19

14.04

4.3

2.4

33.42

33.32

u/l

0.01

205

Idiopathic urticaria

144

739

2.13

14.03

2.5

2.3

31.04

34.94

u/l

0.65

121

626

Disorders of optic nerve and visual pathways

518

3664

1.47

14.02

3.3

2.5

34.16

50.97

u/l

0.69

437

3103

Endometriosis of pelvic peritoneum

807

5545

1.36

13.98

2.4

158.37

38.06

u/l

0.59

685

4699

Carcinoma in situ of skin of ear and external auricular canal

100

448

2.48

13.90

2.4

2.5

27.82

33.77

u/l

1.84

366

Other or ill-defined heart diseases

290

1818

1.67

13.89

3.1

2.5

39.82

67.94

u/l

0.53

254

1567

Other/unspecified reactive arthropathies

365

2419

1.59

13.89

2.8

2.5

34.04

60.58

u/l

0.73

313

2055

Glaucoma suspect

1402

17177

0.80

13.87

2.7

2.5

131.41

48.34

u/l

0.64

1141

14497

Benign neoplasm of ovary

920

7121

1.33

13.85

2.7

2.4

38.29

38.42

u/l

0.01

786

5952

Other hammer toe(s) (acquired)

935

6578

1.33

13.83

2.5

38.75

50.42

u/l

0.73

791

5518

Unspecified misadventure during surgical and medical care

331

2153

1.63

13.81

3.8

2.5

160.44

61.89

u/l

0.51

297

1824

Dissection of aorta

184

1026

1.92

13.80

2.7

2.5

54.82

84.51

u/l

0.24

158

842

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

110

515

2.37

13.78

5.1

2.2

44.87

30.41

u/l

1.03

425

Giant cell arteritis

249

1517

1.76

13.75

2.7

2.3

30.72

37.57

u/l

2.80

201

1253

Bicipital tendinitis

273

1697

1.70

13.74

2.6

2.4

38.39

42.71

u/l

0.34

217

1447

Bronchiectasis

423

2895

1.53

13.71

2.4

33.46

41.36

u/l

1.98

356

2417

Hyperaldosteronism

177

982

1.96

13.69

2.6

32.22

41.71

u/l

1.15

147

828

Other/unspecified soft tissue disorders related to use, overuse and pressure

182

1016

1.92

13.64

2.4

2.2

33.42

43.24

u/l

1.10

158

857

Panniculitis affecting regions of neck and back

203

1168

1.85

13.61

3.4

2.3

33.81

82.92

u/l

0.65

177

1009

Malignant neoplasm of prostate

1218

5714

1.29

13.60

2.3

2.4

36.26

44.82

u/l

1.35

1010

4818

Cauda equina syndrome

442

2.50

13.60

3.4

2.4

31.13

32.10

u/l

0.12

362

Spirochaetal infections, other/unspecified

494

3491

1.48

13.54

2.1

2.5

34.51

53.23

u/l

0.74

419

2937

Polycystic ovarian syndrome, consortium definition

4156

21066

1.15

13.52

2.7

2.4

36.40

40.85

u/l

1.20

3434

17783

Other noninfective disorders of lymphatic vessels and lymph nodes

217

1278

1.81

13.52

2.8

2.3

45.09

43.15

u/l

0.06

182

1072

Other diseases of the respiratory system

1048

8257

1.30

13.52

2.9

2.5

35.05

44.53

u/l

0.82

893

6953

Other respiratory disorders and diseases

1048

8257

1.30

13.52

2.9

2.5

35.05

44.53

u/l

0.82

893

6953

Allergic rhinitis

1654

13507

1.23

13.50

2.3

2.6

37.06

42.57

u/l

0.69

1393

11527

Psoriatic and enteropathic arthropathies

641

4726

1.40

13.49

2.9

2.6

40.17

49.49

u/l

0.42

553

4032

Liposarcoma, including Hilmo

277

2.93

13.44

2.9

2.2

65.95

32.37

u/l

0.53

225

Hypothyroidism, strict autoimmune, 3 medication purchases required

4863

29193

1.13

13.39

2.5

37.48

48.85

u/l

1.87

4016

24835

Conductive and sensorineural hearing loss

3687

27761

0.87

13.37

2.7

2.6

48.25

50.83

u/l

0.10

3100

23508

Gout due to impairment of renal function

339

2.73

13.35

4.6

2.6

43.26

34.91

u/l

1.08

286

LSIL lesion of the cervix uteri, vagina or vulva

742

5607

1.36

13.21

2.5

2.4

40.78

35.98

u/l

0.38

622

4724

Blood alcohol or alcohol intoxication level

150

797

2.04

13.20

4.4

2.7

26.73

101.75

u/l

0.67

121

674

Malignant neoplasm of breast, ER-negative, including Hilmo

1064

7870

1.29

13.20

2.2

38.68

39.82

u/l

0.09

901

6504

Orchitis and epididymitis

475

3345

1.47

13.07

2.8

2.7

40.97

74.86

u/l

0.73

412

2913

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

120

593

2.22

13.07

2.7

2.4

31.95

31.71

u/l

0.03

102

489

2227

17057

1.19

13.07

2.6

2.5

34.99

47.51

u/l

1.99

1879

14311

Trigger finger

778

5928

1.35

13.04

3.0

2.4

39.26

41.85

u/l

0.27

629

5037

Other/unspecified enthesopathies, not elsewhere classified

441

3067

1.49

13.04

3.0

2.4

36.35

41.56

u/l

0.60

378

2591

Coxarthrosis

2789

15533

1.17

13.02

2.7

2.5

69.71

48.35

u/l

0.38

2346

13167

Perineal laceration during delivery

511

5733

0.70

12.99

2.0

2.4

44.08

36.68

u/l

0.34

438

4850

Psoriasis vulgaris

999

7872

1.30

12.99

3.1

2.6

35.56

47.05

u/l

0.97

883

6700

Thyrotoxicosis with toxic multinodular goitre

340

2257

1.59

12.94

2.4

32.24

37.65

u/l

1.53

282

1895

Disorders of oesophagus in diseases classified elsewhere

132

677

2.13

12.94

4.0

2.3

37.65

32.90

u/l

0.68

114

562

Trigeminal neuralgia

341

2264

1.58

12.92

3.0

2.4

36.18

39.91

u/l

0.29

287

1909

Other obstructive and reflux uropathy

227

1368

1.75

12.82

2.9

2.4

34.63

40.29

u/l

0.65

197

1140

Social disorders starting during childhood or adolecense, excluding more controls

169

3.40

12.82

2.7

2.8

29.17

33.59

u/l

0.60

147

Other and unspecified injuries of lower leg

423

2930

1.50

12.82

2.9

2.4

31.68

53.70

u/l

0.74

354

2483

!Aliquae complicationes praecoces traumatis

259

1620

1.69

12.80

3.6

2.7

31.73

67.89

u/l

0.66

220

1384

Early complications of trauma

259

1620

1.69

12.80

3.6

2.7

31.73

67.89

u/l

0.66

220

1384

Abdominal aortic aneurysm (AAA)

453

3142

1.47

12.78

2.5

34.65

36.22

u/l

0.29

394

2603

Acute appendicitis, with complications

1025

8115

1.30

12.78

2.7

2.6

36.96

47.35

u/l

0.90

888

6909

Post-traumatic wound infection, not elsewhere classified

172

966

1.92

12.74

4.1

2.6

31.82

88.89

u/l

0.59

147

814

Specific development disorders of speech and language

308

1929

1.61

12.62

2.6

2.4

27.84

60.52

u/l

0.70

270

1601

Chronic diseases of tonsils and adenoids

4478

25190

1.13

12.61

2.7

2.6

48.96

50.49

u/l

0.04

3822

21485

Vasculitis limited to skin, not elsewhere classified

159

875

1.96

12.59

2.6

2.3

41.16

36.71

u/l

0.24

146

729

Single delivery by forceps and vacuum extractor

496

4119

0.70

12.56

2.1

2.8

44.60

39.24

u/l

0.23

423

3488

Ill-defined and unknown causes of mortality

236

3761

0.61

12.49

2.7

2.5

36.93

39.78

u/l

0.33

180

3169

Isolated proteinuria

169

950

1.92

12.49

3.6

2.4

87.23

89.86

u/l

0.01

153

807

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1618

13472

1.22

12.47

2.8

2.7

55.79

43.76

u/l

0.34

1356

11531

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

123

623

2.14

12.44

2.8

2.3

31.22

42.64

u/l

1.34

109

510

Other encephalitis

166

929

1.92

12.43

2.4

2.5

37.29

37.92

u/l

0.02

149

770

Other and unspecified myopathies

468

3326

1.46

12.40

3.3

2.5

83.43

53.66

u/l

0.27

387

2803

Superficial injury of shoulder and upper arm

651

4874

1.38

12.40

2.6

31.64

47.71

u/l

0.97

562

4146

Temporal arteritis

215

1300

1.77

12.29

2.6

2.3

30.54

37.18

u/l

2.39

178

1076

Amoebiasis, including avohilmo

237

3.00

12.27

2.5

29.75

237.08

u/l

0.50

198

Somnolence

402

2.47

12.26

3.4

2.6

30.14

32.59

u/l

0.28

332

Complications of the puerperium, not elsewhere classified

227

1387

1.73

12.24

2.2

2.3

29.75

37.93

u/l

2.34

191

1148

Vulvovaginal ulceration/inflammation in other diseases

370

2521

1.53

12.24

2.8

2.3

40.46

36.28

u/l

0.15

315

2101

Car occupant injured in noncollision transport accident

209

1253

1.77

12.21

3.3

2.5

29.97

75.54

u/l

0.64

183

1070

L02BA Anti-estrogens

889

6969

1.31

12.16

2.3

2.4

49.32

39.03

u/l

0.48

755

5844

Ganglion

1093

8768

1.27

12.09

2.5

2.4

58.16

39.28

u/l

0.38

899

7456

Exposure to other and unspecified forces of nature

206

3.21

12.09

3.9

2.6

42.33

33.91

u/l

0.38

172

Rare circulating lymphoid malignancy, including Hilmo

151

825

1.95

12.06

4.3

2.2

30.94

39.89

u/l

0.82

128

662

Pediculosis, acariasis and other infestations, including avohilmo

920

7240

1.30

12.04

3.0

2.6

32.76

43.68

u/l

0.91

767

6200

Other disorders of adrenal gland

256

1621

1.67

12.04

3.5

2.3

33.95

70.82

u/l

0.65

221

1352

Malignant neoplasm of larynx

377

2.45

11.96

2.4

2.2

36.73

32.61

u/l

0.30

304

Giant cell arteritis with polymyalgia rheumatica

215

1310

1.76

11.95

2.6

2.4

30.54

37.13

u/l

2.45

178

1085

Viral infections of the central nervous system, including avohilmo

418

2932

1.49

11.95

3.0

2.5

32.63

55.34

u/l

0.77

354

2498

Sequelae of intentional self-harm, assault and events of undetermined intent

201

3.19

11.92

5.9

2.6

35.66

32.27

u/l

0.35

164

Nail disorders

462

3301

1.45

11.90

3.9

2.5

33.83

53.38

u/l

0.74

389

2815

Thiazolidinediones

590

4388

1.39

11.88

3.1

2.5

31.89

42.43

u/l

4.13

474

3782

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

133

3.93

11.88

1.9

2.9

25.25

28.63

u/l

0.67

106

Infliximab

131

690

2.05

11.84

2.4

2.6

35.25

102.09

u/l

0.48

124

595

Burns and corrosions of external body surface, specified by site

571

4223

1.40

11.83

2.7

2.6

33.37

50.31

u/l

0.86

480

3610

Intracranial and intraspinal abscess and granuloma

364

2.54

11.83

4.4

2.6

198.46

32.26

u/l

0.50

307

Shoulder region

100

481

2.31

11.80

3.7

2.5

28.66

36.01

u/l

1.35

403

Pure hyperglyceridaemia

135

720

2.02

11.77

3.0

2.6

64.13

39.55

u/l

0.58

112

603

Malignant neoplasm of anus and anal canal

154

3.60

11.76

2.7

1.9

30.39

36.05

u/l

0.42

126

Other immunodeficiencies

346

2.57

11.76

2.9

2.4

30.51

33.17

u/l

0.23

287

Redundant prepuce, phimosis and paraphimosis

1039

8180

1.28

11.73

3.2

2.9

40.90

61.73

u/l

1.14

889

7144

Sequelae of injuries of head

287

1875

1.61

11.72

3.1

2.7

34.30

44.12

u/l

1.47

244

1600

Coronary artery bypass grafting

1279

7733

1.25

11.72

2.6

2.5

37.97

46.58

u/l

0.95

1060

6561

Injuries involving multiple body regions

217

1329

1.73

11.69

3.4

2.5

38.36

74.10

u/l

0.49

181

1138

Focal epilepsy

1101

8877

1.27

11.69

2.7

2.6

40.57

43.83

u/l

0.18

931

7524

Nasal polyp

979

7795

1.29

11.67

2.5

2.7

38.66

50.23

u/l

0.64

823

6647

Pyogenic arthritis

344

2333

1.54

11.65

3.2

2.6

242.41

59.31

u/l

0.43

295

1982

Malignant neoplasm of breast, HER-negative

969

7395

1.29

11.64

2.2

39.07

39.84

u/l

0.05

814

6114

Ehlers-Danlos syndrome

329

2.61

11.63

3.2

2.4

31.23

31.45

u/l

0.02

271

Benign neoplasm: Oesophagus

380

2.49

11.63

2.7

2.5

37.25

31.59

u/l

0.61

319

Nonalcoholic steatohepatitis

312

2.69

11.60

3.0

2.4

30.33

32.88

u/l

0.22

261

Other follicular disorders

403

2822

1.49

11.60

3.3

2.5

36.88

56.35

u/l

0.58

348

2404

Cardiomyopathy in other diseases

160

3.47

11.60

2.1

2.0

479.45

30.17

u/l

0.49

133

Hypocalcemia

145

798

1.97

11.58

4.3

2.4

32.88

41.82

u/l

0.78

128

670

Complications predominantly related to the puerperium

1319

10851

1.24

11.58

2.4

33.51

37.84

u/l

1.18

1109

9155

Dislocation, sprain and strain of joint and ligaments of hip

217

1334

1.73

11.57

2.4

2.5

53.82

36.05

u/l

0.40

176

1121

Pregnancy with abortive outcome

3644

16796

1.14

11.55

2.4

34.40

41.70

u/l

2.58

3074

14088

Superficial injuries involving multiple body regions

159

898

1.90

11.55

3.6

2.5

39.71

86.94

u/l

0.43

133

768

Prophylactic surgery

233

2.95

11.54

3.2

2.1

30.82

32.21

u/l

0.11

197

Skin changes due to chronic exposure to nonionizing radiation

2086

16169

1.19

11.52

2.6

2.5

34.80

47.53

u/l

1.91

1764

13569

Spondylolisthesis/Spondylolysis

940

7460

1.29

11.52

2.7

2.4

37.00

50.60

u/l

1.21

786

6359

All dysplastic lesions of the cervix uteri, vagina or vulva

1507

12248

1.22

11.49

2.6

2.4

37.26

38.23

u/l

0.12

1260

10362

Abnormal findings on examination of urine, without diagnosis

242

1531

1.67

11.45

3.5

2.5

73.31

71.63

u/l

0.01

214

1294

Hypertrophic cardiomyopathy

233

1463

1.69

11.44

3.0

2.5

137.74

40.94

u/l

0.47

202

1231

Postpartum care and examination

357

3252

0.67

11.43

2.9

2.5

33.98

37.82

u/l

0.58

314

2762

Family history of malignant neoplasm

598

4478

1.38

11.43

2.8

2.3

43.61

48.69

u/l

0.17

535

3758

Other and unspecified haemorrhagic conditions

102

500

2.24

11.41

3.0

2.5

36.00

34.24

u/l

0.13

413

Calcinosis cutis

5.99

11.39

2.7

3.5

32.33

28.18

u/l

0.34

Pneumonia derived septicemia

193

1155

1.78

11.38

3.4

2.5

36.49

77.74

u/l

0.48

155

963

Collapsed vertebra, not elsewhere classified

223

2.97

11.36

2.6

2.0

33.00

34.41

u/l

0.10

188

Viral conjunctivitis

133

716

2.01

11.33

2.8

2.4

32.44

101.16

u/l

0.52

119

614

Other injuries of lower limb, level unspecified

334

2.59

11.32

3.6

2.5

75.79

32.36

u/l

0.42

284

Hypotension due to drugs

442

2.32

11.29

3.0

2.5

32.44

33.14

u/l

0.05

367

Nonischemic cardiomyopathy

512

3749

1.41

11.28

2.7

2.6

37.00

53.22

u/l

0.65

429

3199

Other ill-defined and unspecified causes of mortality

215

3414

0.61

11.27

2.7

2.5

37.65

39.60

u/l

0.19

162

2864

Mental retardation, excluding more controls

175

980

1.81

11.26

2.4

26.97

42.45

u/l

2.44

136

827

Other and unspecified aplastic anaemias

353

2.51

11.23

4.1

2.5

30.49

170.62

u/l

0.51

293

Complications of other internal prosthetic devices, implants and grafts

229

1437

1.68

11.19

3.4

2.2

38.94

38.27

u/l

0.05

196

1205

Drug-induced headache, not elsewhere classified

181

3.29

11.18

4.0

2.5

31.84

27.94

u/l

0.55

150

Tic and related disorders

299

2.57

11.16

2.3

2.2

162.82

36.27

u/l

0.49

253

Other congenital malformations of skin, including avohilmo

432

3087

1.45

11.14

2.6

2.5

31.57

53.99

u/l

0.82

361

2616

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

201

1223

1.74

11.14

2.8

2.4

33.53

79.73

u/l

0.62

167

1037

Drug-induced osteoporosis with pathological fracture

108

548

2.18

11.10

4.1

2.4

35.23

33.92

u/l

0.14

448

Ingrowing nail

294

1955

1.58

11.10

4.1

2.5

34.11

63.43

u/l

0.63

244

1661

Panniculitis, unspecified

324

2.56

11.01

3.8

2.1

30.88

39.08

u/l

0.86

281

Pain associated with micturition

627

4757

1.36

10.97

2.8

2.4

35.65

49.40

u/l

0.71

536

3969

Eosinophilic disease (BM)

399

2.34

10.95

2.7

2.2

29.05

153.21

u/l

0.52

338

Motor disorders, excluding more controls

287

2.53

10.94

2.2

2.6

24.53

36.34

u/l

3.30

241

Complications of cardiac and vascular prosthetic devices, implants and grafts

117

610

2.07

10.93

4.4

2.3

45.19

33.30

u/l

1.18

108

514

Other and unspecified vasculitis limited to skin

139

768

1.95

10.92

2.7

2.3

43.26

35.54

u/l

0.42

128

641

Malignant neoplasm of larynx, including Hilmo

100

491

2.18

10.92

2.3

2.2

53.50

41.69

u/l

0.25

395

Other and unspecified types of non-Hodgkin lymphoma, hilmo

226

1426

1.68

10.88

2.8

2.4

35.88

39.56

u/l

0.38

198

1196

Caught, crushed, jammed or pinched in or between objects

288

1916

1.57

10.85

3.0

2.7

32.19

66.40

u/l

0.77

252

1646

Other congenital malformations of integument, including avohilmo

106

4.26

10.75

1.9

2.2

31.31

31.45

u/l

0.01

Behavioural disorders

128

691

1.99

10.75

3.2

2.5

28.70

35.19

u/l

1.35

106

583

Synovial cyst of popliteal space [Baker]

385

2713

1.47

10.75

2.6

2.3

49.27

42.12

u/l

0.30

313

2274

Deficiency of other B group vitamins

122

649

2.02

10.74

3.8

2.4

40.73

34.16

u/l

0.44

105

541

Assault by sharp object

109

560

2.12

10.70

4.7

2.8

31.47

125.50

u/l

0.58

488

Actinic keratosis

2018

15773

1.18

10.70

2.6

2.5

34.81

47.31

u/l

1.79

1705

13234

Disorders of continuity of bone

544

4063

1.38

10.68

3.9

2.5

36.17

50.56

u/l

0.63

448

3440

Other and unspecified disorders of adult personality and behaviour

174

3.23

10.63

3.8

2.5

27.86

35.08

u/l

0.63

142

Hyperkinetic disorders (excl. ADHD)

115

592

2.06

10.63

2.7

2.5

27.57

114.68

u/l

0.56

510

Single spontaneous delivery

1710

10650

0.83

10.59

2.3

2.5

36.68

37.78

u/l

0.19

1437

8924

Other noninflammatory disorders of uterus, except cervix

1114

6036

1.26

10.59

2.6

2.5

57.81

43.81

u/l

0.31

926

5089

Speech disturbances, not elsewhere classified

466

3402

1.42

10.58

3.1

2.5

34.52

39.71

u/l

1.26

400

2852

Degeneration of the brain due to alcohol

131

719

1.97

10.58

4.6

2.7

31.48

42.23

u/l

0.91

115

613

Other keratitis

606

4602

1.36

10.57

3.1

2.6

59.88

49.22

u/l

0.17

501

3937

Monoplegia

488

2.21

10.57

3.1

2.4

33.36

36.31

u/l

0.28

411

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

407

2.33

10.57

3.5

2.5

31.47

32.73

u/l

0.14

338

Marginal zone B-cell lymphoma, including Hilmo

453

2.24

10.56

2.5

2.2

31.80

45.46

u/l

0.69

364

Arthropathy in Crohn disease

325

2.52

10.50

3.0

2.6

32.64

30.18

u/l

0.37

262

Adrenocortical insufficiency

202

1251

1.71

10.50

3.5

2.4

35.10

81.50

u/l

0.62

177

1043

Chronic ulcer of skin, not elsewhere classified

361

2527

1.49

10.49

3.8

2.4

34.30

38.64

u/l

0.83

293

2127

Wide developmental disorders, excluding more controls

142

772

1.87

10.46

2.1

2.4

25.93

33.95

u/l

3.34

114

669

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

124

671

2.00

10.46

3.2

2.5

29.55

32.13

u/l

0.40

102

575

Injury of other and unspecified intrathoracic organs

336

2325

1.51

10.41

3.6

2.6

65.53

61.55

u/l

0.05

290

1989

Hypertrophy of breast in women and men

1013

8209

1.26

10.40

2.4

2.5

34.24

38.26

u/l

0.93

868

6885

Other bursopathies

664

5117

1.33

10.37

2.7

2.4

44.92

41.96

u/l

0.19

553

4338

Peroneal tendinitis

107

552

2.10

10.35

2.5

2.1

32.05

128.41

u/l

0.58

470

Burns classified according to extent of body surface involved

308

2.56

10.35

3.7

2.6

32.02

32.54

u/l

0.05

253

Benign neoplasm of meninges

550

4139

1.38

10.35

2.6

2.4

32.64

38.63

u/l

2.15

474

3471

Thyroiditis

383

2720

1.47

10.33

2.3

2.4

45.20

39.00

u/l

0.28

319

2281

Degeneration of nervous system due to alcohol

131

726

1.95

10.27

4.6

2.7

31.48

42.07

u/l

0.89

115

615

Lichen simplex chronicus and prurigo

342

2382

1.50

10.27

3.3

2.4

32.34

60.04

u/l

0.76

292

2020

Benign neoplasm: Other and unspecified parts of mouth

187

1144

1.74

10.27

2.6

2.5

39.01

43.37

u/l

0.30

158

950

Type 1 diabetes, wide definition

1117

9140

1.24

10.25

6.1

2.4

27.35

41.46

u/l

7.69

813

7925

Encephalitis

168

999

1.79

10.24

2.4

37.19

37.28

u/l

0.00

151

834

Benign neoplasm: Anus and anal canal

159

932

1.83

10.23

3.0

2.4

38.87

35.28

u/l

0.30

135

784

Other congenital malformations of circulatory system

154

896

1.85

10.23

2.2

2.5

32.43

44.03

u/l

1.18

131

752

Familial hypercholesterolemia

697

5412

1.32

10.23

3.2

2.5

37.78

62.21

u/l

0.90

577

4586

Superficial injury of neck

124

675

1.98

10.22

2.5

2.4

31.77

108.93

u/l

0.54

100

561

Anaemia in chronic diseases classified elsewhere

144

822

1.89

10.21

6.7

2.5

109.10

101.09

u/l

0.03

124

690

Osteonecrosis due to drugs

504

2.18

10.16

2.7

2.5

27.74

34.69

u/l

1.62

416

Benign neoplasm: Cerebral meninges

504

3756

1.39

10.15

2.6

2.4

32.81

39.03

u/l

2.01

436

3150

Lesion of lateral popliteal nerve

267

1776

1.58

10.14

3.7

2.5

43.59

41.21

u/l

0.14

232

1517

Benign neoplasm: Tongue

162

959

1.81

10.12

2.8

2.5

33.06

42.96

u/l

1.12

141

803

Acute laryngitis and tracheitis

596

4464

1.35

10.08

2.8

2.5

42.62

37.43

u/l

0.39

517

3823

Alzheimer’s disease (Late onset)

1202

8160

1.23

10.05

2.2

2.4

56.28

38.88

u/l

0.40

990

6787

Nonsuppurative otitis media

1206

8635

1.23

10.05

2.9

2.5

71.40

40.53

u/l

0.36

1028

7350

Open wound of hip and thigh

184

1125

1.73

10.03

3.1

2.7

33.18

77.18

u/l

0.52

159

953

Congenital malformations of the musculoskeletal system, not elsewhere classified

498

2.16

10.01

2.8

2.5

32.47

31.48

u/l

0.09

414

Wet age-related macular degeneration

905

7011

1.27

10.00

2.4

41.93

38.16

u/l

0.39

730

5862

Hypertrophy of breast

888

7128

1.28

9.99

2.3

2.4

34.98

37.21

u/l

0.36

759

5956

Benign neoplasm: Appendix

359

2.41

9.98

3.1

2.5

32.75

32.12

u/l

0.07

301

Organic, including symptomatic, mental disorders

2787

17277

1.15

9.97

2.7

2.5

47.31

48.79

u/l

0.05

2304

14580

Muscle strain

190

1173

1.71

9.97

3.1

2.2

31.20

44.29

u/l

2.07

168

1005

LSIL lesion of the cervix uteri

580

4418

1.35

9.91

2.5

2.3

40.17

35.63

u/l

0.29

486

3741

Car occupant injured in other and unspecified transport accidents

975

7910

1.26

9.90

3.2

2.6

108.47

44.17

u/l

0.43

844

6737

Focal epilepsy, strict definition

1005

8179

1.26

9.90

2.7

2.6

40.45

44.57

u/l

0.21

843

6911

Other disorders of the genitourinary system

672

5231

1.32

9.89

2.7

2.4

33.47

39.06

u/l

2.12

579

4380

Ankylosing spondylitis

432

3148

1.42

9.89

2.8

2.5

123.21

54.93

u/l

0.39

366

2727

Drug-induced polyneuropathy

304

2.57

9.86

4.1

2.3

28.16

34.74

u/l

0.85

250

Bursitis of shoulder

146

844

1.85

9.86

2.7

2.2

38.70

45.73

u/l

0.30

122

718

Congenital malformations of the circulatory system

727

5542

1.31

9.84

2.5

2.6

35.86

46.21

u/l

0.59

628

4704

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

199

1247

1.68

9.83

9.9

2.3

31.23

32.14

u/l

0.15

154

1086

Congenital obstruction of the pelviureteric junction

292

2.60

9.82

3.2

2.3

33.20

28.99

u/l

0.70

239

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2662

17234

1.15

9.82

2.6

2.4

35.85

38.75

u/l

0.77

2257

14547

Osteoporosis with pathological fracture (FG)

401

2899

1.44

9.80

3.0

2.4

51.30

39.99

u/l

0.43

352

2423

Hyperplasia of prostate

1785

8568

1.19

9.76

2.7

2.8

38.42

63.55

u/l

1.60

1508

7417

Lymphoid leukaemia

289

1970

1.54

9.76

3.2

2.5

32.04

39.12

u/l

1.61

254

1633

Meralgia paraesthetica

195

1221

1.69

9.75

3.2

2.4

47.32

43.06

u/l

0.10

167

1040

Polymyalgia rheumatica

687

5370

1.32

9.73

2.6

2.4

41.52

39.27

u/l

0.27

594

4502

Dentofacial anomalies [including malocclusion]

4024

28399

1.12

9.69

2.6

34.53

46.10

u/l

2.92

3427

24175

Open wound of shoulder and upper arm

125

695

1.94

9.68

3.0

2.6

37.17

105.37

u/l

0.48

111

582

Additional codes for the location of defect, injury or illness

320

2229

1.50

9.68

3.2

2.5

31.17

40.29

u/l

2.56

253

1889

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

112

600

2.00

9.68

2.8

2.2

39.74

43.20

u/l

0.12

488

Abscess of lung

497

2.13

9.67

4.3

2.5

31.48

34.08

u/l

0.29

424

Liposarcoma

212

2.85

9.66

3.5

2.1

77.60

32.08

u/l

0.53

172

Essential (haemorrhagic) thrombocythaemia

189

1175

1.70

9.65

2.2

2.1

32.46

35.83

u/l

0.68

162

958

Defect, injury or illness of neck

202

2.95

9.62

3.3

2.7

30.76

28.47

u/l

0.50

167

Pollen allergy

946

7560

1.26

9.62

2.3

2.6

35.66

43.87

u/l

0.63

799

6459

Special screening examination for neoplasms

334

2340

1.48

9.61

3.5

2.3

36.56

43.39

u/l

0.66

284

1991

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

418

3049

1.42

9.57

2.6

2.4

35.81

35.08

u/l

0.09

373

2577

Other noninflammatory disorders of vagina

405

2942

1.42

9.50

2.5

2.4

59.32

38.11

u/l

0.73

348

2462

FESS (DNB20)

367

5077

0.70

9.49

2.6

38.77

49.08

u/l

0.49

302

4327

Oligomenorrhoea

182

1124

1.70

9.48

2.8

2.2

35.50

38.81

u/l

0.20

140

940

Benign neoplasm: Ill-defined sites within the digestive system

186

3.03

9.47

3.3

2.6

33.81

28.92

u/l

0.58

155

Contusion of toe(s) without damage to nail

153

906

1.79

9.47

3.5

2.3

35.40

38.66

u/l

0.21

133

760

Renal tubulo-interstitial disorders in diseases classified elsewhere

295

2.51

9.45

4.8

2.6

37.91

33.44

u/l

0.51

249

Mouth breathing

2061

17901

1.17

9.45

2.6

2.7

47.74

48.71

u/l

0.03

1708

15265

Generalized epilepsy

222

1441

1.62

9.44

2.8

2.5

34.00

73.09

u/l

0.60

198

1205

Helminthiases

106

565

2.04

9.42

2.6

37.81

33.17

u/l

0.28

464

Medial epicondylitis

208

1332

1.64

9.41

2.8

2.3

48.96

44.19

u/l

0.11

173

1147

Use of donepezil

685

8286

0.77

9.38

2.1

2.4

70.23

37.88

u/l

0.43

561

6914

Other and unspecified injuries of wrist and hand

213

1372

1.63

9.37

3.1

2.4

30.37

72.24

u/l

0.62

192

1139

Viral encephalitis, not elsewhere classified/unspecified

118

652

1.95

9.35

3.3

2.5

29.92

32.22

u/l

0.33

557

Implicit parasitic Sepsis, including avohilmo

181

3.00

9.31

3.2

2.1

34.24

32.11

u/l

0.21

150

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

332

2339

1.47

9.29

2.6

2.3

36.26

34.78

u/l

0.17

298

1985

Other specified disorders of kidney and ureter

178

1104

1.71

9.28

2.6

2.5

37.09

85.86

u/l

0.57

161

926

Scabies, including avohilmo

761

6051

1.29

9.27

3.0

2.6

30.31

45.31

u/l

1.20

631

5182

Ectopic pregnancy

854

6886

1.27

9.25

2.6

2.4

33.81

38.39

u/l

1.32

727

5782

Other specified and unspecified retinal disorders

197

1253

1.66

9.25

3.2

2.5

43.12

41.10

u/l

0.10

168

1063

Alkalosis

4.80

9.24

7.1

3.0

25.10

26.41

u/l

0.12

Other specified/unspecified soft tissue disorders

252

1689

1.56

9.20

3.2

2.2

34.13

41.21

u/l

1.05

208

1416

Anankastic personality disorder

213

1379

1.62

9.20

3.0

2.4

36.48

75.72

u/l

0.57

182

1169

Suppurative and unspecified otitis media

1903

14577

1.17

9.19

2.8

2.6

57.75

41.87

u/l

0.28

1620

12484

Other symptoms and signs involving the circulatory and respiratory systems

322

2259

1.47

9.19

3.2

2.3

37.06

63.04

u/l

0.64

280

1911

Congenital ovarian cysts

227

1490

1.60

9.18

2.5

2.3

45.38

36.34

u/l

0.29

198

1243

Malignant neoplasm of tonsil and base of tongue, including Hilmo

125

706

1.89

9.15

3.4

2.4

44.88

42.25

u/l

0.10

109

578

Dystonia

294

2038

1.51

9.15

2.3

2.4

32.19

64.23

u/l

0.74

242

1717

Autonomic disorders

141

826

1.82

9.14

2.8

2.4

32.05

34.05

u/l

0.26

125

693

SLE (Finngen)

190

1201

1.67

9.13

2.9

2.2

38.62

40.54

u/l

0.16

162

997

Other abnormalities of plasma proteins

523

2.07

9.09

3.5

2.2

35.80

33.79

u/l

0.14

441

Palmar fascial fibromatosis [Dupuytren]

706

5577

1.29

9.08

2.9

2.5

32.10

41.67

u/l

5.50

586

4707

Sulfasalazine

1469

12498

1.19

9.00

2.5

64.86

45.19

u/l

0.39

1269

10568

Other injuries of upper limb, level unspecified

414

2.21

9.00

2.5

30.55

31.46

u/l

0.13

345

Achilles tendinitis

521

3966

1.35

8.99

2.8

2.4

197.81

52.34

u/l

0.43

443

3415

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

328

2318

1.46

8.95

2.7

2.4

36.41

40.02

u/l

0.41

285

1929

Other disorders of optic [2nd] nerve and visual pathways

334

2380

1.46

8.92

3.4

2.4

32.48

58.38

u/l

0.69

286

2016

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

430

2.18

8.90

4.7

2.4

44.04

31.48

u/l

0.41

355

Other and unspecified acute skin changes due to ultraviolet radiation

136

795

1.83

8.89

2.6

2.4

40.32

33.49

u/l

0.59

112

658

Contact with other hot fluids

173

1077

1.70

8.88

2.8

2.5

31.74

81.62

u/l

0.58

148

918

Recurrent dislocation of patella

257

1740

1.53

8.88

3.0

2.4

28.39

61.91

u/l

0.65

222

1477

Pneumococcal septicemia

180

1132

1.68

8.86

3.1

2.5

38.06

77.33

u/l

0.44

142

947

Foreign body in alimentary tract

285

1976

1.51

8.85

2.8

2.5

77.55

64.21

u/l

0.12

234

1665

Other localized connective tissue disorders

116

650

1.92

8.83

3.0

2.4

28.78

37.35

u/l

1.77

539

Benign mammary dysplasia

728

5806

1.29

8.83

2.5

2.4

41.14

38.94

u/l

0.21

615

4836

Evidence of alcohol involvement determined by blood alcohol level

493

2.08

8.82

3.3

2.6

27.56

134.97

u/l

0.56

414

Contusion of ankle

218

1431

1.59

8.82

3.0

2.4

31.41

37.24

u/l

1.40

179

1209

Drug-induced neutropenia

377

2750

1.43

8.82

3.4

2.5

30.93

55.62

u/l

0.79

331

2327

Persons encountering health services in circumstances related to reproduction

3117

18672

1.13

8.81

2.6

2.8

37.59

44.73

u/l

1.27

2685

15977

Rheumatoid arthritis

1665

12674

1.18

8.79

2.5

37.52

45.79

u/l

1.07

1405

10728

Left bundle-branch block

367

2660

1.43

8.77

2.4

37.78

41.86

u/l

0.52

297

2269

Acute myeloid leukaemia and myelodysplastic syndromes

115

640

1.90

8.77

2.3

2.2

60.42

33.66

u/l

0.49

516

Other otitis externa (chronic)

353

2547

1.44

8.76

2.8

2.5

31.78

57.55

u/l

0.75

293

2146

100

533

2.00

8.75

2.8

2.3

28.01

30.37

u/l

0.50

433

Other misadventures during surgical and medical care

141

838

1.80

8.75

3.8

2.4

39.05

92.81

u/l

0.45

129

706

Carrier of infectious disease

141

837

1.80

8.73

3.2

2.4

35.39

92.29

u/l

0.48

125

695

Benign neoplasm: Parotid gland

399

2941

1.41

8.69

2.7

2.5

39.13

55.09

u/l

0.46

343

2493

Personal history of medical treatment

352

2.29

8.68

3.0

2.4

31.11

31.36

u/l

0.03

288

Viral conjunctivitis, including avohilmo

214

1407

1.60

8.66

2.6

2.4

33.08

72.21

u/l

0.60

183

1189

Generalized epilepsy, strict definition

126

727

1.85

8.61

2.7

2.5

27.82

39.08

u/l

2.38

110

598

Coxarthrosis [arthrosis of hip](FG)

3042

18712

1.13

8.60

2.7

2.6

66.52

45.25

u/l

0.42

2561

15857

Focal brain injury

316

2238

1.46

8.59

2.8

2.5

36.69

39.54

u/l

0.19

260

1931

Otitis media, unspecified

555

3940

1.33

8.59

2.8

2.4

29.40

35.74

u/l

3.74

459

3322

Female genital prolapse

1454

6855

1.20

8.56

2.5

2.4

40.14

42.52

u/l

0.18

1247

5785

Hypertension, Pulmonary Arterial

224

2.62

8.54

2.6

2.3

61.33

31.52

u/l

0.48

186

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

153

932

1.73

8.53

2.9

2.2

31.23

41.30

u/l

1.95

127

778

Acquired absence of organs, not elsewhere classified

402

2.19

8.52

3.5

2.1

32.77

33.88

u/l

0.12

326

Disorders of speech understanding and production

217

1405

1.58

8.52

2.5

2.4

28.13

33.04

u/l

2.25

193

1154

Disorders of porphyrin and bilirubin metabolism

361

2.26

8.51

2.7

29.73

33.08

u/l

0.46

313

Habit and impulse disorders

526

2.01

8.51

3.0

2.9

34.54

133.29

u/l

0.55

446

Malignant neoplasm of tongue

106

583

1.95

8.51

3.0

2.2

34.94

43.88

u/l

0.45

472

Postzoster neuralgia

102

557

1.99

8.50

2.9

2.5

30.08

32.46

u/l

0.42

459

Antenatal screening

1093

5058

1.23

8.48

2.1

2.5

35.97

38.26

u/l

0.38

944

4281

Drug-induced cataract

137

816

1.80

8.46

5.8

2.6

42.19

41.06

u/l

0.06

121

694

Striae atrophicae

362

2.25

8.46

2.3

2.5

31.70

32.03

u/l

0.03

299

Malignant neoplasm of tonsil and base of tongue

105

577

1.95

8.44

3.3

2.4

35.78

44.59

u/l

0.46

474

Tibial collateral bursitis [Pellegrini-Stieda]

329

2.30

8.38

2.4

2.0

30.22

37.13

u/l

0.78

279

Contracture of joint

376

2.20

8.36

3.7

2.4

37.10

39.17

u/l

0.11

313

Alcoholic cardiomyopathy

144

3.10

8.33

3.2

2.9

27.15

36.11

u/l

0.85

123

Other and unspecified injuries of ankle and foot

225

1506

1.56

8.33

2.8

2.4

36.84

38.13

u/l

0.10

193

1264

Dementia in other diseases classified elsewhere

238

1613

1.54

8.32

2.7

2.4

40.97

36.65

u/l

0.23

195

1363

Hyperhidrosis

158

974

1.70

8.31

2.4

2.0

64.67

38.47

u/l

0.41

141

796

Mixed hyperlipidaemia

193

1250

1.61

8.31

2.6

164.75

40.40

u/l

0.48

165

1063

Myositis

139

833

1.77

8.30

2.6

2.3

64.76

45.74

u/l

0.38

120

698

Malignant neoplasm of hypopharynx, including Hilmo

155

2.96

8.29

3.2

1.9

35.75

63.44

u/l

0.43

124

Hypothyroidism due to medicaments and other exogenous substances

393

2.18

8.27

2.9

2.3

42.16

35.04

u/l

0.20

323

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

195

1272

1.62

8.27

2.8

2.5

32.50

41.80

u/l

1.38

173

1066

Dermatographic urticaria

350

2548

1.42

8.23

2.6

2.4

33.23

56.78

u/l

0.66

290

2141

Other disorders of patella

870

7122

1.25

8.20

2.6

35.41

48.61

u/l

1.08

750

6093

Frontotemporal dementia

176

2.90

8.17

2.7

2.6

36.95

35.17

u/l

0.09

141

Sicca syndrome [Sjögren]

445

3369

1.37

8.17

2.4

42.24

39.32

u/l

0.27

373

2828

Fistulae involving female genital tract

535

1.98

8.14

3.0

2.3

35.47

40.34

u/l

0.43

453

Burn and corrosion of wrist and hand

202

1330

1.59

8.14

2.3

2.5

32.08

73.80

u/l

0.61

168

1141

Dronedarone medication

155

962

1.71

8.14

2.7

2.4

40.39

40.94

u/l

0.03

122

816

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

208

1380

1.58

8.13

3.0

2.4

32.81

75.83

u/l

0.65

170

1158

Other and unspecified erythematous conditions

178

1142

1.65

8.12

2.7

2.3

42.82

37.33

u/l

0.33

154

952

Delivery

1760

10679

0.86

8.12

2.3

2.5

36.83

37.77

u/l

0.16

1482

8947

Impaction of intestines

193

2.73

8.11

4.0

2.2

37.70

30.02

u/l

0.55

164

Benign neoplasm: Skin of eyelid, including canthus

789

6412

1.26

8.09

2.5

36.89

46.69

u/l

0.67

631

5399

Persistent delusional disorders

383

2839

1.39

8.05

3.1

2.5

33.65

57.63

u/l

0.77

341

2413

Dermatitis due to substances taken internally

283

1996

1.47

8.03

3.1

2.3

36.56

62.00

u/l

0.52

242

1685

Endometriosis of ovary

817

6265

1.25

8.02

2.3

2.4

38.35

43.32

u/l

0.44

690

5299

Fibrosis of liver

266

2.49

8.00

3.8

2.5

41.94

34.65

u/l

0.38

225

Polyarthritis, unspecified

191

1248

1.61

7.98

2.8

2.5

34.47

39.68

u/l

0.95

146

1054

Psoriatic arthropathies

506

3907

1.33

7.95

2.9

2.6

37.82

52.09

u/l

0.58

437

3330

Drug-induced hypoglycaemia without coma

510

1.99

7.95

5.4

2.4

28.34

35.03

u/l

1.02

420

Amyloidosis, other/unspecified

538

1.95

7.93

2.7

2.6

43.07

34.01

u/l

0.99

461

Viral infections of the central nervous system

364

2684

1.40

7.93

2.9

2.5

33.23

56.20

u/l

0.70

310

2299

Sub-endpoint used in defining T1D endpoints

1459

12333

1.18

7.91

6.0

2.5

41.50

43.51

u/l

0.08

1093

10562

Seborrhoeic keratosis

1309

11170

1.19

7.89

2.7

2.5

35.08

41.91

u/l

2.23

1105

9455

Diabetic retinopathy, excluding more controls

1349

6417

1.20

7.86

5.2

2.8

35.75

45.56

u/l

1.22

1055

5310

Use of antiglaucoma preparations and miotics

397

2971

1.38

7.84

3.3

2.4

38.93

54.20

u/l

0.43

332

2468

Sarcoidosis

663

5307

1.28

7.82

2.8

2.6

40.77

47.57

u/l

0.31

548

4505

Marginal zone B-cell lymphoma

279

2.37

7.82

2.8

2.1

34.37

54.41

u/l

0.60

222

Other retinal artery occlusion

125

741

1.79

7.81

2.9

2.4

36.66

34.43

u/l

0.28

105

622

Nontoxic goitre/thyroid nodule

1526

13191

1.18

7.81

2.5

39.58

44.19

u/l

0.40

1254

11060

Fall involving bed

174

1120

1.63

7.79

2.9

2.4

26.30

35.84

u/l

4.70

152

928

Injury of muscle and tendon at forearm level

107

608

1.89

7.79

4.5

2.8

79.17

36.37

u/l

0.58

525

Nonhereditary hypogammaglobulinemia

361

2.21

7.79

2.6

2.4

34.88

29.32

u/l

0.66

297

Systemic lupus erythematosus

190

1249

1.60

7.78

2.9

2.3

38.62

41.59

u/l

0.26

162

1032

Benign neoplasm of major salivary glands

480

3697

1.34

7.76

2.6

2.5

38.12

52.13

u/l

0.52

411

3110

Shock, not elsewhere classified

253

2.42

7.75

3.7

2.0

28.06

32.58

u/l

0.55

210

Lesion of ulnar nerve

717

5794

1.27

7.74

3.2

2.6

42.50

42.21

u/l

0.01

588

4975

Cardiomyopathies, Secondary/extrinsic

217

2.60

7.74

3.3

2.2

30.29

34.30

u/l

0.30

187

Melanocytic naevi of lower limb, including hip

238

1640

1.52

7.73

2.9

2.4

33.88

66.85

u/l

0.58

207

1377

Spondylopathies (FG)

682

5478

1.27

7.73

2.7

2.6

91.17

47.59

u/l

0.40

576

4685

Acute nasopharyngitis (common cold)

573

4473

1.30

7.70

3.5

2.9

129.19

43.95

u/l

0.53

499

3877

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

256

2.45

7.69

2.9

2.4

31.80

32.97

u/l

0.09

212

All dysplastic lesions of the cervix uteri

1274

10689

1.19

7.69

2.5

2.4

36.87

37.13

u/l

0.03

1068

9062

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

200

2.71

7.69

3.1

2.6

32.78

34.33

u/l

0.10

165

Flatulence and related conditions

240

2.43

7.69

3.7

1.9

31.35

36.68

u/l

0.52

198

Diabetes mellitus in pregnancy

1580

8660

1.17

7.68

2.8

2.3

34.24

38.18

u/l

0.65

1313

7375

Malignant neoplasm of floor of mouth, including Hilmo

223

2.54

7.68

2.9

2.1

50.05

36.48

u/l

0.35

187

Effects of foreign body entering through natural orifice

1226

10428

1.20

7.66

2.6

2.7

48.48

45.53

u/l

0.12

1043

8945

Other acute skin changes due to ultraviolet radiation

179

1165

1.62

7.66

3.0

2.4

37.48

36.97

u/l

0.04

147

969

Myelodysplastic syndrome, including Hilmo

136

826

1.73

7.64

2.4

2.3

48.47

33.86

u/l

0.62

115

665

Other bursitis of elbow

276

2.38

7.63

2.8

2.1

33.31

35.23

u/l

0.17

230

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

194

1287

1.58

7.61

3.0

2.4

33.78

79.51

u/l

0.65

165

1088

Malignant neoplasm of endocrine gland, including Hilmo

381

2845

1.38

7.60

2.7

2.3

36.32

54.39

u/l

0.50

323

2368

Hydrocele

534

4174

1.31

7.57

3.4

2.8

48.15

71.61

u/l

0.56

453

3612

Disorders in reading

518

1.94

7.56

2.6

2.5

27.40

131.91

u/l

0.56

425

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

129

776

1.75

7.55

2.7

2.2

42.13

41.06

u/l

0.05

108

620

Multiple myeloma

129

776

1.75

7.55

2.7

2.2

42.13

41.06

u/l

0.05

108

620

Golimumab

192

1273

1.58

7.55

2.6

50.23

78.60

u/l

0.33

162

1084

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

540

4207

1.31

7.54

2.5

41.33

48.09

u/l

0.21

452

3561

Other disorders of prostate

168

1081

1.63

7.49

2.5

2.6

47.21

44.85

u/l

0.07

139

925

Malignant neoplasm of palate, including Hilmo

183

2.73

7.49

3.0

2.1

584.76

31.86

u/l

0.49

144

Paranoid personality disorder

103

586

1.88

7.48

2.5

30.91

117.56

u/l

0.53

492

Burns and corrosions of multiple and unspecified body regions

123

735

1.78

7.48

3.0

2.6

29.97

104.59

u/l

0.60

630

Alzheimer’s disease, strict definition

1274

8767

1.19

7.48

2.2

2.4

58.85

39.46

u/l

0.48

1049

7302

Glaucoma-related operations

294

2120

1.44

7.46

2.3

2.4

39.70

35.98

u/l

0.27

248

1769

Any dementia, excluding more controls

1761

10547

1.16

7.44

2.3

2.4

52.01

50.35

u/l

0.04

1434

8868

Ovarian dysfunction

367

2733

1.38

7.43

2.6

2.3

39.09

34.13

u/l

0.37

303

2288

Iridocyclitis

1151

9769

1.20

7.42

3.5

2.6

77.36

44.18

u/l

0.55

982

8313

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

418

3179

1.35

7.40

2.6

2.3

35.81

36.96

u/l

0.14

373

2667

Secondary parkinsonism, excluding more controls

122

727

1.76

7.39

2.1

2.4

27.25

36.30

u/l

2.86

103

611

Malignant neoplasm of base of tongue, including Hilmo

227

2.48

7.38

3.9

2.0

63.75

40.01

u/l

0.66

181

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS